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ABSTRACT 
Amoebic gill disease (AGD), caused by Paramoeba sp., is the most serious 
infectious disease infecting sea caged Atlantic salmon, Salmo salar L., in Tasmania, 
Australia. After AGD had been described from Tasmanian salmonids, it also 
emerged as a problem in other countries. Major outbreaks have occurred in France, 
Spain and Ireland and disease, although not to the same extent, has been reported in 
the US and New Zealand. 
In Tasmania at present, treatment consists of a series of freshwater baths given 
during the critical high temperature, high salinity periods of the year. These baths 
last between two to three hours and during a normal summer fish are usually treated 
two to three times. However, there have been summers when up to eight baths have 
been undertaken and it appears recently, that this scenario is becoming more 
common. 
Because of the time and monetary costs associated with AGD, the Tasmanian 
industry is constrained with regards to increasing production and thus it's 
competitiveness in international and domestic markets. Any strategy that would 
eliminate or even reduce the number of baths required would be of substantial 
commercial value. All attempts to find a practical chemotherapeutic agent have been 
fruitless, thus immunisation and/or immunostimulation appeared to offer the best 
hope of providing an alternative treatment strategy. 
This project reports for the first time, the presence of varying degrees of resistance to 
AGD in fish that have been previously infected and then treated using freshwater 
bathing and demonstrates that this resistance can be modulated via the use of the 
immunostimulant, levamisole. It is also the first report of the use and efficacy of 
levamisole as an immunostimulant of the nonspecific defence system of Atlantic 
salmon. 
In order to achieve the results obtained a number of novel and improved 
experimental techniques were developed and are reported here. 
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INTRODUCTION 
Amoebic gill disease (AGD), caused by Paramoeba sp., is the most serious 
infectious disease affecting and constraining the production of sea-caged Atlantic 
salmon, Salmo salar L. and rainbow trout, Oncorhynchus mykiss (Walbaum) 
mariculture in Tasmania (Munday, Foster, Roubal & Lester, 1990). Mortalities of up 
to 2% per day, reaching a total of 50% have been recorded (Munday et al., 1990). 
Indeed, this disease, together with the suboptimal osmoregulatory performance of 
rainbow trout in full salinity seawater, has led to this species being cultured almost 
exclusively in brackish water in Tasmania. Prior to the spring of 1984, when 
significant quantities of Atlantic salmon and rainbow trout were first placed in sea 
cages at various sites in Tasmania, the disease had been previously undescribed in 
Australia (Munday, 1985). 
The Tasmanian Atlantic salmon industry generates more than $100 million 
(Smithies' pers. comm., 1998) annually and is one of the most important industries in 
the State of Tasmania. It is envisaged the industry will expand production to $400 
million by the year 2010. Threats to the expansion of the Australian industry include 
the improving Norwegian and Chilean products, the introduction of imported 
salmonid product to the domestic market and the changes required in husbandry 
techniques to cope with more intensive culture. Strategies in place to deal with these 
threats include production cost minimisation programmes, marketing campaigns to 
promote home-grown product and the conduct of cutting edge research and 
development. At present, however, the greatest threat to the Tasmanian salmonid 
industry comes from AGD. 
In France, AGD has emerged as a major problem in sea-farmed Atlantic salmon, but 
it is of lesser importance in rainbow and brown trout, Salmo trutta L. (Baudin 
Laurencin2 , pers. comm., 1995). Major outbreaks of AGD have been described in 
Atlantic salmon farmed in Ireland (Rodger & McArdle, 1996; Palmer, Carson, 
Ruttledge, Drinan & Wagner, 1997) and the disease has been reported in this species 
in Chile (Groman3 , pers. comm., 2000) and Washington State (Findlay, Zilberg & 
Munday, 2000). Recent outbreaks of AGD in Atlantic salmon in Spain have been 
extremely serious and it has been suggested that these may result in the collapse of 
Smithies T. Executive Officer of the Tasmanian Salmon Farmers Association, Tasmania, 
Australia 
2 Baudin Laurencin, F. CNEVA, Brest, France 
3 Groman, D. Atlantic Veterinary College, University of Prince Edward Island, Prince Edward 
Island, Canada 
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the industry (Echabe4, pers. comm., 2000). Outbreaks in the Pacific salmons, have 
been minor and sporadic, and it may be that these species are inherently resistant to 
the disease. Kent, Sawyer & Hedrick (1988) reported minor out-breaks in coho 
salmon, Oncorhynchus kisutch (Walbaum), in Washington State and California, and 
C. Anderson (pers. comm., 1995) has diagnosed occasional outbreaks in chinook 
salmon, Oncorhychus tshawytscha (VValbaum), held in poor water conditions in New 
Zealand. There have also been reports of AGD due to a Paramoeba sp. occurring in 
turbot (Scophthalmus maximus L.) in Spain (Dykova, Figueras, Novoa & Case!, 
1998) 
In Australia, prior to the introduction of out-of-season smolts, infestations of 
Paramoeba sp. associated with clinical disease were only seen when water 
temperatures rose above 12 °C. However, with the introduction of out-of-season 
smolts clinical disease may occur in these fish even when temperatures drop below 
12°C. It appears that salinity has a more marked effect with clinical disease 
occurring only when salinities approach 35%o. This was demonstrated in the summer 
of 1995 when a major field study failed due to a large freshwater spike that 
maintained the fish in salinities of less than 8%0 for mire than a Week. Clinical 
disease was not experienced on that particular site at all during that summer. While 
this is the situation in Tasmania, in Washington State and Spain strains from some 
species are able to stand significantly lower salinities. Kent et al., (1988) reported 
that the optimal salinity for growth of the Washington State strains was between 15 
and 20%o. Dykova et al., (1998) and Paniagua, Fernandez, Ortega, Parama, 
Sanmartin & Leiro (1998) grew the strains isolated from turbot at 22%o and 10-30%o, 
respectively. Growth at these salinities suggests that these strains are euryhaline. 
At present, amoebic gill disease of salmonids in Tasmania is controlled by a series of 
freshwater baths given during the critical high temperature, high salinity periods of 
the year (ie usually November to April/May). These freshwater baths last between 
two and three hours and during a normal summer fish are usually treated two to three 
times. However, there have been summers when up to eight baths have been 
undertaken and it appears recently that this scenario is becoming more common. 
Freshwater bathing adds significant cost to the production of Tasmanian salmonids. 
Any strategy that would eliminate or even reduce the number of baths required would 
be of substantial commercial value. All attempts to find a practical chemotherapeutic 
agent have been fruitless thus immunization and/or immunostimulation appear to 
offer the best hope of providing an alternative treatment strategy. 
4 Echabe, A. Luso-Hispana de Acuicultura, Puerto de Meiras, Spain 
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The most outstanding feature of amoebic gill disease is the presence of excessive 
mucus on the gills. Microscopically, the most significant pathology is hyperplasia of 
the epithelia leading to fusion of the secondary lamellae and the formation of large 
interlameller vesicles or cysts (Kent et al., 1988; Munday etal., 1990). 
Ultramicroscopically, the pseudopodia of the amoeba can be seen penetrating cavities 
at the surface of the degenerating epithelial cells or even invading cell junctions * 
(Roubal, Lester & Foster, 1989). 
While P. pemaquidensis is regarded as the cause of amoebic gill disease of salmonids 
in Australia (Roubal et al., 1989; Munday etal., 1990), it is also widely described as 
a free-living organism (Page, 1973). Although this amoeba is readily grown on 
artificial media, the cultured organisms have proven to be non-pathogenic to 
salmonids (Kent etal., 1988; Howard & Carson, 1993). Amoebic gill disease can, 
however, be produced in naïve salmonids by cohabitation with diseased fish (Findlay 
et al., 1995), or by exposure to ameobae isolated from the gills of fish with AGD 
(Zilberg & Munday, 2000). This suggests that virulence factors crucial to the 
establishment of disease are absent from the cultured Paramoeba organisms. 
There is a considerable body of anecdotal evidence suggesting that fish that have 
been previously exposed to AGD become relatively resistant to re-infection 
(Percival5 pers. comm., 1995). However, studies using cultured and wild harvested 
Paramoeba sp as immunogens both parenterally and enterically or as polyclonal 
antisera against Paramoeba have failed to provide protection against the disease 
(Alchlaghi etal., 1996; Zilberg & Munday, 2000a). This anomalous situation was 
one of the facets investigated in this study. 
Clarification of the nomenclature used within this study is needed since confusion 
may surround the identification of the parasite that causes amoebic gill disease. 
Using immunoperoxidase staining, Howard and Carson (1993) have shown that their 
isolate is the predominant organism on the gill of diseased salmonids. However, they 
have not speciated the organism. Kent et al., (1988) identified the organism causing 
gill disease in Washington State as Paramoeba pemaquidensis and by using complete 
185 rDNA sequences (2104 bp) for 4 Tasmanian and one each Irish and USA 
P. pemiquidensis strains associated with AGD, Wong & Elliot (2000) have 
confirmed that the Tasmanian Paramoeba strains were identical and the Irish and 
USA strains had >98% similarity. However, the fact that Washington State and 
5 Percival, S. Aquaculture Development and Veterinary Services Pty Ltd, Aliens Rivulet, Tasmania 
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Spanish isolates can grow at 10-30960, which is significantly lower than that tolerated 
by the Tasmanian isolates, suggests that the Paramoeba organisms causing AGD 
consist of a number of subspecies, or possibly even species. As a result, I have used 
Paramoeba sp. when referring to the causative organism of AGD. 
The initial aim of this study was to scientifically test the hypothesis that salmonids 
develop relative resistance to reinfection with Parameoba sp. after one or more 
attacks of AGD. In order to achieve this, a reproducible system for producing AGD 
• in susceptible species has been developed and techniques for quantifying disease and 
immune parameters optimized. 
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The purpose of this review is to provide an outline of the fish immune and defence 
response so as to more adequately demonstrate interactions between Atlantic salmon 
and Paramoeba sp.. The review is not intended to be a comprehensive examination of 
the immune and defence capabilities offish. 
DESCRIPTION OF THE DEFENCE SYSTEMS IN FISH 
Two types of immune responses occur in vertebrates including fish: the specific, that 
combines humoral and cellular components directed against specific antigens and the 
nonspecific component that depends principally on phagocytic cells (cellular 
component) and soluble antimicrobial factors (humoral component) (Anderson, 
1974; Ingram, 1980; Fletcher, 1982). Immunity, however, is a relative term and 
there are fine lines of distinction between the terms resistance, immunity and non-
susceptibility. 
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Resistance  
Resistance usually describes some barrier that prevents the entry into and/or 
attachment to an otherwise susceptible host of a pathogen. These barriers may be 
physical or chemical. In fish, the skin, gills and alimentary tract usually provide the 
first line of defence. All of the above surfaces are covered with mucus that not only 
forms a physical barrier but may also contain factors that inhibit the penetration and 
survival of a pathogen. Studies on resistance to, rather than immunity against, 
pathogens by fish are sparse. However, there is some evidence (Bowers & 
Alexander, 1981) demonstrating that fish that are treated with an hyperosmotic 
solution prior to exposure to a microorganism become more susceptible to invasion. 
These workers demonstrated that when brown trout (Salmo trutta) were exposed to 
hyperosmotic stress, Escherichia con could be isolated from the blood stream soon 
after. In contrast no bacteria could be isolated from non-stressed fish. This suggests 
that the disruption to the gill epithelium caused by hyperosmotic stress renders the • 
normally resistant fish at risk of invasion. Thus, it may be concluded that the 
physical barrier provided by the epithelium and their mucus secretions plays an 
integral, but sometimes over-looked, role in protection against infection and 
preservation of internal homeostasis. 
While chemical defence may form a significant part of resistance under this 
definition, it is more appropriately dealt with for the purposes of this thesis under the 
heading of nonspecific defence. Once the physical barriers have been breached, the 
host must rely on cellular and humoral defences and if there has been no prior 
exposure to the pathogen then these defences would be nonspecific (Fletcher, 1982). 
Non-specific defence system 
The first and often most important responses of fish to infectious agents are non-
specific (Blazer, 1991). This is particularly true of cool and cold water fish because 
the development of the specific immune response is temperature dependent 
(Avtalion, 1981), with antigen specific responses occurring more slowly at lower 
temperatures. The intrinsic broad-spectrum barriers of the non-specific defence 
response important in fish include the inflammatory response, various microbial 
inhibitory substances of the mucus and sera, and the circulating and tissue 
phagocytes (Ellis, 1982a; Anderson, 1992; Raa, 1996). In fact the nonspecific 
natural substances found in normal healthy fish such as precipitins, lysins, 
agglutinins and C-reactive protein may help to overcome various diseases before the 
specific immune responses occur (Dash, Saha, Sahu & Gangal, 1993). 
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The Inflammatory Response 
The basic response of all vertebrates to tissue injury is inflammation (Kreier & 
Mortensen, 1990). The rupture of the basement membrane, in tissues where these 
occur, provides a site for the interaction of the pathogenic agent with the cells and 
humoral factors able to limit the spread and rid the area of injurious agents and 
damaged tissue. This sets the stage for healing. Three major events occur during the 
inflammation process (Figure 1): 
An increased blood supply to the area 
Increased capillary permeability that allows the soluble mediators of immunity to 
reach the site of infection 
• The migration of monocytes (in particular monocyte derived macrophages), 
neutrophils and cytotoxic cells towards the area 
Figure 1 The inflammatory response 
• lib 
VASODILATION 	• 
\ • H2O 
• • 
FIBRINOGEN 
• ALBUMIN •  • • ah 
• • • • 
110 S. 	• •41/ RBC• 
ENDOTHELIAL/ 
CONTRACTION •al 
H20 
EXUDATION 
• • 0 • 
• 
Reproduced after WebPath (2000) 
Non-specific cellular defence 
Although many soluble factors, serum proteins and cells participate in the 
inflammatory response, the phagocytic cell and its products maintain the central role. 
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Macrophages have been recognized as the principal phagocytic cell and play a vital 
role in many aspects of piscine immune responses. Although they do not have 
immune specificity (Clem, Sizemore, Fellsaesser & Miller, 1985), macrophages are 
important accessory cells in initiating specific immune responses and are also potent 
effector cells capable of killing a wide range of pathogens (Secombes, 1990). Many 
studies have demonstrated macrophages to be highly phagocytic for inert and 
antigenic material (Ellis, Munro & Roberts, 1976; McKinney, Smith, Haines & Sigel, 
1977; Braun-Nesje, Bertheussen, Kaplan & Seljelid, 1981). 
It is a widespread belief that two important differences exist between macrophages of 
some teleost species and those of mammals. The first is the apparent lack of Fc and 
C3 receptors on fish macrophages and the second, the lack of opsonic activity of fish 
antibody and complement (Wrathmell & Parrish, 1980). These differences suggest 
that the mechanisms of phagocytosis and intracellular killing, both of which are 
enhanced by the antibody-complement complexes in mammals, may be different in 
some fish species (Ellis, 1982a). 
There are results, however, that indicate that salmon macrophages possess receptors 
that bind to human complement factors, C3b and C3bi, and agarose beads coated 
with these factors are readily phagocytosed (Johnson & Smith, 1984). Furthermore, 
Matsuyama, Yano, Nakao & Yamakawa (1991) reported carp C3 to be involved in 
phagocytosis by carp peritoneal neutrophils. Elevated phagocytosis was displayed 
when sheep red blood cell and yeast were treated with normal carp serum. Also 
treatment of the neutrophil surface protein with trypsin significantly decreased 
phagocytosis, suggesting the presence of C3 receptors. Similarly, Nonaka, Iwaki, 
Nakai, Nozaki, Kaidoh, Nonaka, Natsuume-Sakai & Takahashi (1984) demonstrated 
that antisera to trout C3 inhibited the phagocytosis of complement-coated sensitized 
erythrocytes. 
Historically, the role of neutrophils in fish has been confused and poorly defined 
(Ellis, 1982a). Numerous authors suggested that there was very little evidence that 
neutrophils in fish were actively phagocytic, in fact, they have been reported to have 
no phagocytic properties (Ellis etal., 1976; McKinney etal., 1977) or to be, at best, 
weakly phagocytic (Young & Chapman, 1978). However, it is now well established 
that fish neutrophils are phagocytic (MacArthur & Fletcher, 1985) with the 
occurrence of a biphasic (ie neutrophils followed by macrophages) inflammatory 
response. Further, the findings that fish neutrophils possess most of the enzymes 
found in mammalian neutrophils suggest they play an active role in defence 
mechanisms. 
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It has been suggested that the fish neutrophil may carry out a bactericidal role 
extracellularly rather than intracellularly (Ellis, 1982a). Neutrophils can kill by both 
oxygen dependent and independent mechanisms, including nitric oxide. They 
produce a more intense respiratory burst than macrophages and their secretory 
granules contain highly cytotoxic proteins such as acid hydrolases, myeloperoxidase, 
lactoferrin and lysozyme (Roitt, Brostoff & Male, 1993). 
While it is well recognized that there is an increase in the number of eosinophilic 
granulocytes (Lester & Daniels, 1976; Reimschusessel, Bennett, May & Lipsky, 
1987), neutrophils and macrophages (Sommerville, 1981; Pilsford & Matthews, 
1984; Roubal, Lester & Foster, 1989) after a fish succumbs to infection the role that 
each of these cells plays in the immune and defence response is still perplexing. 
Non specific humoral defence 
The serum and mucus of fish contains a number of substances, which are not 
immunoglobulins, that affect the growth of micro-organisms (Alexander, 1985). 
Alexander (1985) classified these substances into the following four groups 
according to the affect they have on the invading organism: (a) microbial growth 
inhibitory substances; (b) enzyme inhibitors; (c) lysins; and (d) agglutinins and 
precipitins. 
Microbial growth inhibitory substances 
These substances act either by depriving the invading organisms of essential nutrients 
or by interrupting metabolic pathways. Many of the acute phase proteins act to 
inhibit growth of an invading parasite and are so-called because the concentration of 
a number of these inhibitory substances increases rapidly during an infection. 
Transferrin displays anti-microbial properties when not fully saturated, and 
consequently has been shown to play a role in the pathology of many infections by 
limiting the amount of endogenous iron presented to pathogens, by chelating the 
metal, and making it unavailable for use by the organisms (Weinberg, 1974). The 
role of transferrin in disease resistance in fish has been examined using a number of 
species. The results, however, are contradictory and there seems to be a lack of 
standardization between and within experiments. Winter, Schreck & McIntyre 
(1980) demonstrated that fish with effective variants of transferrin showed low 
mortality when infected with BKD, Renibacterium salmoninarum. Conversely, 
Withler & Evelyn (1990) concluded that the differences in resistance to BKD they 
demonstrated were not related to the effectiveness of the transferrin type, as fish 
which showed the greatest resistance had only 4% TfC and the least resistant strain 
had 27% TfC. It is, however, agreed that certain genotypic variants are better able to 
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compete for iron than others and resistance lies in the differential avidities of the 
different transferrin types for iron binding (Ingram 1980). Winter etal., (1980) 
concluded that whether or not genotypically effective transferrin confers a disease 
resistance advantage may be irrelevant in commercial species as the fish exhibiting 
effective transferrin grew so much slower than those with a less effective variant. 
Thus, it is unlikely that this type of resistance is being selected for in saLmonid 
populations. 
Caeruloplasmin is another acute phase protein. It complexes with divalent metal 
cations such as copper but its defence role would appear to be more through its 
ability to oxidise ferrous iron to ferric, thus increasing the removal of iron from the 
environment, than as a chelator of copper (Alexander & Ingrain, 1992). Modulation 
of caeruloplasmin concentration in fish may occur as a result of contact with certain 
substances. Syed, Coombs & Keir (1979) demonstrated that fish that had been 
exposed to the aquatic metal pollutant cadmium displayed elevated concentrations of 
caeruloplasmin. 
Interferon is perhaps the most important of the proteins that interferes with the 
replication and growth of potential pathogens. The defensive mechanism allows 
infected cells some measure of protection and the viral-inhibiting protein either 
modifies or prevents the development of lesions (Baron, Brunell & Grossberg, 1979). 
It has been shown in salmonids that interferon has a specific protective affect upon 
cells and an inhibitory affect on virus replication (DeKinkelin & Dorson, 1973; 
Okamoto, Shiralcura, Nagalcura & Sano, 1983). Interferon may also play a 
significant role in the activation of macrophages. Graham & Secombes (1988, 1990) 
demonstrated that rainbow trout leukocytes produced macrophage activation factor 
(MAF) after mitogen stimulation and that the MAF from these leukocytes also 
conferred resistance to infectious pancreatic necrosis virus. It is probable that this 
MAF is in fact a Type II interferon. 
Enzyme Inhibitors 
While it recognized that the antiproteinases present in the serum of vertebrates 
primarily function to maintain homeostasis of the blood and other body fluids they 
also act to inhibit the actions of the many parasites that carry out extra-organism 
digestion of the host tissue. 
Many of the proteinase inhibitors of mammals have not been identified or isolated 
from fish (Alexander & Ingram 1992). However, the "all-purpose" proteinase 
inhibitor, a2-macroglobulin, which inhibits enzymes from all four of the proteinase 
groups, has been reported to occur in fish by Ellis, Hastings & Munro (1981). 
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a2-macroglobulin principally inactivates pathogens via a "wrap-round" method, 
however it can also bind covalently to some enzymes and adhere to others 
(Alexander & Ingram 1992). There seems to be contrasting views on the action of 
proteinase inhibitors in the process of disease resistance. Ellis et al. (1981) and Ellis 
(1987) demonstrated that the proteases of Aeromonas salmonicida were inhibited by 
the a - globulins in fish serum while Ellis & Stapleton (1988) concluded that the 
susceptibility of salmonids to furunculosis correlated directly with the activation of 
the proteases of A. salmonicida by components of the fish serum. 
Fish serum also contains other common groups of protease inhibitors such as 
inhibitors of serine proteinases, cysteine proteinases, aspartic proteinases and metallo 
proteinases (Raa, 1996). 
Substances which cause lysis 
These substances are all enzymes that act either singularly such as lysozyme and 
proteinase or in a complex such as that observed in the complement system. These 
enzymes act to degrade or digest components of an attacking organism. 
Lysozyme 
Lysozymes are ubiquitous enzymes (Jolles & Jolles, 1984). In fish, lysozyme has 
been detected in the blood, mucus and many other tissues (Fletcher &White, 1973; 
Lindsay, 1986; Grinde, Lie, Poppe & Salte, 1988). There is a wide variation in the 
concentration of lysozyme detected in different teleost species. The salmonid family 
and in particular rainbow trout have high levels of lysozyme when compared to 
members of the cod and tuskfish families (Grinde et al., 1988). 
The specific substrate of lysozyme is 3-(1-4) linked N-acetyl-D-glucosamine, N-
acetyl-muramic acid peptidoglycan. Lysozyme appears to be involved in defence 
against viruses, neoplasms, bacteria, and possibly fungi and insects. 
There seems to be some inconsistencies in the demonstration of the presence and 
levels of lysozyme. Although there are numerous methods to measure lysozyme 
described in the literature, only two are used consistently:- turbidimetric method 
(Parry, Chandan, & Shahani, 1965) modified by Sankaran & Gurnani (1972) and the 
lysoplate assay (Osserman & Lawlor, 1966). Both of these assays rely on the ability 
of lysozyme to lyse cells of Micrococcus lysodeikticus and it appears that optimal 
results depend on a range of variables including the pH and ionic strength of buffers. 
There has not yet been an international standardization of the methods thus it seems 
that lysozyme concentration and activity reported by different authors cannot be 
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directly compared. In some cases even experimental results that have been obtained 
using identical methods cannot be compared because they are expressed in different 
units. 
Other non-specific 4/sins 
Besides lysozyme, a variety of lysins have been described from the mucus and serum 
of fish. Hjelmeland, Christie & Raa (1983), demonstrated that the skin mucus of the 
rainbow trout, Oncorhynchus mykiss; charr, Salvelinus alpinus; cod, Gadus morhua; 
coalfish, Gadus virens; redfish, Sebastes marinus; and plaice, Pleuronectes platessa 
contain proteolytic enzymes which appeared to be identical to the pylorus caecal 
trypsin, but is secreted into the mucus. Itami (1993) described the bacteriolytic 
activity of the skin mucus of ayu, Plecoglossus altivelis and demonstrated the 
presence of antibody, lysozyme,.haemagglutinin and a vibriolytic substance. While 
several authors have demonstrated the presence of chitinase and chitobiase in various 
organs and blood of teleosts (Olcutani & Kimata, 1964; Fletcher & White, 1973; 
Fange, Lundblad & Lind, 1976; Goodrich & Morita, 1977) it appears that their roles 
and derivation is, as yet, undetermined. A number of authors have claimed that these 
enzymes may have a protective function against invasion by chitin-containing fungi 
and invertebrate parasites (Fange et al., 1976; Ingram, 1980). However Lindsay 
(1986) demonstrated that the pattern of enzyme distribution was not consistent with a 
role in defence. Furthermore, Fletcher & White (1973) showed that the presence of 
chitinase was closely related to the diet of the fish and that its activity was lost from 
non-feeding fish. 
Complement 
The complement system is a complex composed of at least 18, and possibly 20 
proteins, of which 11 have been isolated and characterized (Porter, 1977). The most 
recognized role of complement is its' ability to affect cell membranes leading to 
osmotic lysis and cell death. Further consequences of complement activation include 
increased vascular permeability, chemotaxis of leukocytes and their retention at sites 
of tissue injury, and the enhancement of phagocytosis (Fletcher, 1982). 
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activity in glucan-treated fish. Sakai (1981, 1983), Jenkins & Ourth (1991) and Watts 
(2000) have also reported immunoglobulin-independent haemolysis, indicative of an 
alternative pathway, in carp, rainbow trout, catfish and tuna respectively. Recently, 
HaIvor & Robertsen (1997) detected the complement component C3 in the mucus of 
P-glucan treated Atlantic salmon. 
Several authors have stated that the alternative pathway is of primary importance in 
the lower vertebrates. Roberts (1978) suggests that the importance of the properdin 
pathway resides in the possibility that antibody is not required to initiate the 
complement reaction, thus it has a great advantage in the poikilotherms, where 
conditions are not always favourable for the protein synthesis necessary for 
production of antibodies. Kaastrup (cited in Alexander, 1985) even goes so far as to 
say that the alternative pathway is the only one present in fish. However, it has been 
demonstrated in numerous fish species that IgM has the ability to fix complement 
and activate its lytic properties. Cushing (1945) demonstrated that carp serum 
contained three of the four classic components found in guinea pig serum. Nonaka, 
Iwalci, Nakai, Nozalci, Kaidoh, Nonaka, Natsuume-Sakai & Takahashi (1984) have 
similarly shown the complement system in rainbow trout has many similarities to 
mammalian complement. The presence of complement or haemolytic activity has 
also been recorded from the albacore, Thunnus alalunga (Giclas, Morrison, Curry, 
Laurs & Ulevitch, 1981), brown trout (Ingram, 1987) and bluegill, Lepomis 
macrohirus (Smith, Potter & Mechant, 1967). Nevertheless no fish species has been 
found that contains all of the components Cl to C9 recognized in the mammalian 
classical pathway (Sakai, 1992). 
C-reactive protein 
CRP is a member of the acute phase protein group and while its function remains 
uncertain it has been reported to be involved in phagocytic activity, opsonisation, 
interactions with complement, anti-bacterial lysis and agglutination (Pepys, 1981; 
Alexander, 1985). 'CRP-like' proteins are widely distributed among both 
invertebrates and vertebrates (Kreier & Mortensen, 1990) and fish are no exception. 
CRP has reported in many teleosts including the plaice, Pleuronectes platessa; eel, 
Anguilla japonica; lumpsucker, Cyclopterus lumpus; rainbow trout, Onchorhynchus 
mykiss; and tilapia, Sarotheroden mossambicus (Alexander & Ingram, 1992). In fish, 
unlike the situation in mammals, CRP is present at most times and at levels up to 500 
times greater. 
C-reactive protein resembles immunoglobulins in several properties and its broad 
specificity for group-specific C-polysaccharides (mucopeptide and N-acetyl 
galactosamine-6-phosphate) commonly found in the cell walls or surface structures 
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of invading organisms suggests it may afford a nonspecific primary defence role 
(Fletcher, 1982). 
Agglutinins and Precipitins 
Essentially, precipitation and agglutination is simply the aggregation of molecules 
and cells respectively. Like other vertebrates, fish possess a variety of substances 
that cause the agglutination and/or precipitation of carbohydrate residues. These 
factors are physico-chemically, biologically and antigenically distinct from antigen-
stimulated, immune antibodies or immunoglobulins (Alexander & Ingam, 1992). 
Even so, there is some confusion in the literature between non-Ig agglutinins and 
natural Igs that has led to the term antibody being used in reference to both the 
above. 
Goldstein & Poretz (1986) defined a lectin as "a carbohydrate-binding protein (or 
glycoprotein) of non-immune origin which agglutinates cells and/or precipitates 
glycoconjugates" and now, nonspecific agglutinins and precipitins are generally 
recognized under the term lectin. These agglutinins have been identified in fish. 
However studies on the specificities and functions of natural haemagglutinins 
(lectins) in fish are sparse. 
lmmunit 
It was stated earlier in this review that there is a fine line of distinction between 
resistance, immunity (both passive and active) and non-susceptibility. Perhaps the 
distinction between nonspecificity and specificity could identify appropriate lines. In 
a general sense, a distinction between innate and acquired could also represent an 
appropriate distinction; with innate aligning with nonspecific and acquired with 
specific. 
The word 'immune' is derived from the Latin word 'immunis', which means 'safe by 
exemption', and therefore strictly speaking, would include all means by which an 
organism may rid itself of invading pathogens. However, nonspecificity may be 
more appropriately aligned with resistance and innate natural defence, while the 
terms immunity, immunise and immune response tend to reflect an acquired selective 
response or the induction of a selective response, in which specific antibodies or a 
specific attack sequence is produced against invading organisms. Immunity is 
generally attributed to an inherited ability to produce antibodies, whether this is 
natural immunity where antibodies are produced against certain pathogens without 
actual stimulation by homologous antigens from the pathogens, such as described in 
the section on agglutinins and precipitins, or acquired immunity where a host is 
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stimulated to produce antibodies by contact with antigens. Where this line becomes 
less clear is with the phenomenon of passive immunity, where antibodies produced 
by one animal are transferred to another to engender immunity. While the donor 
species must still be able to produce antibodies, the recipient of these antibodies need 
not be immunocompetent. Strictly speaking, for the individual involved, this may 
fall outside the above definition of immunity. 
The second component of specific immunity, cell-mediated immunity, is not directly 
associated with killing via antibodies but, inter alia, initiates their production. Many 
of the wide ranging aspects of this immune response are intrinsically linked with the 
nonspecific defence system. 
Semantics aside, for the purpose of the next part of this literature review, immunity 
will be discussed in the terms of specific responses both cell mediated and humoral. 
Specific Immune System 
Specific Humoral Immunity 
Humoral immunity relies on the circulation of antibodies within the fluid system of a 
host to combat pathogens. Antibodies belong to the group called immunoglobulins 
and the striking feature in teleosts is the presence of only one class of 
immunoglobulin (Ig) (compared to five in mammals) (Ellis, 1982a). This 
immunoglobulin is most like mammalian IgM and can be found in most of the tissue 
fluids in fish including plasma, lymph, skin, gut and gill mucus and bile (van 
Muiswinkel, 1995). More recently, there has been some evidence that a second class 
of immunoglobulin may be present in fish. Wilson, Bengten, Miller, Clem, 
Dupasquier & Warr (1997) reported the presence of immunoglobulin, much like 
human IgD in channel catfish (ktalurus punctatus). 
Like mammals and birds, fish have two main populations of lymphocytes, T 
lymphocytes and B lymphocytes. Although the source of these cells in fish in 
unknown it is likely to be the kidney (Ellis, 1988). On exposure to an antigen the T 
and B cells cooperate in the response but it is the B cells that form the major 
component of specific humoral immunity. Once the antigen has been presented to 
the B cells, these differentiate into plasma cells which produce antibody specific to 
the stimulating antigen or into cells which are capable of becoming plasma cells on 
subsequent exposure to antigen and are therefore called memory cells (Ellis, 1988). 
Figure 3 illustrates the events leading to the production of antibodies. 
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Figure 3 Events leading to the production of antibodies 
Plasma Cell 
Reproduced after Perez (2000) 
Specific Cell Mediated Immunity 
Specific cell mediated immunity is T cell dependent and refers to all the 
manifestations of the specific immune response which do not involve antibodies 
(Gudkovs, 1988). Although T helper cells are necessarily involved in the production 
of antibodies and therefore remain linked to the humoral immune response, the T cell 
population possesses clones that are responsible for cell-mediated immunity (Rijkers, 
1982). 
The T lymphocyte population can be divided into distinct groups according to the 
function of that sub-population. According to Ellis (1988) and Kennedy-Stoskopf 
(1993), these include: 
• Cytotoxic killer cells that are capable of lysing foreign cells 
• Lymphokine producing cells which produce substances that enhance the killing 
capacity of macrophages through activation 
• Suppressor cells which regulate the production of antibodies and lymphokines 
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In general, the cell-mediated component of the specific immune response includes 
the hypersensitivity reactions, transplantation responses, inhibition of macrophage 
migration and the mixed lymphocyte reaction. To these, can be added the helper 
function as mentioned above. Certain aspects of cell mediated immunity are not 
necessarily manifest to the benefit of the animal and there have been a number of 
studies done which demonstrate these affects of cellular immune reactions and the 
kinetics of this component. 
Taking evidence provided in studies on transplantation and graft reactions in fish (see 
reviews by Cushing, 1970; Ellis, 1982b; Secombes, 1991; Stet & Egberts, 1991), 
essentially, the cellular reactions in fish are the same as for mammals. Rijkers (1982) 
summarised the cellular immunological characteristics of fish that are in accordance 
with mammals: 
• Second-set grafts are rejected more rapidly than first-set 
• Immunological memory is long-lived; memory is donor specific 
• Xenografts (from different species) are rejected faster than allografts (from the 
same species) 
• No isohaemagglutinating antibodies are involved in the rejection process 
• The antigen dose does not affect the median survival time of the grafts 
• Only living tissue evokes immunological memory 
Hypersensitivity reactions have not been thoroughly studied in fish, though there is 
evidence that they do exist. It is thought that 'Strawberry disease' (of unknown 
aetiology) in salmonids, may be related to allergic or hypersensitivity reactions 
(Kfoury, Okamoto, LaPatra, Tanaka, Suzuki, Motonishi & Ikeda, 1994). Similarly, 
hypersensitivity has been shown to be active in other granulomatous diseases of fish, 
such as tuberculosis and lymphocystis with sensitized lymphocytes demonstrated in 
the later stages of disease (Timur, Roberts & McQueen, 1977a,b). Baldo & Fletcher 
(1975) reported hypersensitivity skin reactions in various flatfish species in reaction 
to C-polysaccharide substances and Bartos & Sommer (1981) found that rainbow 
trout developed a hypersensitivity reaction against Mycobacterium tuberculosis and 
M. salmoniphilum in the skin and the thymus. 
Hypersensitivity reactions often coincide with the development of macrophage 
migration inhibition that, as the name suggests, inhibits the movement of 
macrophages. In animals that have been sensitized with an appropriate antigen, a 
lymphokine that inhibits movement of macrophages in the surrounding area is 
released from T-like lymphocytes. Macrophage migration inhibition has been shown 
to occur in both elasmobranchs and teleosts (Gudkovs, 1988). In particular, Smith, 
McCarthy & Paterson (1980) showed that the lymphocytes of the brown trout, Salmo 
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trutta fario, immunized against Aeromonas salmonicida inhibited macrophage 
migration in the presence of antigen. 
The aspect of cell-mediated immune responses in fish against pathogens is little 
explored (van Muiswinkel, 1995). However, together with the studies mentioned 
above, the following workers have demonstrated the cellular immune function in 
teleosts. Thomas & Woo (1990) and Li & Woo (1995) demonstrated a cell-mediated 
immune response in rainbow trout. There was evidence of antibody independent 
cell-mediated cytotoxicity in fish vaccinated against Cryptobia salmositica. Whyte, 
Chappell & Secombes (1989) showed that in vitro killing of the digenean cercariae, 
Diplostomum spathecum was not increased using antiserum-coated larvae or in vivo-
activated macrophages individually, but when they were combined increased killing 
occurred. 
IMMUNOSTIMULATION 
By definition, an immunostimulant is a chemical or drug that elevates nonspecific 
defence mechanisms or the specific immune response (Anderson, 1992). In the strict 
sense of the word, immunostimulation has been used for close to a century with 
reports from the early 1900s on the use of lanolin, paraffin and other oils in 
conjunction with vaccines to increase antibody production and vaccine efficacy 
(McKercher, 1986). Because the processes of the specific immune and nonspecific 
defence systems are interwoven and highly interdependent, as previously discussed, 
when an immunostimulant enhances the nonspecific defence system it will also 
activate processes in the specific immune system (Raa, 1996). For this reason, I 
firmly believe that although a large proportion of the studies on 
immunomostimulation in fish report only on the specific immune component, the 
substances that were used should be considered for their potential to modulate the 
nonspecific defence system. At this point in time there is no reason to believe that 
the application of immunostimulants in most circumstances is not modulating both 
the nonspecific and specific components of a fishes response. 
Sindermann (1984) recognized that the immune system will be influenced by the 
genetic constitution, age, sex, nutritional status and hormonal balance of the fish, 
with the additional impact of environmental variables, both natural and man-induced. 
In the intensive aquaculture situation whereby some of the above factors may be 
compromised, aquatic animals become highly susceptible to infectious disease. 
During the last decade, immunostimulants have become recognized as potential 
substances for heightening the activity of the defence mechanisms in aquatic animals 
and conferring protection against disease. 
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Recognized immunostimulants in fish, include bacterial cell wall fragments, P-1,3- 
glucans of yeast and mycelial fungi, peptides and a number of synthetic products 
(Raa, 1996). There are many functions that may be modulated when an 
immunostimulant is used to treat fish. However, the most widely recognised and the 
most often demonstrated is that of phagocytic regulation. Given the important role of 
phagocytes in the uptake of antigens, this too adds weight to the postulate that in 
most circumstances both the specific and nonspecific functions are being modulated. 
There have been three excellent reviews on immunomodulation in fish in recent 
times by Anderson (1992), Raa (1996) and Sakai (1999), so there is no need to go 
over common ground in this review. 
A summary of the immunomodulators that have been used in fish and the affects 
these had on various nonspecific defence system and specific immune functions is 
presented in Table 1 (Appendix 1). This table has been put together from 
information in the reviews mentioned above as well as an extensive literature review. 
GILL-ASSOCIATED AMOEBAE INFECTIONS IN FISH 
Gill associated ameobae have been reported in finfishes since the early 1900s. Until 
recently most reports of these amoebae were from finfish reared in freshwater 
(Kubota & Kamata, 1971; Sawyer, Hnath & Conrad, 1974; Sawyer, Hoffman, Hnath 
& Conrad, 1975; Taylor, 1977; Daoust & Ferguson, 1985; Nash, Nash & Schlotfeldt, 
1988). These amoebae were placed in various genera including Thecamoeba, 
Amoeba, Acanthamoeba, Naegleria and Vahlkampfia. However, during the late 
1980s, and until present, there have been an increasing number of marine fishes from 
an increasing number of locations affected by gill-amoeba. All verified pathogenic 
marine amoebae have so far, been from the genus Paramoeba. 
Paramoeba sop.  
Amoebae of the genus Paramoeba Schaudinn, 1896, are exclusively marine and have 
a wide distribution throughout the world. Amoebae belonging to the genus 
Paramoeba are characterized by the presence of a parasome in close relationship to 
the nucleus (Cann & Page, 1982; Page, 1973). Despite the consistency of the 
structural characteristic, the various species within this genus show great ecological 
variability. 
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Many of the species described from this genus are free living, including the type 
species P. eilhardi, P. schaudinni, and P. aesturina (Cann & Page, 1982). Little else 
is known about them, other than P. aesturina can be cultured on artifical media 
(Cann & Page, 1982). P. perniciosa is regarded as an obligate parasite of the blue 
crab (Callinectes sapidus), and has not been grown on artificial media (Sprague, 
Beckett & Sawyer, 1969). P. invadens is a significant pathogen of sea urchins 
(Strongylocentrotus droebachiensis), can be cultured on artificial media and disease 
can be produced in susceptible hosts using cultured organisms (Jellet & Scheibling, 
1988). Recently, significant mortality occurred in lobsters in Long Island, California 
due to a Paramoeba species (Cavvthorn4 , pers. comm. 2000). Investigations on this 
outbreak are continuing. 
Munday (1986) reported the occurrence of disease associated with a marine amoeba 
in farmed salmonids early in 1985 but at that stage the organism had not been 
identified. It was not until 1988 that Kent et al., (1988) and Munday, Foster, Roubal 
& Lester (1990) described severe disease associated with Paramoeba in salmonids 
reared in seawater in California and Washington and Tasmania, respectively. These • 
were the first reports of Paramoeba affecting a vertebrate. Subsequent Paramoeba 
infections in a range of fish species including', Atlantic salmon, coho salmon, 
rainbow trout, brown trout and turbot have been reported in Ireland (Rodger & 
McArdle 1996; Palmer, Carson, Ruttledge, Drinan & Wagner, 1997), Chile (Groman 
pers. Comm., 2000), France (Baudin Laurencin pers. comm., cited in Findlay & 
Munday, 1998), Spain (Paniagua, Fernandez, Ortega, Parama, Sanmartin & Leiro 
1998; Dykova, Figueras, Novoa & Casel, 1998; Echabe pers. comm., 2000.) and New 
Zealand (Anderson5 pers. comm., 1990). 
Of the Paramoeba species that infect aquatic animals, it is the one found in seawater 
reared finfish that has been of greatest interest to aquaculturists and fish health 
scientists. It has been tentatively speciated as P. pemaquidensis. While this species 
has been implicated as the cause of disease in numerous species of the salmonid 
family the reasons why this normally free-living organism colonizes the gills is still 
not completely understood (Nowak & Munday, 1994). It is interesting to note that the 
reports of many of the freshwater amoeba include accounts of bacterial infection in 
association with the amoebae. These workers concluded that the amoebic infection 
may have been opportunistic as a result bacterial growth; the overgrowth of bacteria 
provided a rich source of nutrition for the normally free-living amoeba. Roubal, 
Lester & Foster (1989) did not find large bacterial loads in association with 
Paramoeba infections in marine fish although Garland (pers. comm. cited in 
4 Cawthorn, R. Atlantic Veterinary College, University of Prince Edward Island, Prince Edward 
Island, Canada 
5 Anderson, C. Ministry of Agriculture Fisheries, Upper Hutt, Wellington, New Zealand 
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Munday, Lange, Foster, Lester & Handlinger, 1993 found increased bacterial loads 
by culture. 
Structure of Paramoeba pemaquidensis 
Paramoeba pemaquidensis may appear in two forms. Amoebae removed from the 
gills of salmonids commonly exhibit many fine radiate pseudopodia (Plate 1). This 
transitional or floating form is 20 to 30 [ffn in diameter (Cann & Page 1982; Munday 
et al., 1990). The locomotive form is elongated with blunt pseudopodia (Plate 2). 
They measure between 20 and 35 pm along the longest axis (Cann & Page 1982). 
Ultrastructurally, and depending on the plane of section, a nucleus and one or two 
parasomes may be seen. At times, dense condensations of chromatin occurs at the 
poles of the parasome (Munday etal., 1990). 
Plate 1 Transitional or floating form Paramoeba sp. 
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Plate 2 Locomotive form Paramoeba sp. 
Pathology associated with Paramoeba infections 
The outstanding lesion in amoebic gill disease is a severe mucoid branchialitis. 
Histologically, this branchialitis is characterised by uneven epithelial metaplasia, loss 
of secondary lamellae, gill fusion, mucus formation, mononuclear cellular reaction 
and in some cases haemorrhage (Munday et al., 1993) (Plate 5). The associated 
hyperplasia leads to clubbing and fusion of the secondary lamellae and the formation 
of large vesicles or cysts (Plate 3;Plate 4) (Munday etal., 1990). Plate 6 shows 
normal gill structure. 
Page 29 
Chapter 1: Literature Review 
Plate 3 	Gill pathology caused by amoebic gill disease-hyperplasia leads 
to clubbing and fusion of the secondary lamellae and formation of large 
vesicles x75 
Plate 4 	Gill pathology caused by amoebic gill disease-note amoebae 
concentrations along gill and also their inclusion in the large vesicles 
x100 
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Plate 5 	Gill pathology caused by amoebic gill disease-amoebae in situ, 
note cellular infiltration of gill x400 
Plate 6 	Normal gill structure x200 
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The lesions of AGD may be found anywhere along the length of the primary lamellae 
(Munday etal., 1990) with the highest concentrations of lesions occurring on the 
upper region of the gill arch (Adams, 2000). Microscopically, it is possible to see 
eroded areas on the lamellae where the organisms attach and ultramicroscopically, 
pseudopodia of the amoebae can be seen penetrating cell junctions and cavities at the 
surface of degenerating epithelial cells (Munday et al., 1990). In these areas, actively 
secreting mucous cells are numerous, both at the surface and deep within the 
hyperplastic epithelium (Munday et al., 1990; Zilberg & Munday, 2000a). In 
contrast, chloride cells are reduced in number in the affected areas (Munday et al., 
1990). In some cases, sections of hyperplastic tissue can be seen sloughing off with 
the Paramoeba attached to it. In these cases gill lamellae are visibly damaged with 
exposed blood vessels or entirely lost (Zilberg & Munday, 2000a). 
A notable feature of the associated pathology is the infiltration of neutrophils in the 
hyperplastic epithleiurn and filamentary connective tissues. As the disease 
progresses these become mainly of a mononuclear type and in fishes that are 
recovering, particularly rainbow trout, mononuclear nodules can be seen along the 
primary lamellae and basal interlamellar tissues (Munday et al., 1990). 
Epidemiology and treatment of AGD of salmonids in Tasmania  
AGD is not a consistent threat at all times of the year. Epidemiological studies 
suggest that this most probably relates to environmental factors such as salinity and 
temperature (Munday et al., 1993, Clark & Nowak, 1999) and the management 
, practices of moving fish to sea and freshwater bathing (Munday et al., 1990). 
Although amoebae can be found on the gills of salmonids during winter and spring, . 
clinical disease is usually only seen when water temperatures exceed 12°C (Munday 
etal., 1990). A recent study by Clark & Nowak (1999) reported the occurrence of 
AGD in water temperatures of 10.6°C, but this was preceded by higher temperatures. 
Even more marked is the affect of salinity with clinical disease only becoming 
established when salinities approach 35%0. The failure of a major field trial due to a 
large freshwater spike keeping salinities low was mentioned in the introduction. 
However, in the study by Clark & Nowak (1999), disease was reported at 7.2%0 for a 
very limited period of time and residual infection due to preceeding periods of the 
high temperatures and salinities explain this anomaly. 
AGD is currently treated and controlled by the use of freshwater baths and/or 
brackish water culture sites (Zilberg, Findlay & Munday, 2000). To bath fish, whole 
cages are usually brought to shore and fish are transferred to land-based tanks or to 
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floating envelopes filled with freshwater at a maximum salinity of 496o, but 
preferably less (Plate 7) (Munday et al., 1990). The optimal time period to hold 
these fish in freshwater is between two and three hours (Findlay & Munday, 1998) 
although in practice these periods may exceed eight hours (Plate 8) (Bender6 , pers. 
comm., 2000). After bathing, the fish are moved into a seapen (Plate 9) and towed 
back to location on the lease (Plate 10). More recently, one company has begun using 
platform cages where bathing can be done on-site. 
6 Bender, P. Huon Aquaculture, Tasmania 
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Plate 7 	Atlantic salmon being moved to the freshwater bath 
Plate 8 	Atlantic salmon infected with AGD are held in freshwater baths 
for two to three hours 
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Plate 9 	After two to three hours the bathed fish are returned to their 
seawater pen via hydraulic lift 
Plate 10 	Aerial photo of Tasmanian salmon farm. Cages are set in 
designated patterns for husbandry and management reasons. The large 
dam provides freshwater for AGD bathing. 
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Munday et al., (1990) reported that freshwater treatment acts in three ways, namely: 
• to reduce the numbers of amoebae on the gills; 
• to remove the seawater stable mucus that covers the gills; and 
• to reduce any hypematraemia which may have developed. 
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The following chapter describes the methods and materials that have been used on 
more than one occasion and also those that were fundamental to many aspects of this 
research. 
AGD CHALLENGE TRIALS 
Atlantic salmon weighing between 100 -200 g were used throughout this study. All 
fish were naive in relation to AGD, having been maintained in freshwater in 40001 
Rathburn tanks connected to individual biofilters (Plate 11). The water temperature 
was maintained at 14°C via an automated temperature probe connected to a heat 
exchanger and pump. When these naive fish were needed for challenge experiments 
they were acclimatized to seawater over a ten day period. All fish were identified by 
colour coded Hallmark® tags which were inserted before the acclimatization period. 
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Plate 11 Experimental tanks- 40001 Rathburn holding tanks  with biofilter 
and sump located to the side. A temperature probe sits  inside the tank 
at all times, with heat exchanger situated in the rafters above 
Salmon were infected with Paramoeba sp. by cohabiting them with fish that had 
AGD, following the advice of Searle' (pers. comm., 1988). 
With the exception of losing three tanks of fish due to failed heat regulators and 
eutrophication of the water through unapproved overfeeding, water parameters were 
maintained within the optimal range for Atlantic salmon. In a number  of instances 
estuarine water, with salinities ranging from 20-28%o, was delivered by the contractor 
instead of full salinity seawater (ie 35%o). On one occasion this resulted in the loss of 
AGD. 
For freshwater tanks salinity was always below 2%o, temperature was held at 14°C 
with a range between 13.6-14.8°C, dissolved oxygen (DO), pH, ammonium and 
nitrate levels were maintained within acceptable levels. 
For seawater tanks the salinity was maintained above 32%o, depending on the need at 
the time (see protocol for establishment of AGD infection) and temperatures were 
7 Searle, L. Marine Research Laboratories, Taroona, Tasmania 
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maintained at between 11.2-16.7°C. DO, pH, ammonia and nitrates were maintained 
within acceptable levels. 
All experiments conducted as part of this project were done with the approval of the 
University of Tasmania Ethics Committee for Animal Experimentation. 
Quantification of AGD lesions 
For each experimental AGD challenge, the number of AGD lesions on the first gill 
arch (including left and right sides) of each fish included in the trial was quantified 
weekly using a system modified from Alexander (1991). 
Once weekly for four weeks post exposure, all fish included in the trial were 
removed from the trial tank and held in a separate tank. Fish were then lightly 
anaethetised and the number of lesions present on the left and right first gill arch 
were counted (Plate 12). 
A gill lesion was defined as a focal mucoid patch, white to cream in colour. The 
size of the lesions ranged from just visible to the naked eye to diffuse large 
patches covering many gill filaments and containing more than one focal point. 
In the initial stages of infection mucoid patches were easily distinguishable as 
separate lesions but as the disease progressed focal patches began to coalesce and 
form large areas of excess mucus. In these cases clearly visible focal points 
within diffuse areas of hyperplasia were present. Each focal point was counted as 
a one patch. 
It was recognised that this method of lesion quantification was at risk of being 
subjective so each fish was identified with an individually numbered tag, as 
mentioned previously, to allow blind counts to be conducted using two different 
methods. The first was for three people to count lesions on the same group of 
fish and the second was for the same person to count lesions on selected fish 
twice but not consecutively. There was a consistency rate of 96.5% between all 
counts, with the maximum percentage difference of 3% in the number of lesions 
detected. Thus, it was established that this method of lesion quantification is 
repeatable and therefore an appropriate method for studying experimental AGD. 
A subsequent study conducted by Zilberg & Munday (2000) has also validated 
this method. 
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Plate 12 Mucoid lesions on the gills of Atlantic salmon infected with AGD-
the lesions on this fish have began to coalesce 
The presence of Paramoeba associated with the lesions was confirmed  by 
microscopic examination of wet preparations of gill scrapings using both bright and 
dark field illumination. Paramoeba infection was further confirmed at various 
intervals throughout the study by immunofluorescent antibody test (IFAT). 
IMMUNOFLUORESCENT ANTIBODY TEST 
Immunostaining is a sensitive immunological technique that can be used to detect 
antigen in fish. The indirect fluorescent antibody test (IFAT) was used  to 
periodically confirm the presence of Paramoeba sp. in gill tissue samples and 
smears. Tests were conducted to establish the correlation between the presence of 
gill patches and Paramoeba sp. 
The LFAT requires the use of a primary antibody followed by an anti-antibody IgG. 
The methods and materials used for the production of these are found below. 
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Initially, gill smears were prepared and heat fixed. The primary antibody, rabbit anti-
Paramoeba, diluted to the appropriate concentration in IF antibody diluent was 
applied. The slides were incubated at 37 °C for 60 minutes in a humidified incubator 
before being rinsed with PBS for five minutes. The slides were dried and a 
fluorescein isothiocynate labeled sheep anti-rabbit IgG, diluted to the appropriate 
concentration in PBS was overlaid. The slides were incubated as before for 45 
minutes and rinsed twice more as previously described. After being mounted in 
alkaline buffered glycerol they were observed, at 100x magnification using an ultra-
violet microscope. 
IFAT- preparation of antibody 
Antisera were raised by intravenous injection of rabbits with sonicated Paramoeba. 
Injections ranging from 300 000 to 3 million amoeba were administered at three day 
intervals for three weeks. No adjuvant was used. Antisera were collected four weeks 
after the last injection. 
To determine how specific the antibody was, pure cultures of four different non-
Paramoeba species were reacted with the antisera using an anti-rabbit fluorescent 
label. Antisera were tested at a low dilution of 1:100. A negative control of 
phosphate buffered saline was also included. Slides were examined by 
epifluorescent UV microscopy for the presence of labelled amoeba and scored as 
either a positive or a negative. 
To determine if the antiserum to the strain of Paramoeba that was injected into the 
rabbit was specific for AGD-associated Paramoeba isolates in general, eight isolates 
were reacted with the original strain of Paramoeba using an anti-rabbit fluorescent 
label, as above. 
CULTURE OF PARAMOEBA SP. 
Maintenance of cultures 
Many species of amoeba grow readily on solid phase substrate with malt-seawater-
yeast (MSY) agar being the most common (Kalinina & Page, 1992). Paramoeba sp. 
was cultured as described by Howard, Carson & Lewis (1993). 
The growth medium was made by mixing 75% 0.2um filtered seawater and 25% 
distilled water with 0.1% w/v yeast extract, 0.1% w/v malt extract and 30% w/v agar 
(Oxoid No.1). The solution was autoclaved at 121°C for 20 minutes and allowed to 
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cool to 60°C before the antifungal pimaricin (Sigma) was added at a final 
concentration of 21.5lig per ml of agar. 
The molten agar was then poured into 10cm diameter bioassay dishes (Nunc, 
Denmark) and allowed to solidify overnight at room temperature. The plates were 
seeded with 2m1 of Xanthomonas maltophilia suspension (concentration 1.5 x 108 
cells.m1 -1 ) and allowed to dry for one hour. Paramoeba sp. cultures were initiated by 
placing agar squares that had been freshly excised from pure cultures obtained from 
Mt. Pleasant Animal Health Laboratories, Prospect, Tasmania on the pre-seeded 
plates. Cultures were maintained at 20°C in sealed containers to minimize 
evaporation. The plates were subcultured every four weeks. 
As required, large numbers of Paramoeba sp. were grown using 23x23cm square 
culture plates (Nunc, Denmark). The only difference to the culture technique 
described above was that these plates were overlayed with sterilised seawater and the 
temperature adjusted according to the requirements for the experiment to be 
conducted. 
Xanthomonas maltophilia culture  
Original cultures of X maltophilia were obtained from Mt. Pleasant Animal Health 
Laboratories. Liquid cultures were grown by seeding nutrient broth (Oxoid No. 2) 
with 1-two bacterial colonies removed from cultures maintained on blood agar plates. 
The liquid cultures were incubated at 37 °C for 72 hours before the bacteria was 
harvested by centrifugation. The collected cells were washed three times in PBS 
before being aliquoted and stored at 4°C. 
PHAGOCYTOSIS ASSAY 
The ability of fish phagocytes to ingest particles is usually demonstrated with an in 
vitro phagocytosis assay. These tests are expensive and labour intensive. To 
overcome this an in vivo phagocytosis assay was devised that is very cheap to run 
and reduces the factors that result in high individual variation. 
Preparation of yeast cells 
Suspensions of cells of the yeast Saccaromyces cerevisiae (108 cells.m11 ) were 
prepared in phosphate buffered saline (PBS) (pH 7.4). The equivalent amount of 
0.8% congo red was added to the yeast suspension before it was autoclaved at 121°C 
for 20 minutes. This yeast cell solution could be stored refrigerated for up to 72 
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hours. Before use, the yeast cells were washed five times in sterile PBS (3 minutes at 
300g) and resuspended in the initial volume of PBS. 
In vivo phagocytosis methodology 
Fish were anaesthetised with 40mg.E 1 benzocaine (10% wv-1 ethyl-4-aminbenzoate 
in acetone) to Stage III or surgical procedure anaesthesia as described by Ross and 
Ross (1984). Each fish was weighed and injected with 0.1m1 per 100g body weight 
of the yeast solution via the caudal vein. The fish were revived and held in 4001 
plastic tanks supplied with oxygen for two hours. After the holding period the fish 
were anaesthetised once again and bled by severing the caudal vessels. 
Preparation of the cell suspension  
The head kidney was removed and placed on a stainless steel mesh sieve (0.3mm) in 
a petri dish containing 5m1 of PBS. The kidney tissue was pushed through the mesh 
and the resulting homogenate passed through a loosely packed glass wool syringe 
column to remove tissue and cellular debris and red blood cells. The suspension was 
allowed to settle for 15 minutes and then gently layered upon 2m1 of Histopaque 
1077 (Sigma). The layered cell suspension was centrifuged for 15 minutes at 400g. 
Following centrifugation, the white blood cell interface layer was removed and 
washed in 3m1 PBS (three minutes at 200g). The supernatant was decanted and the 
pellet resuspended in 0.5m1 of PBS. The solution was vortex mixed and a drop 
placed on a glass slide and covered with a coverslip. Cell viability (>95%) was 
confirmed using trypan blue exclusion (0.5% trypan blue solution). Viability was 
tested as confirmation for what I believed already to be the case that phagocytes were 
viable and able to phagocytise and that there was not a large number of in vivo 
senescent cells as a result of the treatments. 
Phagocytic cells, defined as neutrophils and macrophages and identified accordingly, 
were counted until 100 cells that had consumed yeast had been recorded. The 
number of yeast cells in each phagocyte was counted and the phagocytic index and 
phagocytic capacity and phagocytic activity calculated as follows: 
• Phagocytic index (PI) is the total number of yeast cells consumed, divided by the 
number of consuming phagocytes. 
• Phagocytic capacity (PC) is the total number of phagocytes containing a given 
number of yeast cells divided by the total number of phagocytes containing any 
yeast. 
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• Phagocytic activity (PA) is the number of consuming phagocytes divided by the 
total number of phagocytes counted. 
STATISTICAL ANALYSIS 
One-way and two-way analysis of variance tests, Tukey's (HSD) and LSD tests were 
performed using the general linear models procedure of the SAS system for 
Windows 6.11. Data were considered to be significant at the 5% level (p<0.05). 
Regression analyses were performed using the statistical package of Microsoft Excel 
97. 
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INTRODUCTION 
There is little doubt that the Paramoeba sp. that can be isolated from the gills of 
Atlantic salmon and rainbow trout in Tasmania is the aetiological agent of AGD. 
However, Koch's postulate has not been fulfilled in relation to infecting susceptible 
animals with the cultured organism. 
Irrespective of whether Koch's postulate had or could be fulfilled, it was necessary to 
have a method of consistently reproducing the disease in an experimental situation in 
order to effectively study the response of Atlantic salmon to AGD. Two approaches 
were used. 
One method was to attempt to reproduce AGD using cultured Paramoeba sp.. This 
approach had been tried by Kent et al. (1988), Howard etal. (1993) and Searle (pers. 
comm., 1988) without success. While it is most likely cultural conditions (eg type 
and variety of 'food' items) that cause Paramoeba to lose their virulence when 
cultured, there were practical constraints that could have accounted for the above 
failures to reproduce the disease and my study addressed some of these. In the trial 
described here, varying concentrations of Paramoeba were used in the water column 
and the organism was subjected to different temperature regimes in an effort to 
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mimic the natural situation. Also, I instituted a more stringent experimental design 
protocol than the above-mentioned researchers. 
The other method was to expose naïve fish to infected fish (cohabitation method). 
This was based on the serendipitous observation of Mr Lance Searle of the 
Tasmanian Department of Sea Fisheries that when uninfected trout came in contact 
with infected fish they developed AGD. This observation was subsequently 
experimentally verified by Howard et dl. (1993) using rainbow trout. However, they 
only maintained experimental disease for 14 days. For my work it was necessary to 
reproduce the disease in Atlantic salmon and maintain it for an extended period of 
time. 
METHODS AND MATERIALS 
The following methodology development studies were undertaken prior to and 
during the main part of my research prop-am. 
Cultured Paramoeba 
The experiment reported here was designed to test the infectivity of cultured 
Paramoeba sp. to Atlantic salmon. 
Large numbers of Paramoeba sp. were cultured using the method described in 
Chapter 2. Paramoeba Were harvested by washing the surface of the plates with 
sterilised seawater. Two 30 litre tanks of amoebae suspension at concentrations of 
5000 amoebae/mL and 15 000 amoebae/mL were set up, with one treatment at each 
concentration using Paramoeba maintained at 20°C and the other with Paramoeba 
acclimated to 14°C. All baths were maintained at 14°C and aerated to the extent 
necessary to keep the amoebae suspended in the water column. 
The viability of the organisms to be used in this experiment was established by 
adding 0.5% trypan blue solution to an aliquot of the Paramoeba suspension. The 
number of viable cells were counted using a haemocytometer and the percentage 
calculated. 
Fifteen 100g Atlantic salmon smolts were added to each bath for two hours. This 
process was repeated with a second group of fish to increase to 30 the number of fish 
that had been exposed to cultured Paramoeba. It is acknowledged that the ideal 
experimental design would be to bath all 30 fish for each treatment at once, however 
resource limitations meant this was not possible. 
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After the two hour bath, the fish were placed in four separate 4000L fibreglass tanks 
and maintained using the protocol for the maintenance of Paramoeba infection, as 
described in Chapter 2. Each week, for the four weeks post-treatment, all fish were 
anaesthetised and all gill arches were examined for signs of amoebic gill disease. In 
addition to this, each week five fish from each treatment were killed and the left and 
right first gill arches excised; one arch was fixed in Davidson's fixative for 
histological examination and the second was examined as a wet preparation using 
dark and bright illumination microscopy. After microscopical examination a smear 
was made from each sample and a Paramoeba [FAT conducted using the protocol 
des.cribed in Chapter 2. 
Wild Paramoeba 
For the establishment of a model for infection using fish-associated Paramoeba it 
was necessary to maintain a 'pool' of donor salmon with disease and to use these 
donors to infect experiment fish through cohabitation. The only protocols for 
experimental AGD infection that had been used prior to this study could not maintain 
infected fish for longer than approximately 14 days (Howard et al., 1993) and fish 
that were chronically infected with AGD had never been maintained. Refinement of 
the method that had been previously used was needed. 
Infected fish obtained from Aquatas Salmon Farm, Margate, Tasmania were placed 
into two 40001 fibreglass tanks. Each tank was connected to an individual biofilter to 
permit recirculation of the water. The water temperature was maintained by means 
of a heat exchanger connected to a heat pump with adjustments automatically 
initiated by an electronically controlled temperature probe. 
Initially, 20 naïve fish were introduced to each tank with the donor fish. The 
temperature was maintained at 14°C and the salinity at 35%o. The level of the disease 
was monitored by anaesthetising five fish and recording the number and severity of 
lesions present on the first gill arch. Smears were also made from the gills of each 
anaesthetised fish so an IFAT could be used to confirm the presence of Paramoeba 
in the lesions. Once sufficient disease was established the temperature was lowered 
to 12°C. At 12°C the progression of the disease was easily managed with mortalities 
occurring sporadically. At all times a minimum of 20 fish were maintained with 
AGD. After five mortalities had occurred from this disease reservoir tank five naïve 
fish would be added. However, it was found that at 12 °C, horizontal transmission 
was not always facilitated so the temperature was raised to 14°C when additions were 
made. At 14°C the naïve fish would become infected after four to five days at 
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which point the temperature would once again be lowered to 12°C. Using this 
protocol and maintaining a vigilant monitoring system, AGD was maintained in the 
experimental situation for 18 months. 
RESULTS 
Cultured Paramoeba 
The percentage viability of Paramoeba used in this experiment was greater than 
98%. 
No fish that had been exposed to cultured Paramoeba using the methods described 
above developed AGD and no amoeba could be seen on the gills either histologically 
or microscopically. Further, none of the IFAT tests detected the presence of 
Paramoeba on the gills of exposed fish. 
Wild Paramoeba 
Naïve fish that had been exposed to AGD via cohabitation with donor fish 
consistently developed AGD. The time to when the first lesions could be seen in 
naïve fish varied between four to ten days. As the virulence of the Paramoeba 
increased, as discussed below, the time to when the first lesion could be seen 
decreased. 
The Paramoeba IFAT provided a reasonably reliable means of confirming that 
Paramoeba were associated with the mucosal gill lesions. In most instances where 
lesions were seen, the IFAT confirmed the presence of Paramoeba sp. The 
sensitivity of the IFAT appeared to increase as the disease progressed. In fish that 
were heavily infected the IFAT detected the presence of Paramoeba in 100% of the 
samples taken. However, in the early stages of disease the IFAT did not reliably 
confirm the presence of Paramoeba, even when organisms could be seen under the 
microscope8 . 
More than providing a means for the consistent reproduction of disease, this protocol 
allowed AGD to be maintained in the experimental situation for long periods of time 
(up to 18 months in one instance) and the manipulation, albeit in an imprecise 
manner, of the severity of AGD. 
8 Since these observations, Zilberg & Munday (2000) have confirmed the relatively low sensitivity 
of the IFAT, but the reason(s) is not apparent at this stage. 
Page 48 
Chapter 3: Experimental Reproduction of AGD 
The initial strain of AGD that was obtained from Margate, Tasmania, became very 
virulent after 18 months continual passage into naïve fish and was causing pathology 
and death in short periods of time, so the decision was made to acquire another field 
strain. This strain was maintained using the same techniques described above. 
It was noted during the establishment of this infection protocol that fish that had been 
chronically infected with AGD over the period in which a number of sequential 
additions of naïve fish had been made, often became resistant to acute AGD 
infections. It was also noted that if these fish were the only donor fish in the tank 
when naïve fish were added, it took a longer period of time (ie two weeks instead of 
one week) for AGD infection to become established in the naïve fish. 
Another incidental observation that was made during the establishment of an 
infection protocol was that the addition of a protein skimmer9 to a tank holding AGD 
infected fish resulted in a spontaneous resolution of disease, together with clearing of 
Paramoeba from the gills. This observation was not further investigated. 
DISCUSSION 
As discussed in Chapter 1 there are at least three species of Paramoeba that have 
been associated with disease in susceptible animals. Of these, Koch's postulate has 
been fulfilled for only one; P. invadens. 
There does, however, appear to be some debate in the scientific community regarding 
the use of Koch's postulate to prove the aetiological cause of disease. As an 
example, information was recently forwarded to me from Dr Matti Kiupel of the 
Animal Disease Diagnostic Laboratory, Indiana, USA, suggesting that Koch's 
postulate is no longer the standard test to prove an aetiology. The molecular updated 
version of Koch's postulate consists of proof that the organism is associated with a 
lesion/disease, to identify this organism (isolating it or confirming sequence data etc) 
and reproducing the disease somehow....." 
Put simply, a protein skimmer consists of a reaction chamber where the water is mixed with small 
air bubbles. As the bubbles rise through the water, protein molecules are attracted to the water/air 
interface and become attached to the air bubble, rising to the top of the reaction chamber where 
they are collected. This removes the proteins from the system before the bacteria can digest them. 
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The opposing view is that fulfilment of Koch's postulate is the only conclusive proof 
of aetiology. Dr Douglas Gregg of the Foreign Animal Disease Diagnostic 
Laboratory, USA commented 'that while opinions based on comparative pathology, - 
electron microscopy, comparative immunology, immunohistochemistry, and in-situ 
hybridization...are interesting and cannot be ignored, the final answer on the 
aetiology of a disease awaits the fulfilment of Koch's postulate (in more than one 
laboratory). Until the agent can be isolated in vitro and disease then reproduced, most 
scientists should be skeptical' (Gregg, 1996). 
Where disease has been reproduced using organisms isolated from diseased animals, 
such as has been done by Zilberg, Gross & Munday (2000) who reproduced disease 
using Paramoeba sp. isolated from infected gills, it appears that the fulfilment of 
Koch's postulate in relation to the in vitro isolation of the organism and subsequent 
reproduction of disease may be outdated. It is suggested that microbiological and 
molecular constraints in the period Koch's postulate was first accepted as the 
standard for proof of the aetiology of disease led to the conclusion that in vitro 
culture was the only way to 'isolate' a given pathogen. Given the developments in 
these fields, it is intriguing that the strict application of Koch's postulate has 
persisted. Certainly in the instance of AGD, the aetiological agent has been defined 
by the above authors without strict fulfilment of Koch's postulate. 
Even so, this does not eliminate the possibility that some other co-factor such as 
the presence of a virus or bacterium or another predisposing factor, may be 
required along with Paramoeba sp. Certainly other workers in the field including 
Kent et al (1988), Munday et al (1990) and Nowak & Munday (1994) have 
suggested that pre-disposing factors may influence the development of AGD. 
However, more recent work conducted to Zilberg & Munday (2000b). 
demonstrated that Paramoeba sp. will attach to healthy epithelium suggesting 
that the gills do not have to be damaged in order to allow the infection to occur 
and that the attachment of Paramoeba sp. triggers epithelial lesions in healthy 
gills. Also, Zilberg, Gross & Munday (2001) reproduced the disease with 
isolated Paramoeba sp.. Therefore, if a virus or a bacterium is involved it must by 
a commensal of the amoeba, something yet to be researched. 
As previously stated, whether Koch's postulate had, could or needed to be fulfilled it 
was necessary to optimise an infection regime as well as develop a protocol that 
allowed AGD to be maintained in the experimental situation. 
In my trials the only difference between the two procedures for the establishment of 
AGD was that cultured organisms were used in one and wild Paramoeba released 
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from the gills of infected fish in the other. The materials and methods described 
above for the cultured Paramoeba trials were the same as those used in the 
cohabitation study. Naïve fish from the same group of post-smolts were used as the 
challenge fish in both trials, the same batch of seawater was used and the temperature 
regime used in the cultured Paramoeba trial mimicked that of the cohabitation 
challenge. The cohabitation protocol consistently led to the reproduction of disease; 
the protocol using cultured Paramoeba did not. Although all practical constraints 
associated with reproduction of AGD using cultured organisms have not yet been 
ruled out it, given the mounting evidence, these seem to be an unlikely reason for the 
failure of cultured organisms to reproduce disease. Further, Zilberg etal. (2000) 
demonstrated that only 230 Paramoeba sp. per litre harvested from infected fish and 
directly added to a bath with naïve fish were needed to establish infection. Thus, 
even if less than 10% percent of the cultured Paramoeba sp. used in this study were 
virulent, as has been demonstrated in certain circumstances for cultures of 
Aeromonas salmonicida (Ishiguro, Kay, Ainsworth, Chamberlain, Austen, Buckley 
& Trust, 1981), the minimum infective dose was clearly exceeded. 
It appears most likely that cultured Paramoeba are missing out on 'something' or 
getting 'something' in the culture process that renders them non-virulent. The 
phenomenon of loss off or decreasing virulence in pathogenic organisms is not 
uncommon. A lot of the knowledge on virulence and virulence factors of pathogenic 
organisms is the result of studies using bacterial pathogens. However, there are 
number of studies on protozoan pathogens, particularly Entamoeba histolytica that 
may indicate reasons for the loss of virulence that is seen in cultured Paramoeba sp.. 
In 1960, Vincent & Neal (1960) described the gradual decrease in virulence of E. 
histolytica maintained in vitro. These workers also demonstrated that virulence 
could be restored if the cultured organisms were passed through host cells. 
Although virulence was never completely lost during the Vincent and Neal study, it 
indicates that 'something' was not right in the in vitro environment. Subsequent 
studies by, inter alia, Wittner & Rosenbaum (1970); Phillips, Diamond, Bartgis & 
Stuppler (1972) and Bos & Hage (1975) suggested that the virulence of E. histolytica 
could depend on an episome-like factor that required direct contact with live bacteria 
in order to be expressed. Given that Paramoeba sp. has always been cultured using 
Xanthomonas maltophila as a source of nutrition, it may be that this bacteria does not 
provide the necessary properties in order for virulence to be expressed in the amoeba 
(in this respect it would be useful to determine the sugar moieties on X maltophila). 
This scenario has certainly been demonstrated for E. histolytica. Padilla-Vaca, Anlcri, 
Bracha, Koole & Mirelman (1999) demonstrated that E. histolytica grown with a 
galactose (Gal) /N-acetyl-D-galactosamine (GalNAc) binding strain of E. coli 
showed markedly reduced adherence and cytopathic activity. Specific lectin gene 
Page 51 
Chapter 3: Experimental Reproduction of AGD 
probes revealed a decrease in the transcription and expression of the Gal/GaINAc 
light subunit. This effect was not observed when E. histolytica was grown with a 
marmose-binding strain of E. coli. These workers concluded that the light subunit of 
the amoebic lectin is involved in the modulation of the parasite adherence and 
cytopathic effect. 
One common theme for many pathogenic organisms is the use of microbial lectins 
for colonization and invasion. In this regard, Mirelman l° (pers. comm., 2000) stated 
that most amoeba infections begin by a lectin mediated binding of the pathogen to a 
host mucosa and the mucus of the gills is an appropriate template. He further 
commented that it is likely that the carbohydrate affinity will be some glycoconjugate 
rich in galactose or N-acetylgalactosamine, as has been found for many of the 
amoeboids. 
In this regard, Ravdin & Guenant (1981) established that adherence and subsequent 
contact dependent cytolysis of the chinese hamster ovary (CHO) cells were nearly 
completely blocked by galactose or N-acetyl-D-galactosamine. This galactose 
inhibition of amoebic adherence was also shown to extend to human erythrocytes and 
neutrophils, certain bacteria, human colonic mucosa and rat and human colonic 
mucins (Petri, 1991). 
Of particular interest to the research on AGD are the studies by Li, Becker & Stanley 
(1988) and Saffer & Petri (1991) that demonstrated galactose in a 01-4 linkage with 
N-acetylglucosamine was the preferred ligand for the amoebic lectin and that N-
acetylglucosamine is a significantly more potent inhibitor of the amoebic lectin than 
is galactose. These workers suggested that the galactose specific lectin that occurs 
on the amoeba may bind N-acetylglucosamine with a much higher affinity than 
galactose. The details of why this finding in E. histolytica may provide evidence of 
the mechanisms for resistance of Atlantic salmon to AGD will be discussed in a later 
chapter. 
It is important to note that not only are there moieties on the amoeba that may 
enhance or facilitate adherence but that there may be lectins on the gills that display 
adherence properties towards sugar moieties on the amoeba. These interactions are 
very complex and it is likely, if not probable, that there is more to adherence and 
cytopathology than the galactose-specific lectin alone. It has been shown for E. 
histolytica that isolates can be grouped into pathogenic and non-pathogenic 
zymodemes on the basis of isoenzyme analysis (Petri, Jackson, Gathiram, Kress, 
10 Mirelman, D. Weismann Institute, Israel 
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Saffer, Snodgrass, Chapman, Keren & Mirehnan, 1990). Similar isoenzyme analysis 
of Paramoeba sp. is warranted. 
Other distinctive features of E. histolytica that may relate to, or indicate, 
pathogenicity include the thickness of the cell surface coat. El-Hashimi & Pittman 
(1970) and Lushbaugh & Miller (1974) showed that invasive forms of amoebas have 
a thicker and more prominent surface coat. A thicker surface coat may indicate an 
increase in the moieties specific to adherence and cytopathology. 
The overall surface charge of a given strain of amoeba may also indicate 
pathogenicity. Trissl, Martinez-Palomo & Chavez (1976) demonstrated that low 
virulence strains of E. histolytica could be labelled with cationic ferritin at neutral pH 
and that these strains had an overall negative electrical charge at the cell surface. 
Virulent strains of E. histolytica did not have electrophoretic mobility at neutral pH 
and did not bind cationic fenitin. It is interesting that Martin (1987) showed that 
Paramoeba pemaquidensis, the presumed agent of AGD, required a minimum 
surface negative charge for adhesion to substrata. 
All of the above variables are likely to be influenced by artificial culture and need to 
be addressed in a logical sequence if Koch's postulate needs to be fulfilled. 
Just as the attenuation of virulence in pathogenic organisms that are cultured so often 
happens, the increase in virulence following passage through susceptible hosts is 
equally well reported. Eldar, Bejerano, Livoff, Horovitcz & Bercovier (1995) and 
Mateos & Paniagua (1996) demonstrated an increase in the virulence of Aeromonas 
hydrophila and Streptococcus sp. respectively with serial passage through susceptible 
hosts. This study reports a similar situation for Paramoeba sp. For a large 
proportion of this study, one strain on Paramoeba sp. was maintained. However, as 
discussed previously, after continual passage into naive fish, this strain was causing 
significant pathology and mortality in very short periods of time, so it was decided to 
obtain another field strain to continue the challenge trails. Although the mechanisms 
for the increase in virulence are unclear, some insight may be gained from evidence 
relating to the attenuation of virulence. Presumably, an increase in virulence would 
be expressed as a result of a changed composition of the moieties associated with the 
surface coat. 
Some comment on the possible reasons why a protein skimmer may have resulted in 
resolution of the disease and removal of Paramoeba from the gills is needed. 
If in fact the composition of the bacteria to which the Paramoeba are exposed 
regulate virulence factors then a change in the protein composition of the tank 
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environment, as a result of the protein skimmer, could result in a decrease in 
transcription and expression of the adherence lectin, as has been demonstrated for E. 
histolytica, or an inhibition of adherence to the gill as a result of the presence of a 
preferred ligand. Alternatively, as Paramoeba are shed from the gills in mucus 
particles (Zilberg & Munday, 2000a) the process may simply have removed the 
organisms from the water column to the extent that a threshold population was no 
longer present in donor fish and an infective dose was not available to naïve fish. 
The application of the hypotheses presented above, in relation to the Atlantic salmon 
acquiring resistance to AGD will be discussed in later chapters. 
While a protocol using cultured organisms for the reproduction of AGO would 
provide a means of carrying out highly controlled tanks trials, irrespective of season, 
as well as reducing the monetary and time costs because 'donor' fish would not be 
needed, the development of a protocol which allows the maintenance of 'donor' and 
experimental fish indefinitely has been a major achievement. Without this protocol 
effective and robust in vivo experimental studies of AGD could not have been 
undertaken. 
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INTRODUCTION 
During the early years of amoebic gill disease occurring in farmed salmonid stocks in 
Tasmania it was noted that fish often experienced three waves of infection coupled 
with the need for three rounds of freshwater bathing. There was much anecdotal 
evidence suggesting that fish that had been previously infected with AGD and treated 
with a freshwater bath appeared to be relatively resistant to re-infection. Often, the 
third bath was carried out in response to only a small percentage of the fish relapsing. 
Thus, it appeared that the success of the freshwater baths was dependent on fish 
acquiring immunity. 
Page 55 
Chapter 4: Demonstration of Resistance to AGD 
Atlantic salmon have been shown to respond to Paramoeba antigens, both when 
immunized parenterally with killed and live organisms, and when subjected to severe 
natural and experimental infections (Akhlaghi, 1994). As well as humoral 
antibodies, it is possible that local (gill mucus) antibodies may be formed, and as 
with bacterial gill disease (Lumsden, Ostland, MacPhee, Derksen & Ferguson, 1994), 
these may be protective. The trial described here was designed to test this 
possibility, as well as provide firm evidence for the development of resistance in fish 
that had previously suffered from AGD. 
• As well as testing whether AGD induced a specific immune response, a phagocytosis 
assay was conducted on infected fish during this challenge trial in order to detect if 
the nonspecific defence response was influenced by the infection. 
As it had been reported that osmoregulation can be compromised in fish severely 
affected with AGD (Munday et al., 1990), the opportunity was taken to record the 
plasma osmolality in fish from each of the experimental groups. 
MATERIALS AND METHODS 
AGD challenge trial  
Initially, two replicates of 50 Atlantic salmon smolts of 100-150g bodyweight (mean 
134.6g ± 9.8g) naive for AGD, having been maintained in freshwater, were placed in 
tanks maintained at 14 °C with 12 Atlantic salmon post-smolts infected with AGD. 
After four weeks all fish displayed lesions and mortalities had occurred. With the 
exception of eight fish from each tank (which were used in a phagocytosis assay 
described below), the surviving fish were transferred to a freshwater tank where they 
recovered quickly. After a further four weeks, the fish were divided into two groups 
and placed into seawater tanks with equal numbers of naive fish. Infection was 
initiated by adding twenty post-smolts with AGD to each tank. The severity of the 
resultant AGD was quantified as described previously (Chapter 2) and the number of 
mortalities in each group recorded. 
Osmolalit 
During the post-exposure weekly gill counts, blood samples were taken, using a 
heparinized tuberculin syringe fitted with a 21 gauge needle, from the caudal vessel 
of ten fish from each of the infected, naive, control and donor groups. The blood was 
immediately centrifuged, the plasma separated and stored on ice until use as soon as 
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practicable on the same day. The plasma osmolality of each sample was measured by 
vapour pressure osmometry (Advanced 505 osmometer). 
Detection of anti-Paramoeba antibodies 
At the completion of the above challenge, serum and mucus was collected from each 
of the remaining fish in each of the four groups and assayed for the presence of anti-
Paramoeba antibodies. 
Serum collection 
Fish were anaesthetised as previously described (Chapter 2). Each fish was turned 
into the supine position and held in a cradle with head elevated. Prior to the fish 
being bled from the caudal vessel, the body mucus was removed with paper 
towelling and the fish wrapped in paper towels to prevent contamination of the gill 
mucus. As much blood as possible was collected from the caudal vessel using a 21- 
gauge needle and a 15m1 syringe; this was allowed to clot overnight at 4°C. The 
samples were centrifuged at 1500g for 15 minutes, the serum aliquoted and stored at 
-80°C until use. 
Mucus collection 
With the fish's head still elevated the tail was severed at the peduncle region and then 
the heart was exposed. The gills were perfused with heparinized saline by direct 
puncture of the bulbous arteriosus or ventricle using a 21-gauge needle and a 50m1 
syringe. Depending on the size of the fish complete perfusion generally occurred 
after about 30 seconds and 20-30m1 of saline had been injected. Perfusion was 
judged as being complete when the gills were blanched white and the fluid flowing 
from the caudal vessels was clear. The gills were excised, weighed and immediately 
placed in an antibody extraction cocktail as described by Lumsden, Ostland, Byrne & 
Ferguson (1993). In short, this consisted of 0.85% saline, 2mM 
phenylmethylsulphonyl-flouride (PMSF), 2mM N-ethylmalemide (NEM), 10mM 
disodiutn ethylenediamine tetraacetate (EDTA), and 0.02% sodium azide (NaN3), at 
4°C for two hours with occasional shaking. After soaking, the gill tissue was 
removed and the mucus preparations were centrifuged at 30 000g for 30 minutes at 
4°C. The resulting supernatants were dialyzed against distilled-deionized water 
containing 2 mM PMSF and 0.02% sodium azide. Additional debris was removed 
from the dialysate by centrifugation (1000g for 15 minutes). The mucus preparations 
were lyophilized and stored in airtight containers until use. Each individual sample 
was resuspended in a volume of PBS with NaN3 proportional to the wet weight of the 
initial sample, before the immunoassay was performed. 
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ELISA 
An enzyme-linked immunosorbent assay (ELISA) was used to determine the specific 
anti-Paramoeba antibody values in serum and mucus samples. The assay used was 
modified from the ELISAs as described by Akhlaghi, Munday & Rough (1993), 
Bryant, Lester & Whittington (1995) and Howard & Carson (1994). The incubation 
intervals, temperature, pH and diluents involved in each step of the ELISA were 
optimized using previously collected serum samples from fish that had been 
inoculated with Paramoeba antigen and fish that were naïve in relation to 
Paramoeba sp.. This minimized background noise and increased the difference 
between the negative and positive control sera. 
Preparation of amoebic antigen 
Paramoeba sp. were cultured as previously described (Chapter 2). The amoebae 
were harvested from plate cultures by washing with filtered sterile sea water (FSSW) 
and the contaminating bacteria used as nutrient substrate were mostly removed by 
centrifugation (1000g for 20 minutes in FSSW, x 3). The washed Paramoeba cells 
were then resuspended in 2mls of FSSW and sonicated. The protein concentration of 
the sonicate was determined and readjusted to give a final concentration of 1mg.m1 -1 . 
The preparation was then stored at —20°C until use. 
Preparation of X. maltophilia antigens 
The soluble antigen was prepared by washing the bacterial cells that had been 
harvested from nutrient broth (as previously described in Chapter 2) with sterile 
distilled water followed by sonication. The protein concentration of the sonicate was 
determined and the antigen stored at —20°C. 
Absorption of X. maltophilia antibodies 
As the Paramoeba harvested for use as the soluble antigen had been cultured using 
X maltophilia for nutrition, the Paramoeba antigen would contain bacterial 
contaminants. To ensure that the results of the ELISA were due only to the presence 
of anti-Paramoeba antibodies, and not anti-X maltophila antibodies, serum and 
mucus samples were absorbed with X maltophilia sonicate. 
Serum and mucus samples were diluted in PBS (1:50) and mixed with X. maltophilia 
sonicate (200ug.m1-1 ) in a ratio of 1:1 for 11/2 hours at 4°C. The absorbed samples 
were then centrifuged for two minutes at 10 000g and the supematant collected for 
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ELISA evaluation. The efficacy of absorption was determined by ELISA, using 
several different dilutions of antigen and antibody. 
General ELISA methodology 
Paramoeba sp. and X maltophilia antigens were diluted in coating buffer (50mM 
sodium hydrogen carbonate, pH 9.5) to a concentration of 5ug.m1 -1 . The 96 well 
microtitre plates (flat bottom polystyrene microtitration ELISA plates by 
Linbro/Titertek) were coated with 100E11 of antigen per well and incubated overnight 
at 4°C. After incubation the antigen solution was flicked off and the wells blocked 
with PBS/3% casein (100111/well) for 30 minutes at 25 °C. The plates were then 
washed three times with PBS/0.05% tween-20. 
Serum and mucus samples which had been diluted 1:100 and 1:10-1:100, with 
PBS/1% casein, respectively, were added to the wells (1000/well) and the plates 
were incubated at 25°C for 90 minutes. All samples were tested in triplicate. After 
washing, mouse anti-rainbow trout monoclonal antibody, supplied by Dr Richard 
Whittington, EMAI, diluted 1:10 in PBS/1% casein was added (1000/well) and the 
plates were incubated for 90 minutes at 25 °C. Plates were washed three times and 
rabbit anti-mouse immunoglobulin conjugated to horseradish peroxidase (Dako ®), 
diluted 1:1000 in PBS/1% casein was added (100W/well) before the plates were 
incubated for a further 90 minutes at 25°C. Plates were washed five times before the 
colour developing solution, OPD (0.07% o-phenyl-enediamine dihydrochloride in 
sodium citrate phosphate buffer with 0.012% hydrogen peroxide, pH 5, 100111/well) 
was added. The plates were incubated in the dark for five minutes before the 
reaction was stopped with 3N hydrochloric acid (501.tl/well). The optical density was 
measured at 492 rim using an automated microplate reader (model EL309). A 
negative and positive control sample was included in triplicate on each plate. 
Correction of optical density readings 
All optical density readings were corrected by the plate correction factor (PCF) that 
follows. Briefly 
PCF= (Target O.D. A/Actual 0.D: A + Target O.D. B/Actual O.D. B + Target O.D. 
C/Actual O.D. C + Target O.D. D/Actual O.D. D) /4 
Where A, B, C, and D indicate the optical densities for the highly positive, the 
medium positive, the low positive and the negative respectively. The target optical 
density refers to the mean optical density for each control over the entire period of 
testing and the actual optical density is the mean optical density of the triplicated 
wells. 
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The positive/negative cut-off was defined as the mean optical density for the negative 
controls plus three standard deviations (Johnson, Roberts & Munday, 1988). Optical 
density readings equal to and above this were considered sero/muco-positive. 
PHAGOCYTOSIS ASSAY 
A phagocytosis assay was performed using 16 fish that were infected with AGD and 
16 fish that had been acclimatized to seawater but naive in respect to AGD. The 
materials and methodology for the in vivo assay that was used here has been 
previously described in Chapter 2. 
RESULTS 
AGD challenge trial  
The AGD lesion patterns for the first trial are shown in Figure 4. It is clear that the 
salmon that had been previously infected with AGD and allowed to recover for four 
weeks in freshwater were significantly more resistant to disease (Fcaic=51.73,  d.f.=1, 
p<0.0001) than the naïve fish. 
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Figure 4 AGD lesion patterns in fish that have previously exposed to AGD 
or were naïve in relation to AGO 
Week 
PE 4W = Fish that had been previously infected with AGD, placed in freshwater for four 
weeks before being re-exposed in this trial; Naive = Fish that were naive in relation to 
AGD prior to being infected in this trial. 
At the first weekly examination, Tukey's grouping did not differentiate between 
treatment groups. However, thereafter and until the completion of the trial, Tukey's 
groupings distinguished the naïve and previously exposed fish; the naïve fish 
displayed significantly more lesions than the fish that had been previously exposed, 
and were obviously distressed. The mean number of lesions in the previously 
exposed fish declined to a low by week four, and indeed, most fish completely 
recovered or were displaying very few minor lesions. Out of a total number of fish 
included in both replicates, 20% (7 out of 40 fish in one tank and 9 out of 40 fish in 
the other) did not recover- that is they showed little or no change in severity or 
number of lesions or had died. These fish accounted for the majority of the total 
count of mucus patches for this group. 
At the end of this challenge there were also marked differences in the mortalities that 
had occurred in each group of fish. Of the 40 donor fish that were used in this 
experiment only 30% remained alive. There were also a relatively high number of 
mortalities in the naive group of fish, with 30% dying before the end of the trial. In 
the previously exposed group of fish, only 9% died as a result of AGD infection. 
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Osmolalitv  
There was a significant difference in plasma osmolality between donor fish, infected 
and naive fish and control fish (F=263.7, d.f. =3, p<0.0001). As can be seen in 
Figure 5, fish that had been chronically infected with AGD for a long period of time 
(donors) displayed a significantly increased plasma osmolality (as indicated by 
Tukey's groupings) when compared to all other groups. The Tukey's groupings did 
not distinguish plasma osmolality levels between fish that had been infected for the 
second time (previously exposed) and those being exposed for the first time (naive). 
However, as previously stated both these groups of fish displayed significantly 
increased plasma osmolality when compared to control fish. 
ELISA 
As described above, at the completion of this trial, blood and mucus samples were 
collected from surviving fish and ELISAs were performed using known positive and 
negative sera as controls. Using the convention that the negative: positive threshold 
is calculated as the mean of the controls plus three standard deviations of the optical 
density (Johnson et al., 1988), it was found that there were no significant ELISA 
reactions with the mucus samples. However, 100% of the serum samples taken from 
donor and recently infected naive fish contained anti-Paramoeba antibodies, as did 
68% of the serum samples taken from previously infected and re-exposed fish. None 
of the serum samples taken from control fish contained anti-Paramoeba antibodies 
(Figure 6). 
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Figure 5 Serum osmolality of groups of fish with varying exposure to 
AGD 
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Control = Fish that were maintained in full salinity seawater but were not exposed to 
AGD; PE = Fish that were previously infected with AGD, treated with a freshwater bath 
and reexposed; Naive = Fish that were previously naive in relation to AGD but were 
exposed in this trial; Donor = Fish that were maintained with AGD for extended periods of 
time. 
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Figure 6 ELISA results indicating the presence/absence of anti-
Paramoeba antibodies in serum samples taken from fish with varying 
exposure to AGD 
Control = Fish that were maintained in full salinity seawater but were not exposed to 
AGD; PE = Fish that were previously infected with AGD, treated with a freshwater bath 
and reexposed; Naïve = Fish that were previously naïve in relation to AGD but were 
exposed in this trial; Donor = Fish that were maintained with AGD for extended periods of 
time. 
Phaqocytosis assay 
Head kidney cells that had been collected from the fish that had AGD demonstrated 
enhanced phagocytic abilities for all measured parameters. There were significant 
increases in the phagocytic index (PI), phagocytic capacity (PC) and phagocytic 
activity (PA) for AGD affected fish (Table 2). As can be seen in (Figure  7) for AGD 
affected fish there is a right shift in the phagocytic profile of yeast consumption per 
phagocyte. This represents an increased ability to engulf particles and is indicative 
of a stimulated nonspecific defence system. 
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Table 2 Comparison of phagocytic parameters in AGD infected and 
uninfected Atlantic salmon 
Group 	 Phagocytic 	Phagocytic Capacity (PC) 	Phagocytic 
Index (P1) 1-3 	4-6+ 	Activity (PA) 
yeast/cell yeast/cell 
AGD infected 1.9675 89% 	11% 43.3% 
Naive 1.5163 97.13% 	2.87% 33.9% 
Statistical 
analysis 
Fcalc =65.40 Fcalc =24.77 F1 =114.33 
d.f. =1 d.f. =1 d.f. =1 
p<0.0001 	 p<0.0001 	 p<0.0001 
Figure 7 Comparative phagocytic assay result for fish exposed and not 
exposed to AGD 
50 — 
40 — 
30 — 
20 — 
10 — 
7 	1 
1 	2 	3 	4 	5 	6 	6+ 
Ntunbei of yeast cells phagocytised pel phagocyte 
Control = phagocytes harvested from fish maintained in sea water but not exposed to 
AGD; AGD = phagocytes harvested from fish maintained in sea water and infected with 
AGD 
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DISCUSSION 
This trial confirms the hypothesis that salmonids, which have suffered an attack of 
AGD and have been allowed to fully recover, develop significant resistance to re-
infection. An interesting observation was that the previously-exposed fish initially 
appeared to be as susceptible as the naive fish, but at two weeks after re-exposure, 
they displayed resistance. The mechanism involved is unclear but may relate to the 
time required for the various nonspecific defence responses to have a significant 
effect on the Paramoeba. As discussed below there is no evidence that anti-
Paramoeba antibodies are protective. 
These results, as well as those reported by Aldilaghi (1994), Howard & Carson 
(1994) and Zilberg & Munday (2000b), provide no indication that the detected 
antibodies are at all protective. There is no correlation between the presence of 
antibodies and a demonstrable resistance to Paramoeba sp. All serum samples taken 
from infected naive and donor fish contained anti-Paramoeba antibodies, yet it was 
these groups of fish that displayed the most severe lesions and the highest number of 
mortalities. In the previously exposed fish, only 68% were positive for anti-
Paramoeba antibodies, yet the majority of fish in this group fully recovered without 
further treatment. 
It appears likely that the antibodies detected in the present study are relatively short 
lived. Once the infection is cured, as for the previously exposed group of fish (ie the 
stimuli to maintain the antibodies is removed), the antibodies disappear soon after. 
The rationale for this is that all donor fish and naive fish that were displaying lesions 
were 100% positive for anti-Paramoeba antibodies but only 68% of the previously 
exposed fish, that were displaying no or few lesions were positive for anti-
Paramoeba antibodies. 
Although it is a possibility that the ELISA used in this study failed to detect the 
protective antibody, it is well known that all antibodies are not protective. Unless 
antibodies can neutralize the components of pathogenicity they are valueless in 
giving protection. This scenario is particularly well known for Aeromonas 
salmonicida (Cipriano & Heartwell, 1986) and Edwardsiella ictaluri (Saeed & 
Plumb, 1986). In these instances there is little correlation between detected 
circulating antibody titres and protective immunity. It is important to realize then that 
assays of antibody levels may give no indication of the degree of protection unless 
they are against protective antigens. 
The absence of demonstrable anti-Paramoeba antibodies in gill mucus suggests that 
surface antibodies against Paramoeba sp. are not involved in natural immunity to 
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AGD. Previous studies by workers including Lumsden etal. (1994); Lumsden et al. 
(1993); Rombout, Taveme, van de Kamp & Taveme- Thiele (1993) and Lobb (1987) 
have demonstrated the existence of a mucosal antibody response in teleosts. Many of 
the results suggest differences in the composition of serum and mucus 
immunoglobulins indicating that immunoassays capable of detecting serum 
antibodies may not necessarily detect mucosal antibodies. However, studies by St. 
Louis-Cormier, Osterland & Anderson (1984) and Itami, Takahashi, Okamoto & 
Kubono (1988) using different teleost species did not reveal any differences between 
mucus and serum immunoglobulin. 
Lumsden et al. (1995) suggest that the most likely reason experiments fail to detect a 
given mucosal response is due to the relative insensitivity of the detection techniques, 
although those authors recognize that in some cases even the most sensitive tests do 
not detect a response. It may be that the differences in composition of mucus and 
serum antibodies are dependant on the origin of the same (ie where mucosal 
antibodies are due to serum transudation or active transport they are most likely to 
have a similar composition to those detected in the serum, but where they originate 
from local production they are more likely to be structurally distinct). If the latter is 
the case for the response of Atlantic salmon to amoebic gill disease then the 
monoclonal antibody used in the present study would not necessarily detect a gill 
mucus antibody and this aspect therefore remains unresolved. 
It has been demonstrated in a number of cases that soluble antigens are poor 
immunogens, at least for the stimulation of specific mucosal antibodies in fish. 
Rombout etal. (1989) could not identify any specific cutaneous antibodies in carp 
after oral administration of the antigen ferritin and Burgess (1988 as cited in Jenkins, 
Wrathmell, Harris & Pulsford, 1994) could only detect very low levels of antibodies 
in the bile and mucus in rainbow trout after immunization with human gamma 
globulin. Further, Bruce & Ferguson (1986) suggested that the absorption of soluble 
protein antigens across mucosal tracts may result in the revelation of epitopes of the 
molecule that are stimulatory for T-suppressor cells and also in the corresponding 
loss of determinants specific for T-helper cells, both of which can result in minimal 
immune responses. However, antibodies have been generated in the cutaneous 
mucus of channel catfish (Lobb, 190), rainbow trout (Davidson, 1991, as cited in 
Jenkins et al., 1994) and sheepshead (Lobb & Clem, 1981) in all cases with 
particulate antigens. 
Another explanation for the apparent inability to detect a protective antibody is that 
these may be formed against extracellular or metabolic products of the Paramoeba. 
If this were the case, the protocol used in this study would not detect them because 
washed Paramoeba cells were used. This may also be the reason why the studies by 
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Alchlaghi (1994), Howard & Carson (1994) and Zilberg & Munday (2000b) have 
failed to detect or induce protective antibodies. 
There is some evidence however, that extracellular products, including proteases are 
poor immunogens in salmonids. The findings of Ellis, Stapleton & Hastings (1988) 
did not support the assumptions by other workers, that protection afforded by 
vaccines composed of either crude extracellular products (ECP) or partially purified 
protease was the result of a specific immune response, at least in respect of antibody 
production. Also Hastings & Ellis (1988) showed that when rabbits were immunized 
using formalin inactivated toxoid of ECP of Aeromonas salmonicida, antibodies to at 
least 14 components of the ECP could be detected. In trout, antibodies to only four 
ECP antigens could be detected. These results indicate that extracellular antigens 
may require modification in order to improve their immunogenicity in fish. 
Furthermore, even though fluid-phase endocytosis is recognized as the process by 
which antigens contained within external substances are internalized and 
subsequently transported to their intracellular destination, there is evidence that in 
fish macrophages this may not be of such importance for uptake of extracellular 
macromolecules as it is for turnover of cellular membranes. Lauve & Dannevig 
(1993) demonstrated that salmonid head-kidney macrophages endocytosed a fluid 
volume corresponding to approximately 1.4% of their cell volume per hour but in the 
same period internalised approximately 70% of its surface area. They concluded that 
internalisation of cellular membranes was more important but that it would be of 
interest to know whether the process of endocytosis may be influenced by 
macrophage stimulators which cause increased secretory activity of macrophages. 
Even if, as the evidence is pointing, the composition of Paramoeba antigens is not 
suitable to induce a specific protective immune response, there is no reason to 
believe that other defence systems (ie the nonspecific) are not engaged. It is likely, 
and there is ample evidence that a variety of antigens elicit an innate, nonspecific 
defence response. Yersinia ruckeri antigens were found to stimulate the nonspecific 
cellular defence system of rainbow trout (Siwicki, Anderson & Dixon 1992). The 
addition of lysates from Goussia carpelli resulted in an increase of phagocyte activity 
in cells isolated from carp (Steinhagen & Hespe, 1997). Aeromonas salmonicida 
infection was shown to increase the levels of lysozyme, protease activity, haemolytic 
activity as well as serum complement (Moyner, Roed, Sevatdal & Heum, 1993) and 
carp infected with Eimeria subepithelialis displayed augmented serum lysozyme 
levels and phagocytic ability (Studnicka & Siwicki, 1990). 
The augmentation of phagocytic ability demonstrated in this study may have been 
initiated by soluble antigens present in a layer of extracellular material that is, 
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presumably, laid down as the Paramoeba moves along. Pinto da Silva & Martinez-
Palomo (1974) demonstrated that in actively moving Entamoeba histolytica cells a 
continuous shedding of surface components appears to take place. The thin layer of 
material that accumulates as microexudates has cytochemical properties similar to 
those of the antigenic surface coat. Given the evidence above, it is possible that these 
soluble antigens elicit stimulation of the nonspecific defence system of fish affected 
by AGD. The remote siting of the Paramoeba in relation to the specific humoral 
immune system (ie Paramoeba are mainly superficial and have 'never been noted to 
be phagocytosed) provides further evidence for such a mechanism. 
On the evidence thus far, including the absence of demonstrable anti-Paramoeba 
antibodies in the mucus and demonstrated lack of protection by serum antibodies, 
together with the remote siting of AGD infection in respect to the humoral immune 
system one must begin to think about the role of the nonspecific defence system in 
resistance to AGD. Indeed, the phagocytic assay results indicate that AGD infection 
may lead to the immunostimulation of the nonspecific defence system. Whilst the 
process of phagocytosis itself is unlikely to play a large part in resistance to AGD, 
augmentation of phagocytic ability is indicative of possible increases in numerous 
other nonspecific defence parameters. These factors are clearly of interest, especially 
where there is a coincidental increase in disease resistance. 
It is important to keep in mind that because of the complex interrelations between the 
nonspecific defence system and the specific immune system as discussed in Chapter 
one, it seems possible, if not likely; that stimulation of the nonspecific defence 
system may result in stimulation of the specific immune system (ie an increase in the 
speed and magnitude of a specific immune response). This will be discussed in more 
detail in later chapters. 
There are obviously deleterious effects of AGD infections and Munday et al. (1990) 
have previously reported that clinically affected fish have markedly elevated blood 
sodium levels and subclinically affected animals have lower, but still abnormal 
levels. The results of the present osmolality experiment confirm previous results that 
fish with long-established lesions suffer from osmoregulatory failure. However, 
while fish exhibiting extensive, but short term lesions exhibit elevated plasma 
osmolality, the recorded levels do not indicate osmoregulatory failure. 
It is probable that the decreased number of chloride cells observed in the affected 
areas of clinically affected fish (Munday et al., 1990) inhibit osmoregulation. The 
osmoregulatory failure that is seen in chronically affected fish is likely to be related 
to the formation of gill 'cysts'. In a proper functioning gill, chloride cells open to the 
surface of the gill and are in constant contact with the surrounding environment. 
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When these cells form 'cysts' in the gills and are no longer in contact with the 
environment of the fish, the massive flux of salt across the gills can no longer occur. 
This results in increasing osmotic imbalance and without treatment, often death. 
In affected fish that are freshwater-bathed, the immediate improvement in general 
health can be explained by the reduced need for the fish to pump salt out of their 
system against an ionic gradient and a partial restoration of ionic balance. Work 
conducted by Bakke, Bjerknes & Oevreeide (1991) confirms that Atlantic salmon 
held in freshwater for varying periods of time show significantly lowered sodium and 
chloride values when compared to fish held in saltwater. These workers reported 
that although plasma sodium levels return to pretreatment levels quickly after return 
to saltwater, chloride levels show a somewhat slower rise back to pretreatment levels. 
Although these workers did not further elaborate this result, it may be partly 
explained by the fact that sodium ions leave the gill epithelium passively via the 
leaky tight junctions between chloride cells as opposed to chloride secretion which is 
regulated by the active ATPase sodium pump. 
The longer term recovery that is seen in AGD-affected freshwater bathed fish is 
likely to result from a significant reduction in the numbers of amoebae, which in 
turn, would allow for normalisation of the gill epithelium and restoration of 
functional osmoregulation. 
A particularly interesting result from this trial was the group of previously exposed 
fish that did not develop a useful resistance to reinfection with Paramoeba sp. 
suggesting that these fish may be immunological subperformers. Given that a 
number of the freshwater baths carried out during the high-risk season are due to a 
group of fish apparently relapsing, while the remaining fish appear resistant, it was of 
considerable importance that this issue was further considered. If the number of 
baths could be reduced, this would be of significant value to industry. 
The series of experiments in the next chapter therefore deals with, inter alia, a 
treatment for this group of sub-performers. 
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INTRODUCTION 
Nonspecific defence mechanisms are important to all vertebrates, and fish, especially 
cold-water species, depend more heavily on these nonspecific mechanisms than do 
mammals (Avtalion, 1981). Furthermore, in those instances where pathogens, such 
as Paramoeba sp., infect sites that are relatively insulated from the specific humoral 
immune system, such as mucous surfaces, there seems to be few available options for 
treatment or prophylaxis, other than direct chemical therapeutics, or modulation of 
the nonspecific defence system. As a result of these considerations, and also because 
there was a group of fish which did not appear to develop resistance to AGD after 
freshwater bathing it was decided to investigate the use of immunomodulators. 
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In the last decade there has been increasing interest in the modulation of the 
. nonspecific defence system of fish for both treatment and prophylaxis against 
disease. A number of substances, including levamisole, have been shown to heighten 
the nonspecific defence system capacity. Studies including those by Jeney, Galeotii 
& Volpatti (1994), Mulero, Estaban, Munoz & Meseguer (1998) and Symoens & 
Rosenthal (1977) indicate that treatment with levamisole leads to an enhanced state 
of resistance to various kinds of infections. Levamisole is especially known for its 
ability to restore immunological function in immunocompromised individuals. 
In this series of experiments, modulation of the nonspecific defence system including 
lysozyme, reactive oxygen species, phagocytic ability and lymphocyte stimulation in 
Atlantic salmon following levamisole treatment was investigated. This is the first 
record of the use and efficacy of levamisole on the nonspecific defence system of 
Atlantic salmon. 
Levamisole is a levo-isomer of tetramisole. The chemical name of this synthetic 
compound is 1-2, 3, 5, 6-tetrahydro-6-phenylimidazo[2,1-b] thiazole (Arundel, 
1995). The compound was originally registered as a broad spectrum anthelmintic in 
ruminants and has since been used extensively and safely in veterinary and human 
medicine (Anon., 1991; Arundel, 1995). Levamisole is a known T cell stimulator 
and immunomodulator in mammals. 
Levamisole is rapidly adsorbed and excreted. Peak blood levels in farm animals are 
reached two to three hours following oral dosage and concentrations then decrease 
with little being present after 20 hours. In farm animals it is almost totally excreted 
in the urine and bronchial mucus. In man levamisole has a plasma half-life of about 
four hours, is extensively metabolized in the liver and is virtually eliminated from the 
body within two days (Symoens & Rosenthal, 1977). The half life in eels at 19-23°C 
is remarkably similar at about four hours (Blanc, Loussouam & Pinault, 1991). 
Levamisole is quite stable in acid aqueous media but hydrolyzes in alkaline solution 
(Symoens & Rosenthal, 1977). In relation to levamisole being used as a treatment 
for AGD, this means that in seawater, treatment would be ineffective unless the pH is 
adjusted and the pH of the freshwater treatment should be measured before 
levamisole is added. The benefit of levamisole hydrolysing in an alkaline media is 
that the treatment bath may be released with minimal effect on the environment. 
Levamisole has been demonstrated to augment both the specific immune and 
nonspecific defence systems of fish, but as has been documented in previous 
chapters, there is no correlation between detectable antibody against the Paramoeba 
sp. causing AGD and resistance to the disease. Therefore it was argued that there 
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would be little benefit given these circumstances in considering responses of the 
specific (adaptive) immune system in preference to those of the nonspecific defence 
system. 
The functional abilities monitored in this study such as phagocytic function, reactive 
oxygen species production, lymphocyte proliferation, and lysozyme are important 
elements of the nonspecific defence system. However, their contribution to and 
significance in Atlantic salmon defence mechanisms are dependent on the 
characteristics of the disease agent they act upon. This aspect of immunomodulation 
will be dealt with in a later chapter. 
Given that it had been previously demonstrated that fish infected with Paramoeba sp. 
displayed heightened phagocytic ability and appeared to lack protective antibodies, it 
was hypothesised that if a substance could be found that achieved 
immunostimulation of the nonspecific defence system of Atlantic salmon then 
protection against Paramoeba sp. may be given to these fish. Levamisole was the 
itnmunomodulator of choice because it had been shown to stimulate the nonspecific 
defence parameters in other fish species and it was also known for its ability to treat 
immunocompromised animals (ie the group of Atlantic salmon that do not display 
resistance to re-infection with AGD). 
MATERIALS AND METHODS 
Treatment of Fish  
All experimental fish were maintained as described previously in Chapter 2. Of the 
fish in each group, half were bathed in a freshwater bath with levamisole added at a 
rate to give 5mg.1-1 active principle in the water (treatment group) and the other half 
in a plain freshwater bath (control group). Fish were killed 14 days post-treatment. 
Immunoassays 
Lysozyme Assay 
A turbidometric assay utilizing Micrococcus lysodeikticus lyophilised cells (Sigma) 
was used to determine lysozyme concentrations in the serum and mucus removed 
from Atlantic salmon as described in Chapter 4. Eight samples were used in each 
assay. The assay method was a modification of that used by Sankaran & Gurnani 
(1972) who reported differences in the optimal pH and buffer molarities according to 
whether the fish were from freshwater or seawater. Thus, a series of assays was 
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conducted with pooled mucus and serum samples to optimise the test for use with 
Atlantic salmon maintained in seawater. While it was recognised that different 
buffers may further optimise results it was important to maintain some comparability 
so the same buffer (0.04M phosphate buffer) was use for all assays. 
M lysodeikticus was suspended in phosphate buffer at a concentration of 0.25 mg.ml -
1 . Two hundred microlitres of serum or mucus, diluted with an equal volume of PBS, 
were added to 1.3m1 of the substrate solution at 25°C and the optical density at 
450rim read immediately. After 30 minutes incubation in a humidified environment 
at 25°C the optical density was measured once again. Lyophilised hen egg white 
lysozyme (HEWL) was used to develop a standard curve. 
Serum and mucus lysozyme 'Values are expressed as gg.m1 -1 equivalent of hen egg 
white activity and were derived using the equation derived for the line of best fit. 
Phagocytosis Assay 
The method used for the phagocytosis assay has been previously described in 
Chapter 2. 
Two groups of fish were used in this assay; the first group was treated with 
levamisole and the second acted as a control group and were bathed in freshwater 
only. There were 20 fish per group. 
Reactive Oxygen Intermediate - Superoxide Anion Assay. 
Head kidney cells used in this assay were collected as described for the phagocytosis 
assay in Chapter 2. The only difference being that the white blood cell band was 
removed and washed twice with 3m1 of supplemented L15 medium. After the fmal 
wash, the supernatant is removed, the pelleted cells resuspended in 3m1 of 
supplemented FPS, and the cell number and viability determined by hemocytomter 
counting and trypan blue exclusion, respectively. 
Superoxide produced by the macrophages isolated from the head kidney was 
measured by the reduction of ferricytochrome C as described by Secombes, Chung & 
Jefferies (1988) and Zelikoff, Wang, Islam, Twerdok, Curry, Beaman & Flescher 
(1996). The specificity of the reaction was demonstrated by preventing the reduction 
of ferricytochrome C with exogenous superoxide dismutase (SOD) which dismutates 
any 02- generated to hydrogen peroxide. 
The amount of 02- produced in respiratory burst was quantified by comparing cells 
taken from an individual fish using four different reaction mixtures. Each of these 
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four mixtures contained 500111 of ferricytochrome C (Sigma) (final concentration of 
2mg.m1 -1 prepared in supplemented fish physiological saline) to which had been 
added 106  kidney cells (in a total volume of 250111 of supplemented Leibovitz 
medium). The first two reaction mixtures measured basal levels of 02- so no 
membrane stimulant was added to these mixtures. Exogenous SOD (125 pi, at a 
final concentration of 37.5 gg.m1 -1 prepared in Hanks buffered salt solution (HBBS)) 
was added to one of these mixtures so any basal level 02 - was inhibited. The second 
two reaction mixtures mimicked the first, with the addition of 100111 of the soluble 
stimulant phorbal myristate acetate (PMA) (Sigma) (at a final concentration of 
2.01.1g.m1 -1 , prepared in dimethylsuphoxide, working solution of 100gg.m1 -1 prepared 
in HBSS). An additional tube that contained all of the above-mentioned reagents, but 
without cells, acted as the reaction blank. Fish physiological saline was added to all 
the mixtures to bring the final volume up to lml. 
Each of the mixtures was vortexed for 30 seconds before 200111 aliquots were placed 
in triplicate in 96-well microtitre plates. The absorbance was measured at 550nm 
every ten minutes for two hours and again at 24 hours. Between readings the plates 
were placed in a humidified incubator at 30°C. 
Change in absorbance was calculated by first subtracting the mean of the blank wells 
from all other wells and then subtracting the absorbance of the wells containing SOD 
from that of the non-SOD-containing wells. The results were expressed by 
converting the optical density readings to imol 02 - per 105 cells by multiplying with 
the correction factor of 15.87 as given by Pick & Mizel (1981). 
Mitogen-induced lymphocyte proliferation 
Lymphocytes in the peripheral blood and the spleen were isolated from each of ten 
fish that had been treated with either a levamisole and freshwater bath or a freshwater 
only bath. 
Lymphocytes were isolated by buoyant density gradient centrifugation. This method 
is known to result in high recovery (>95%) of lymphocytes (Braun-Nesje et al., 
1981). For determination of the lymphocyte percentage in each suspension, slides 
were stained with Wright's stain and examined morphologically using light 
microscopy. The final percentage of lymphocytes averaged 96.2%. The remainder 
of the cell suspension consisted of mostly macrophages but at times contained 
thrombocytes and/or granulocytes. 
Peripheral blood lymphocytes were obtained by caudal vein puncture with a 10m1 
sterile syringe pre loaded with heparin 1001g.m1 -1 in PBS (Sigma) fitted with a 21 
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gauge needle. The collected blood was diluted in culture medium by 1:2 to 1:3 and 
centrifuged at 60g for 15 minutes in 10m1 tubes. The supernatant was layered on 2m1 
of Ficoll (Nycomed Pharma AS, Norway) and the tubes were centrifuged at 60g for 
five minutes and then at 550g for 30 minutes. The interface containing the 
lymphocytes was removed and washed twice in PBS +2% foetal calf serum (FCS). 
Cell viability (>95%) was confirmed using trypan blue exclusion (0.25% trypan blue 
solution). 
To obtain spleen lymphocytes, the fish were killed and the spleen was dissected out. 
The spleen was placed in a sterile petri dish and flushed by injecting culture medium 
at various points of the organ. Flushing was performed ten times, using the same 4m1 
of culture medium. This lymphocyte suspension was then layered on 2m1 of Ficoll 
and treated as above. 
The mitogens, phytohaematoagglutinin (PHA) (Sigma), concanavalin A (ConA) 
(Sigma), pokeween mitogen (PWM) (Sigma) and lipopolysaccharide from E. coil 
(LPS) were reconstituted in RPMI-1640 (Sigma), aliquoted and stored at —20°C. 
Spleen or peripheral blood lymphocytes were added to 96-well plates (Coming glass 
works, New York) in 100111 aliquots (2x10 5 lymphocytes per well). Cultures were 
adjusted to 200111 with RPMI-1640 for the unstimulated controls or the mitogen 
diluted in RPMI-1640. 
The optimal response for the respective various mitogen concentrations was 
determined by conducting pre-tests using the method described below. The final 
concentrations of mitogen for which the results are reported here were 201.1g.m1 -1 for 
PHA and 150m.m1 -1 for LPS. The responses to all concentrations of ConA and 
PWM tested were so weak that these mitogens were left out of the final experiment. 
The lymphocytes were cultured in a Gallencamp-Incubator (UK) in water saturated 
air at 15°C for 48 hours. Each well was then pulsed with 0.5 ptCi 3H-Thymedine 
(Amersham, USA) and after a further 24 hours the cells were harvested onto 
harvester filters (Titertek) using a cell harvester (Skarton combi cell harvester, USA). 
After drying, filter pellets were passed into counting tubes and 1.5ml of scintillation 
liquid (Amersham) was added. Incorporated radioactivity ( 3H-Thymedine in newly 
synthesised DNA of proliferating cells) was assessed using a scintillation counter 
(Casey/LKB- Wallace). 
Modulation can be indicated using background count and/or the stimulation index 
(SI). The SI is calculated by dividing the counts per minute (CPM) of the stimulated 
culture by the background CPM. 
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Haematocrit and leucocrit 
Twenty fish from each of the levamisole and freshwater treated group and the 
freshwater only treated group were anaesthetised as previously described and a blood 
sample taken from the caudal vessel. Heparinised haematocrit capillary tubes (Chase 
Instrument Corporation, Glens Falls, NY) were filled to the red line. Duplicate 
samples were taken from each fish. The tubes were then centrifuged at 400g for one 
minute using a haematocrit centrifuge. The percentage erythrocyte (haematocrit) and 
leukocyte (leucocrit) volume was calculated by overlaying the tubes on a sliding 
scale haematocrit reader. 
RESULTS 
Lysozyme assay 
The lysozyme activity in Atlantic salmon serum was found to have an optimum at pH 
5.8 (Figure 8). Lysozyme activity of mucus was also pH dependant with an optimum 
of pH 6.2. HEWL in contrast, exhibited an optimal activity at pH 7.0 with sharp 
declines in activity at acidic and alkaline pH. While it is acknowledged, that because 
of the above results, HEWL may not be the best standard to use for lysozyme assays 
involving fish, it is readily available and consistently used by workers in the field. It 
was used in this study to maintain some comparability between results of our studies 
and those reported in the literature. 
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Figure 8 Effect of pH on the iysozyme activity of serum, mucus and hen 
egg white iysozyme 
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The standard curve developed using HEWL is shown in Figure 9. A second order 
polynomial regression was fitted to the standard (r2= 0.9862) whereby resultant 
optical density readings for serum and mucosal lysozyme for fish could be converted 
to equivalent HEWL concentration using the formula where lysozyme concentration 
= 0.4185 - 5.5969 x change in OD + 65.3178 x change in 0D2. In all cases serum 
and mucus obtained from levamisole-treated fish displayed a significantly increased 
lysozyme activity when compared to control fish (Fcal, =168.2, d.f. =1, p<0.0001; Fcalc 
=221.27, di. =1, p<0.0001, respectively) (Figure 10,Figure 11). Mucosal samples 
had consistently higher lysozyme activity than serum samples. Furthermore, when 
samples were heated-treated, thus inactivating the heat labile components of the 
samples, there was a consistent drop in the lytic activity of all mucus and serum 
samples whether they were levamisole treated or not. 
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Figure 9 Standard curve for hen egg white lysozyme 
A second order polynomial regression was fitted to the curve (r2 =0.9862) 
Optical Density 
Figure 10 Effect of levannisole on serum lysozyme of Atlantic salmon 
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	 Levamisole 
	 Levamisole Heat Treated 
TIT 
Ti eatinel it  
Control = Serum taken from fish that had been given only a freshwater bath; Control 
Heat Treated = as above but the serum was heated; Levamisole = serum taken from fish 
that had been treated with a freshwater and levamisole bath; Levamisole Heat Treated = 
as above but the serum was heated. 
10 — 
Page 79 
Chapter 5: The Effect of Levamisole on the Nonspecific Defence System 
Figure 11 Effect of levamisole on mucus lysozyme of Atlantic salmon 
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Control = Mucus taken from fish that were given a freshwater bath only; Control Heat 
Treated = as above but the mucus was heated; Levamisole = mucus taken from fish that 
had been treated with freshwater and levamisole bath; Levamisole Heat Treated = as 
above but the mucus was heated 
Phagocytosis assay 
Head kidney cells that had been harvested from fish treated with levamisole 
demonstrated significantly enhanced phagocytic function for all measurements of 
phagocytic ability (ie phagocytic index-PI, phagocytic capacity-PC and phagocytic 
activity-PA). 
There was a significant increase in the number of yeast cells consumed per phagocyte 
in fish treated with levamisole (Fcalc=  338.27, df = 1, p<0.0001). The treated fish had 
a PI of 2.31 compared to control fish with a PI of 1.54. As can be seen in Figure 12, 
for levamisole-treated fish there is a right shift in the phagocytic profile of yeast 
consumption per phagocyte, with a significant increase (F calc= 375.02, df = 1, p< 
0.0001) in PC in harvested phagocytes. Of the phagocytic cells harvested from fish 
that had been treated with levamisole 50.03% had consumed one or more yeast cells. 
This is a significant increase (Fcaic= 61.9415, df = 1, p< 0.0001) when compared to a 
phagocytic index of 33.47% for control fish. 
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Figure 12 Comparative phagocytic assay result for fish treated or not 
treated with levamisole 
7  7 7 
1 	2 	3 	4 	5 	6 	6+ 
N umbel of yeast cells phagocytised pel phagocyte 
Control =Phagocytes taken from fish given only a freshwater bath; Levamisole 
=Phagocytes taken from fish treated with a freshwater and levamisole bath. 
Superoxide anion production  
In all experiments the addition of exogenous SOD inhibited the reduction of 
ferricytochrome C by the macrophages, confirming that the assay was specific for 
02-. Figure 13 shows that the macrophages from levamisole-treated fish had a 
significantly increased 02- production with or without PMA stimulation 
(Fca1c=209.66, d.f.=3, p<0.0001). The Tukey's test distinguished between all 
treatments. Furthermore, at 24 hours post-harvest the production of 02 - in PMA 
stimulated macrophages from levamisole treated fish remained at elevated levels 
while all other groups returned to basal levels. 
0 
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Figure 13 Superoxide production from macrophages of fish treated or not 
treated with levamisole 
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Control Unstimulated = macrophages harvested from fish that were given a freshwater 
bath only prior to harvest, but macrophages were not treated with PMA post harvest; 
Control Stimulated = as above, but macrophages were treated post harvest with PMA; 
Levamisole Unstimulated = macrophages harvested from fish that were given a 
freshwater and levamisole bath prior to harvest, but but macrophages were not treated 
with PMA post harvest; Levamisole Stimulated = as above, but macrophages were 
treated with PMA post harvest. 
Mitocien-induced lymphocyte proliferation 
It is thought the results of these lymphoproliferation assays were affected  by 
increased cortisol levels as a result of stresses experienced by the fish being 
transported for three hours and subsequently being held in small tanks, prior to the 
lymphocytes being harvested. Even though these practical difficulties indicate that 
the results presented below should be interpreted with caution, trends indicating 
certain actions of levamisole on the lymphocyte population were obvious. 
Page 82 
Levamisole 
Freshwater 
2 — 
Chapter 5: The Effect of Levamisole on the Nonspecific Defence System 
There were no significant differences between the stimulation indices for either the 
peripheral blood lymphoctye population or the splenic lymphocytes, whether treated 
with PHA or LPS (Fcaic=0.020, d.f.=1, p=0.890; Fcaic=0.338,  d.f=1, p=0.569; 
Fcak=3.51, d.f=1, p=0.080; Fcak=3.72, d.f.=1, p=-0.072, respectively) (Figure 14). 
There were however significant differences in the basal levels of lymphocytes of 
peripheral blood and splenic origins, with the counts per minute being significantly 
increased for levamisole treated Atlantic salmon (Fcak=11.59, d.f=1, p<0.05; 
Fcaic=14.09, d.f=1, p<0.05) (Figure 15). 
Figure 14 Stimulation indices for lymphocytes harvested from fish treated 
or not treated with levamisole 
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Levamisole = lymphocytes taken from fish that had been treated with a freshwater and 
levamisole bath prior to harvest; Freshwater = lymphocytes taken from fish that had been 
given only a freshwater bath; LPS/PBL = Peripheral blood lymphocytes treated with LPS; 
LPS/Spleen = lymphocytes harvested from the spleen and treated with LPS; PHA/PBL = 
Peripheral blood lymphocytes treated with PHA; PHA/Spleen = lymphocytes harvested 
from the spleen and treated with PHA. 
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Figure 15 Basal level counts for lymphocytes harvested from fish treated 
or not treated with levamisole 
Levamisole = lymphocytes harvested from fish that had been treated with a levamisole 
and freshwater bath prior to harvest; Freshwater = lymphocytes taken from fish that had 
been treated with a freshwater bath only; PBL = peripheral blood lymphocytes; Spleen - 
lymphocytes harvested from the spleen. 
Haematocrit and leucocrit 
No significant differences were found between levamisole-treated and control fish 
for haematocrit and leukocrit (Fcalc= 2.71, d.f. = 1, p= 0.1078 and Fcalc= 0.88, d.f. = 1, 
p= 0.3535 respectively). Treated fish exhibited a mean haematocrit level of 48.8% 
and a mean leucocrit level of 1.78%. Control fish had a mean haematocrit level of 
46.9% with a leucocrit value of 1.78% 
DISCUSSION 
In this study all groups of fish given a bath treatment of levamisole had increased 
non-specific defence factor values when compared to control fish. Evidence for the 
efficacy of immunostimulants is of particular interest in circumstances  where the 
host's capacity to mount an immune response is not sufficient to successfully combat 
an invasion by pathogenic microorganisms. In these circumstances, the 
demonstrated increases in the magnitude of the defence reaction may be adequate to 
ensure reasonable protection. 
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Levamisole has been shown to act as an immunostimulant in a number of fish 
species. Siwicici (1987, 1989) described the immunostimulatory activity of 
levamisole in carp spawners, with treated fish displaying elevated leucocyte and 
neutrophil numbers, enhancement of phagocytic activity, leucocyte migration and 
myeloperoxidase activity as well as increases of lysozyme levels and natural 
antibody titres. In their studies, Kajita, Sakai, Atsuta & Kobayashi (1990) showed 
that levamisole stimulated phagocytic activity, chemiluminescence responses and 
natural killer cell activity in rainbow trout. These workers also demonstrated 
activation of the alternative complement pathway. Levamisole also has an 
immunostimulatory effect on the sea bass, Dicentrarchus labrax and the gilthead 
seabream, Sparus auratus as shown by Jeney, Galeotti & Volpatti (1994, 1995) and 
Mulero, Esteban, Munoz & Meseguer (1998) respectively. Both groups 
demonstrated significant increases in respiratory burst and phagocytosis activities. 
Granulocytes and mononuclear phagocytes or macrophages play a central role in the 
cellular part of the nonspecific defence of fish (Dalmo, Bogwald, Ingebrigtsen & 
Seljelid, 1996). In the present study three phagocytic functions were assessed and 
after treatment with levamisole all were increased. Whilst phagocyte killing 
mechanisms are not well established in fish many studies have shown that fish 
phagocytes have potent bactericidal and larvacidal activity and thus possess, 
presumably, both intracellular and extracellular killing mechanisms (Secombes & 
Fletcher, 1992). Further, the presence of nonspecific cytotoxic cells (NCC), similar 
to mammalian nautral killer (NK) cells have been characterized from various fish 
species including channel catfish (Evans, Graves, Cobb & Dawe, 1984) and tilapia 
(Faisal, Ahmed, Peters, & Cooper, 1989). In mammals these cytotoxic cells perform 
antimicrobial and antiparasitic functions. An antiparasitic function of these cells has 
also been shown in channel catfish (Evans et al., 1984). 
If extracellular killing can be facilitated then many implications may follow, 
particularly where parasites such as the causative agent of AGD infest areas that are 
relatively protected from the effects of antibody-mediated immunity. In this context, 
Whyte et al., (1989) demonstrated that normal macrophages from rainbow trout are 
capable of killing non-opsonized diplostomes. Faisal, Perkins & Cooper (1990) 
suggested that the redistribution of nonspecific cytotoxicity in response to parasitic 
invasion, such as occurs in arrowtooth flounder, Atheresthes stomias infested with 
the copepod, Phrixocephalus cincinnatus (Faisal et al, 1990) and in the channel 
catfish, ktalurus punctatus, infested with whitespot, khthyophthirius multifiliis 
(Graves, Evans & Dawe, 1985) may be defence mechanism by which the host 
attempts to counteract the pathogen during early stages of infection prior to its 
establishment in the host. It may be relevant that Ellis (1981) suggested that the fish 
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neutrophils may carry out a microbicidal role extracellularly rather than 
intracellularly. 
Extracellular killing may also involve the release of free radicals such as superoxide 
anions and hydrogen peroxide through the respiratory burst and enzymes such as 
lysozyme. 
It is well documented that the first reaction in the respiratory burst is the one electron 
reduction of oxygen to superoxide (0 2 ), catalysed by NADPH oxidase associated 
with phagocyte membrane (Drath & Kamovsky, 1975; Fihlo, Giulivi & Boveris, 
1993). In the presence of the cytoplasmic enzyme superoxide dismutase (SOD), 
superoxide anions are then converted to hydrogen peroxide (H202). Superoxide, and 
to a great extent, H202 are highly reactive and toxic reactive oxygen intermediates 
(ROI); with H202, in conjunction with myeloperoxidase (MPO) and halide, forming 
the basis of a potent antibacterial system (Chung & Secombes, 1988). Other toxic 
ROIs can be generated, such as hydroxyl radicals (.0H) and singlet oxygen ( 1 02). 
Singly or collectively, these ROIs can participate in the cell-mediated destruction of 
bacteria, fungi, protozoa (Anderson, 1994, Fernandes & Assreuy, 1997) and 
helminths (Kazura, Fanning, Blumer & Mahmoud, 1981; Yazdanbakhsh, Tai, Spry, 
Gleich & Roos, 1987). 
There is also evidence that activated macrophages produce large amounts of an 
unstable gas, nitric oxide (NO) (Moncada, Palmer & Higgs (1991). The role of this 
reactive nitrogen intermediate (RNI) in killing several pathogenic agents such as 
fungi and intracellular protozoans has been well reported (Fernandes & Assreuy, 
1997). In one instance, NO has been shown to exhibit cytotoxic effects on an 
extracellular parasite; Schistosoma mansoni (James & Glaven, 1989). There is 
evidence that peroxynitrite, a reaction product of NO and superoxide anion may be 
the cytotoxic effector responsible for the killing of several agents (Fernandes & 
Assreuy, 1997). 
All of the ROIs, and presumably the RNIs, mentioned above are apparently produced 
by fish phagocytes (Scott & Klesius, 1981; Chung & Secombes, 1988; Aksnes & 
Njaa, 1981; Secombes & Fletcher, 1992), and there is evidence that both intracellular 
and extracellular killing of teleost pathogens are effected by these reactive moieties 
(Stave, Roberson & Hetrick, 1984; Whyte etal., 1989; Jorgensen, Sharp, Secombes 
& Robertsen, 1993). If this is the case for fish infected with Paramoeba sp., then 
even if this killing were at the expense of localised cellular health, it must be seen as 
an advantage given the excellent regenerative powers of fish. It is relevant that, 
Symoens & Rosenthal (1977) reported that levamisole treatment leads to an 
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enhanced state of healing and wound repair. Presumably, enhanced healing would be 
of some benefit to fish with disrupted gill epithelia. 
While lysozyme is generally recognized as being part of the humoral nonspecific 
defence system it could be argued that it makes up part of the cellular nonspecific 
component given that it emanates from phagocytes. Lysozymes are widespread 
enzymes occurring in many teleost tissues and secretions (Lindsay, 1986). With the 
exception of their probable antibacterial role, their function in vertebrates is still open 
to conjecture (Jolles & Jolles, 1984). 
Lysozymes are known to cleave the glycosidic bond between the C-1 of N-
acetylmuramic acid and the C-4 of N-acetylglucosamine of bacterial peptidoglycan. 
It has also been reported to randomly hydolyse 131-4 N-acetylglucosamine linkages 
(Jolles and Jolles, 1984). 
Given the distribution of lysozyme in fish (i.e. in tissues rich in leucocytes and at 
sites where the risk of invasion is high such as skin, gills and gastrointestinal tract) it 
is likely that lysozyme provides a protective function in the teleost, especially as it 
has been demonstrated to be involved in defence against viruses, neoplasms, bacteria, 
fungi and insects (Dobson, Prager & Wilson, 1984). This defence may not direct but 
rather mediated via the stimulatory effects on other macrophage functions (Jones & 
Jones, 1984). 
Reports on the modulation of the lysozyme activity in fish are rare (Mock & Peters, 
1990). However, this study confirms that levamisole can induce increased activities 
of both mucus and serum lysozyme. No attempt will be made to compare the activity 
of lysozyme between fish species because there is such a great interspecies variation 
as shown by Grinde etal., (1988) who reported the lysozyme levels of 12 fish with 
up to four fold variations between species. Furthermore, variation exists depending 
on the origin of the sample. Lindsay (1986) assayed lysozyme from the oesophagus, 
stomach, kidney, spleen, swim bladder and in the mucus and serum. The lowest 
levels reported were from serum and the highest were from the stomach. This pattern 
is compatible with a defence function and it seems likely that lysozyme is an integral 
part of the arsenal of nonspecific defence mechanisms of fish. 
As part of the lysozyme assay, the heat labile component of both serum and mucus 
was studied. It is most likely that the major part of this component was complement 
since it is inactivated by heat and is found in both the serum and mucus. 
Complement acts as a membrane attack sequence that may be initiated by either the 
classical pathway that requires Ig to react with an antigen or via the alternative 
pathway with stimulation from a variety of substances. Heat-treating mucus and 
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serum samples prior to conducting the lysozyme assay did reduce the lytic activity 
but there was not a significant difference between levamisole-treated and control 
fish, which provides evidence that levamisole had no effect on this heat labile 
component. 
The proliferation responses of different lymphocyte populations to different mitogens 
have proved to be very useful in distinguishing T and B lymphocytes in mammals 
(Ellis, 1982). Similar work in fish has demonstrated that T and B lymphocyte 
populations may also occur in these species. Although there were no significant 
differences in the stimulation indices demonstrated in this study, as can be seen from 
Figure 14, there is a general trend in lymphocytes taken from levamisole treated fish 
which indicates that LPS results in an increased proliferation response. Because LPS 
is a known B cell stimulant, the results appear anomolous given that levamisole is a 
T cell stimulant. Levamisole is also known as a prostaglandin blocker and T cells are 
particularly sensitive to prostaglandin. PHA is a T cell stimulant, thus it would be 
expected that lymphocytes taken from levamisole treated fish and stimulated with 
PHA that would show increased proliferation. However, the opposite occurred in my 
results. It is possible that the PHA cultures are not producing much prostaglandin 
therefore levamisole has little effect. LPS is a potent monocyte activator and 
monocytes produce prostaglandins, therefore levamisole could be blocking the 
prostaglandins produced by the monocytes and acting on the lymphocytes. Thus, 
these results indicate that in this instance, levamisole appears to be acting as a 
prostaglandin blocker first and a T cell stimulant second. This pattern of response 
has subsequently been confirmed in another laboratory (Zelikoff 9 , pers. comm. 1997). 
Finally, the levels of haematocrit and leucocrit serve as a general indicator of fish 
health. These parameters are often used as confirmation that an immunostimulant is 
not disturbing the profile of the blood and thus homeostasis of the individual. No 
significant differences were found between haematocrit or leucocrit levels in treated 
and control fish. Thus, it may be concluded that the modulatory effect of levamisole 
does not extend to a modification of the blood profile in this instance. 
This study provides strong evidence that in vivo treatment with levamisole enhances 
the nonspecific immune system as measured by phagocytic ability, superoxide anion 
production, lymphocyte proliferation and lytic lysozyme activity. These findings are 
in accordance with the previously discussed studies of the effects of levamisole in 
other fish species. While there is little information available on the implications of 
9 Zelikoff, J. Institute of Environmental Medicine, New York University Medical Centre, New York 
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these alterations with regard to teleost immune and defence systems and especially 
defence against extracellular parasites, the mounting evidence for AGD infections 
suggested that immunostimulation may offer some benefits. As such, the next part of 
my study examined immunostimulation and the response of Atlantic salmon to 
infection with Paramoeba sp. 
The results of this study may prove to be of practical value, beyond that applicable to 
AGD, given the efficacy of this drug at such low concentrations and the ability to 
treat large quantities of fish at any given time. Furthermore, the prophylactic use of 
levamisole may be of value where situations known to result in stress and exposure 
to disease occur. 
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INTRODUCTION 
The trials described in the previous chapters confirmed the hypothesis that, under 
certain circumstances, salmonids that have suffered an attack of AGD are relatively 
resistant to reinfection. The results of these trials also showed that, as with field 
outbreaks, some fish do not develop a useful resistance to reinfection with 
Paramoeba sp.. Subsequent rounds of bathing for AGD are often done only to treat 
this subpopulation of fish; the rest of the fish appear to be relatively resistant except 
when the challenge is excessive. 
There have been a number of unsuccessful attempts to find a chemotherapeutic agent 
to treat AGD (Alexander; 1991; Cameron, 1994), even though Alexander (1991) and 
Howard & Carson (1994) have shown that several compounds, including levamisole, 
inhibit the growth of Paramoeba sp. in vitro. 
It has been previously demonstrated that immunologically impaired animals often 
respond to levamisole (Symoens & Rosenthal 1977) and there is a large body of 
evidence, including this study (Chapter 5), supporting the immunostimulatory affect 
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of this drug in many fish species (Appendix 1). This, together with the in vitro 
amoebicidal and amoebostatic potential of levamisole provided the incentive to trial 
levamisole as a treatment for AGD. 
The series of trials described in this chapter tested the efficacy of levamisole as a 
treatment for amoebic gill disease in Atlantic salmon. 
MATERIALS AND METHODS 
Trial One 
Initially 140 Atlantic salmon smolts, naive for AGD, were divided equally, and 
placed in two seawater tanks with 30 AGD-infected (donor) Atlantic salmon post 
smolts (Figure 16 Procedure A). During the first week, gill lesions characterised by 
mucoid patches were present on some the naive fish. By the end of the fourth week 
severe lesions, coupled with the presence of large numbers of Paramoeba sp., were 
observed on most of the fish. Mortalities began in the middle of the fourth week. 
After four weeks of infection the remaining fish were removed and divided into the 
groups listed below: 
• 60 fish (30 from each replicate tank) were placed in freshwater for the next four 
weeks (Figure 16 Procedure B) and were no longer involved in this trial. These 
fish were being prepared for use in the next AGD challenge trial 
• 18 fish (by two replicates) were given an industry-simulated freshwater bath with 
levamisole at 5ppm (Figure 16 Procedure C) 
• 18 fish (by two replicates) were given a freshwater bath without levamisole 
(Figure 16 Procedure C) 
The treated smolts were then returned to their respective tanks, with equal numbers 
of naive fish treated in the same manner. That is, two groups of 36 naive fish given 
an industry-simulated freshwater bath with or without 5ppm levamisole (Figure 16 
Procedure D). No donor fish were added for the second phase of this challenge, that 
is, any recrudescence of AGD would result from residual infection in the treated fish. 
To ensure this, tanks were completely drained, scrubbed and washed and then filled 
with freshwater for two hours. This would kill any Paramoeba present in the 
experimental tank system (Howard et al., 1993) 
Weekly for four weeks the severity of infection was monitored. 
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At the conclusion of this trial all surviving fish were given another industry-
simulated bath with or without 5ppm levamisole (same as the previous treatment for 
each group) and these became the 'previously exposed xl ' and previously-exposed 
x2' groups for the next challenge (Figure 16 Procedure E). 
Trial Two 
The next AGD challenge trial involved eight different groups of fish that had been 
infected for varying periods of time and treated for AGD in different ways. For each 
of the following groups, half were treated with a freshwater bath only and the other 
half with a freshwater-levamisole bath (concentration 5ppm): 60 naïve fish, 60 fish 
that had been exposed for four weeks and given a two hour bath, 60 fish that had 
been exposed twice and given a two hour bath at the end of each four week period, 
and 60 fish which had been exposed once and then kept in freshwater for four weeks 
(Procedure F). Each of the eight groups was equally divided and placed into their 
respective tanks. No donor fish were added for this challenge. See Figure 16 for 
flowchart of experimental method and Table 3 for detail of numbers of fish per 
treatment group. 
Weekly for four weeks the severity of infection was monitored. 
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Figure 16 Experimental procedure used in AGO challenge trials 
REPLICATED x2 
70 Naive Atlantic salmon 
30 Donor Atlantic salmon 
14°C Seawater 
4 WEEKS 
     
Procedure D 
A40 Previously exposed fish 
c40 Naive fish 
14°C Seawater 
4 WEEKS 
B30 Infected Atlantic salmon 
14°C Freshwater 
Procedure B 
    
A 30 Previously exposed x2 
C30 Previously exposed xl 
Procedure E 2-3 hour FW + Lev bath 
2-3 hour freshwater bath 
Procedure F 
A 30 Previously exposed x2 
c 30 Previously exposed x I B30 Previously exposed 4 week FW 
30 Naive fish 
14°C Seawater 
4 WEEKS 
Note: matching superscripts denote the same group of fish as they move through the 
experiments 
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Table 3 Summary of experimental groups and results for all levamisole 
AGD trials 
Trial no. / 	Levamisole 	Experimental 	Sample Lesion 	Mortalities 	RPP% 
Treatment size 	No. at 
Dose mg/L 	Procedure 
week 4 
1/PE Lev 5.0 A-C-D 36 8.4 1 97.2 
1/PE RN 0 A-C-D 36 17.9 1 97.2 
1/Naive Lev 5.0 D • 36 16.1 2 94.4 
1/Naive FW 0 D 36 24.1 9 77.8 
2/PEx4 Lev 5.0 A-B-F 30 5.2 0 100 
2/PEx 4 FW 0 A-B-F 30 4.0 0 100 
2/PEx2 Lev 5.0 A-C-D-E-F 30 3.2 0 100 
2/P Ex2 FW 0 A-C-D-E-F 30 4.9 0 100 
2/PE Lev 5.0 D-E-F 30 7.0 2 93.3 
2/PE FW 0 D-E-F 30 N/A 30 0 
2/Naive Lev 5.0 F 30 21.5 7 76.6 
2/Naive RN 0 F 30 • N/A 30 0 
3/PE Lev 5.0 A-C-D 36 4.0 0 100 
3/PE Lev 2.5 A-C-D 31 5.4 0 100 
3/PE Lev 1.25 A-C-D 33 6.1 0 100 
3/PE FW 0 A-C-D 34 25.9 6 82.4 
3/Naive 0 D 40 39.8 15 62.5 
PE= previously exposed, FW= freshwater bath only, Lev= freshwater bath + levamisole, N/A=too 
few fish remaining for lesion numbers to be valid. See Figure 16 for experimental procedures A, B, 
C, D, E & F. APP- relative percentage protection (or the percentage of fish surviving the trial). 
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Trial Three 
Given that it is desirable to minimise the chemicals being used in the production of 
animals for human consumption, this challenge was designed to test the efficacy of 
two concentrations of levamisole lower than that used in the previous trials. 
Initially, two replicates of 80 Atlantic salmon smolts (total of 160 fish) were divided 
equally and placed in two seawater tanks together with 40 AGD-infected post-smolts. 
After four weeks these fish were further divided into four groups (20 
fish/group/tank). One group acted as a control with the other three groups being 
treated with one of the following concentrations of levamisole: 5ppm, 2.5ppm or 
1.25ppm. Another group of 40 naïve fish were given only a freshwater bath and 
divided equally between the two replicate tanks. No donor fish were added for the 
second part of this challenge. 
Each week for four weeks post-treatment the severity of infection was monitored. 
There were unequal numbers of fish in each group of this trial because the covers 
were removed from the experimental tanks just after the levamisole and freshwater 
treatments were done. A number of fish jumped from the tanks and could not be 
replaced without a six week delay. Given that there were still enough fish to conduct 
a statistically robust trial it was decided to continue with uneven numbers of fish. 
RESULTS 
Trial One 
It became apparent in this trial that fish which were experiencing their second wave 
of infection after being given an industry-simulated freshwater bath did not exhibit 
the same resistance to reinfection as fish that were allowed to recover for four weeks 
in freshwater before being re-exposed. However, when fish experiencing their 
second wave of infection were bathed in freshwater and levamisole, demonstrable 
resistance was significantly increased (F calc=51.73, d.f=1, p<0.0001). This was 
particularly apparent at three and four weeks post-exposure to Paramoeba sp. 
Lesions on levamisole-treated salmon experiencing their first wave of infection were 
considerably reduced compared to the number of lesions on their freshwater bathed 
counterparts. In fact, those fish that had been treated with levamisole prior to 
experiencing their first wave of infection were more resistant to infection than fish 
that had been previously exposed and treated only with freshwater, as indicated by 
the number of lesions on the gills. Tukey's groupings and LSD differentiated these 
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two groups of fish. Mortalities due to AGD were significantly reduced in levamisole 
treated fish experiencing their first wave of infection compared to their freshwater 
bathed counterparts, but there was no difference in the number of mortalities in fish 
that had been previously-exposed whether or not they had been treated  with 
levamisole. 
The changes in lesion numbers over the four-week challenge period are shown in 
Figure 17 and a summary of mortality, relative percentage protection (RPP) and 
lesion data for all challenges is presented in Table 3. Experimental procedures may 
be reviewed in Figure 16. 
Figure 17 AGD lesion patterns in fish treated with a freshwater and 
levamisole bath or a freshwater bath only 
0 
	
2 
	
3 
	
4 
Week 
PE = Fish that have been previously exposed; Naïve = Fish that were naive in relation to 
AGD prior to the trial; Lev = Fish were treated with a freshwater and levamisole bath; FW 
= Fish were treated with a freshwater bath without levamisole 
Trial Two 
It was noted that the continual passage of AGD through susceptible fish apparently 
raised the virulence of Paramoeba sp. By the end of this trial, the effects of this 
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increased virulence were evident. While the pattern of infection remained similar to 
that of previous trials, the magnitude of infection was greater, thus affecting the 
outcome compared to the previous trial. Indeed, because of the mortalities that 
occurred in naïve fish and fish that had been exposed to AGD on one occasion, but 
treated with freshwater only, these two groups were withdrawn from the trial before 
four weeks had elapsed. However, their levamisole treated counterparts displayed a 
RPP of 76.6% (naives) and 93.3% (previously exposed) (Table 3). 
As demonstrated in the previous trial, levamisole treated fish were significantly more 
resistant to reinfection than fish treated only with freshwater (Fcalc=191.04, d.f=1, 
p<0.0001; Figure 18). Tukey's groupings and LSD differentiated between fish 
experiencing their first and second waves of infection that had been treated with 
levamisole when compared to their freshwater treated counterparts. Furthermore, 
fish that had been treated with levamisole and exposed to AGD for the first time 
performed significantly better than fish that had been previously exposed to 
Paramoeba sp. and treated only with freshwater, as differentiated by Tukey's 
grouping and LSD. 
Levamisole treatment did not significantly affect the outcome (ie the condition of the 
fish by the end of the trial) for fish that had experienced two waves of infection, but 
it did significantly reduce the number of lesions one and two weeks post exposure, as 
defined by Tukey's grouping and LSD. 
Levamisole treatment did not affect the outcome or lesion numbers for fish that had 
been returned to freshwater for four weeks after initial infection; Tukey's groupings 
and LSD did not differentiate between these groups. 
The differences in lesion numbers between the eight groups may be seen in Figure 
18. A summary of all other data can be reviewed in Table 3. 
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Figure 18 AGD lesion patterns in fish with varying exposures to AGD and 
treated with a freshwater and levamisole bath or a freshwater 
bath only 
2 
	
3 
	
4 
Week 
PE 4W = Fish that had been previously exposed to AGD and kept in freshwater for four 
weeks after, PE X2 = Fish that had been exposed to AGD twice previous to this trial, PE 
X1 = Fish that had been exposed to AGD once previous to this trial, Lev = Fish that were 
treated with a freshwater and levamisole bath; FW = Fish that were treated with a 
freshwater bath only 
Trial Three 
In trial three, groups of fish were treated with different concentrations of levamisole 
(Figure 19). There were no significant differences between lesion numbers or RPP 
for any groups treated with levamisole (Tukey's groupings did not distinguish 
between any of the three levamisole treatments). However, the groups given only a 
freshwater bath had more lesions and greater mortality than those treated with 
levamisole (Table 3). As demonstrated in previous challenges, the naïve fish and 
previously exposed fish bathed in freshwater only displayed significantly increased 
lesion numbers and mortalities when compared to previously exposed fish given a 
freshwater plus levamisole bath (Tukey's differentiated between the three 
levamisole-treated groups and the naive group). 
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Figure 19 AGD lesion patterns in fish treated with varying concentrations 
of levamisole 
PE = Fish that had been infected with AGD prior to this trial, Naive = Fish that were naïve 
in relation to AGD prior to this trial, Lev 5.0 = Fish were treated with a freshwater and 
5ppm levamisole bath, Lev 2.5 = Fish were treated with a freshwater and 2.5ppm 
levamisole bath, Lev 1.25 = Fish were treated with a freshwater and 1.25ppm levamisole 
bath, FW = Fish were treated with a freshwater bath only. 
DISCUSSION 
It is now well established that fish that have been previously exposed to AGD show 
varying degrees of resistance to reinfection, dependent on treatments used. In the 
pilot trial presented in Chapter 4, it was shown that fish that had been exposed to 
AGD, kept in freshwater for four weeks and then re-challenged displayed a high 
level of resistance to reinfection. It is interesting that this same level of resistance is 
not reached when fish are given a single, industry-simulated freshwater bath of two 
to three hours. Even the small decrease in lesion numbers often seen in the fourth 
week after the freshwater bath is illusory due to the coalescence of lesions when fish 
exhibit such high numbers, as well as the death of the most severely affected fish 
which carry the highest number of lesions. Thus, it appears that the fish which are 
exposed to Paramoeba sp. for the first time and then bathed for two to three hours do 
not develop appreciable signs of resistance to reinfection. In fact, their ability to 
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cope with Paramoeba sp. challenge seems little different from that of fish that are 
experiencing their first wave of infection. 
In contrast, fish which have been given two industry-simulated baths display a high 
level of resistance to reinfection. It is notable that there was no significant difference 
in the outcome between this group of fish and those that had remained in freshwater 
for four weeks. The small difference that is seen in the early weeks of the challenge 
may be explained by the fact that fish which are given a two to three hour bath 
probably still maintain low levels of amoebae on their gills after a bath, while fish 
which have been held in freshwater for four weeks are completely cured before being 
re-challenged. 
While there were significant decreases in mortalities and lesion numbers in most of 
the groups of the fish treated with levamisole, it was those fish experiencing their 
second wave of infection (i.e. fish which had been previously infected and given a 
freshwater bath before being re-exposed) benefited most from the treatments. This is 
possibly the result of combined responses to both the infection and the 
immunomodulator. Siwicki et al. (1992) have previously demonstrated that where 
antigens are themselves nonspecific defence stimulators, a synergistic effect was 
evident when levamisole treatment was also used. It would therefore appear that fish 
that had experienced even more waves of infection presumably develop a high level 
of nonspecific defence as a result and the synergistic effect of levamisole is not so 
apparent. . 
It is notable that fish which have been infected and allowed to recover fully in 
freshwater for four weeks display significant resistance to reinfection whether or not 
they are treated with levamisole. It appears that stimulation of the nonspecific 
defence system following one wave of infection coupled with the fact that the fished 
gills would have recovered completely from the infection ensures that these fish are 
almost completely refractory to reinfection. This indicates that re-establishment and 
development of AGD is the result of interplay between immune and defence 
responses (especially the nonspecific defense system, gill health, number and 
virulence of Paramoeba sp. and the environmental conditions (especially 
temperature and salinity)). In this context, it is also relevant that levamisole has been 
reported to significantly enhance the healing process in mammals (Symoens & 
Rosenthal, 1977). This enhanced healing was attributed to the increase of neutrophil 
and macrophage migration to the damaged area, and it is reasonable to assume that a 
similar mechanism may exist in teleosts. 
To put the various responses to levamisole in context it is suggested that the factors 
involved are as follows: 
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• Fish infected for the first time and given a two hour freshwater bath only will 
develop a moderate increase in their nonspecific defense system and will have 
mucus and amoeba removed from their gills. However, the lesions of gill 
hyperplasia and inflammation will remain to attract amoebae (Nowak & Munday, 
1994; Zilberg l° pers. comm., 2000) and some amoebae may survive within cystic 
lesions present in the gills (Munday et al., 1990) 
• Fish infected for the first time and given a two hour freshwater bath containing 
levamisole will experience a very much enhanced nonspecific defence response, 
together with removal of mucus and amoebae, and, therefore, there will more 
likely be resolution, rather than persistence of infection and resultant lesions. 
• In fish that have been previously exposed on two occasions and given two 
industry-simulated baths there are lesions still present but the nonspecific 
immune response has been augmented to a sufficient level to allow recovery. In 
this instance levamisole provides only a temporary advantage of a slightly higher 
resistance to reinfection in the early weeks; probably only indicative of the fewer 
lesions on the gills because of the previous levamisole treatment. 
• Fish that have been infected for the first time and allowed to recover in 
freshwater for four weeks have gills that are in excellent condition when re-
exposed, so while their defence response may not remain at as higher levels as 
the fish that are re-exposed immediately after treatment, the condition of the gills 
compensates for this. 
A central factor in all of the above observations was that in challenges where fish had 
been given an industry-simulated freshwater bath, no 'donor' fish were required to 
re-establish infection, thus indicating some carry-over by treated fish. This is in 
contrast to the trials in which fish are held in freshwater for four weeks. This 
evidence indicates that there may not necessarily be a reservoir of infection in the 
immediate environment, but rather there are enough viable stages left on the fish 
after a two to three hour bath that reinfection is immediately facilitated once the fish 
are returned to sea water. 
Throughout these trials it became apparent that the group of fish that did not 
demonstrate resistance to reinfection remained, albeit at a reduced level. On 
administration of levamisole to these groups the number of 'non-responders' was 
1° School of Aquaculture, University of Tasmania, Launceston, Tasmania 
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reduced but never eliminated. Given that there is a high individual variation in 
defence responses between fish it is likely that levamisole can, in some instances, 
restore a sufficient defence mechanism for a demonstrated resistance to Paramoeba 
sp. but it does not appear to be able to totally restore normal function in all 
immunological sub-performers. It is believed that this too, may be influenced by the 
interplay of factors as described above, but in particular, by the severity of infection 
and condition of the gills at the time of treatment. In regard to this group of fish it 
would be of particular interest to determine the absence or presence of that 'factor' 
discussed below, which has been reported in humans, rabbits and mice treated with 
levamisole (Symoens & Rosenthal, 1977). A similar scenario would appear to apply 
equally well to AGD infections in fish. 
Even though levamisole has been shown to increase antibody titre in fish (Jeney & 
Anderson, 1993; Siwicld, 1987), as previously discussed in Chapter 5, there is no 
apparent relationship between detectable antibodies against Paramoeba sp. and 
resistance to AGD (Findlay, Helders, Munday & Gurney, 1995; Alchlagi, Munday, 
Rough & Whittington, 1996), at this stage, this potential aspect of the drug's 
immunomodulatory repertoire is not thought to be relevant. On the evidence to date, 
it appears that the nonspecific defence system is the most important for Atlantic 
salmon exposed to AGD. 
With regard to the large scale use of levamisole, results from farms have been 
variable. In the first summer that levamisole was used, no AGD occurred as a result 
of a prolonged period of low salinity water covering the farms. The second trial gave 
variable results. In some instances there appeared to be significant protection 
provided to fish treated with levamisole. In a pen of fish treated with levamisole, 
30% displayed AGD lesions and no mortalities were recorded, while in the untreated 
pen, 90% of the fish displayed lesions and mortalities occurred. However, in other 
instances, there did not appear to be any effect. 
There are a number of reasons why levamisole has variable effects when used in the 
farm situation. These too are thought to be dependent on the complex interplay of 
factors discussed above. 
• In the farm situation, bathing is undertaken sometimes prophylactically and at 
other times when only a few lesions can be seen in some fish. If the nonspecific 
defence system is stimulated by the presence of Paramoeba, as has been shown 
in Chapter 4, and the fish are treated before being exposed to a sufficient dose, 
then this stimulation would not be apparent. More than this, the synergistic effect 
that may be seen when levamisole is used in conjunction with an 
inununostimulating antigen would not occur. 
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• Levamisole may only be of benefit where the attacks of AGD are moderate to 
severe. The reasons for this have been discussed previously. 
• Because of practical constraints arising with the transfer of tens of thousands of 
fish from one cage to another, some fish may be left in the freshwater bath for up 
to seven to eight hours. This has been demonstrated to be potentially detrimental 
to the health of the gill (Munday l I , pers. comm. 1997) and may even provide 
areas which are preferential attachment sites for amoebae. 
• The dosage used and the administration of it may not have been done correctly in 
some circumstances. As discussed in Chapter 5, levamisole is 
immunosuppressive when used in high doses and ineffective at low doses. 
Furthermore, it is inactivated at alkaline pH. 
The results from the predominantly experimental studies described in this thesis have 
still to be confirmed under fish farm conditions using statistically valid methods. 
The next part of this discussion will look at the mode of action and clinical effects of 
levamisole in an effort to define some of the reasons why this substance provides 
protection against Paramoeba sp. in Atlantic salmon. Levamisole has been shown to 
be effective in treating a number of diseases and dysfunctions and some of these may 
be relevant in hypothesising the mechanism of action in relation to Paramoeba sp. 
In particular, levamisole is known to treat chronic and recurrent infections, primary 
and secondary immune deficiency states, allergic disorders, rheumatic diseases, 
gastrointestinal diseases and skin disease (Symoens & Rosenthal, 1977). It is also 
very active in a variety of inflammatory conditions (Pillar, 1975). Given that the 
response to AGD is primary inflammation and hyperplasia, the effect of levamisole 
may extend beyond modulation of the defence system to a more specific affect on the 
inflammatory response. 
During levamisole treatment, many studies have shown that immunologic functions 
improved and in most cases T cell and phagocytic functions were heightened 
(Symoens & Rosenthal, 1977). As a rule however, there was no good correlation 
between immunologic and defence system functions and therapeutic effects. None of 
the variables of cellular immunity represents a reliable means of predicting 
11 Munday, B. School of Biomedical Science, University of Tasmania, Launceston, Tasmania 
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therapeutic responses to levamisole treatment (Desidero & Rankin, 1986). This 
makes it's effectiveness as a treatment for AGD even more intriguing. 
In particular, Symoens & Rosenthal (1997) presented the results of research which 
demonstrated that serum from levamisole treated humans, mice and rabbits contained 
at least one dialyzable factor that could be isolated and lyophilised. The factor was 
only found in animals which responded to levamisole and was not observed in non-
responders or untreated animals. The factors when injected in untreated animals 
mimicked the effect of levamisole including enhanced carbon particle clearance and 
converted non-responders into responders. The factor was not a complement factor 
nor a levamisole metabolite. It was not found in animals treated with other 
stimulants such as LPS. Investigation into the occurrence of this 'factor' in Atlantic 
salmon may provide some answers relating to the group of non-responders. As 
mentioned above, research into what this 'factor' is and whether it occurs in Atlantic 
salmon would provide many answers on the AGD pathogen-host relationship. 
The increased protective effect provided by levamisole, that is seen in Atlantic 
salmon, cannot be explained by a direct effect on invading organisms; Howard & 
Carson (1993) demonstrated that it takes at least lOppm levamisole to kill 
Paramoeba sp. in vitro but it may, inter alia, be related to a modulation of lesion and 
wound healing. As previously stated, evidence in the literature, together with results 
presented Nowak & Munday (1994) and Zilberg (pers. comm., 2000) suggest that gill 
hyperplasia and epithelial disruption may attract amoeba. Therefore, any treatment 
that reduces these would presumably result in a less attractive environment for the 
amoeba. Furthermore, if as has been suggested by the numerous workers in the field 
including Munday et al. (1990), that the mucus production facilitates removal of the 
amoebae then there is evidence that levamisole also contributes positively in this area 
(Zilberg, pers. comm. 2000). 
Indeed, there is evidence that levamisole may enhance the nonspecific defence 
system, the specific immune system and the overall health of the gill. From the 
evidence presented in this thesis, levamisole can make a vital contribution to the 
resistance demonstrated by Atlantic salmon exposed to Paramoeba sp. 
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GENERAL DISCUSSION - 
At the commencement of this project, there were still significant areas of knowledge 
in relation to the disease and causative agent that were anecdotal and had not been 
tested by rigorous scientific inquiry. Paramoeba sp. had been isolated and could be 
cultured, but disease could not be reproduced using these cultured organisms. Fish 
had been experimentally infected using a cohabitation technique but these could not 
be maintained for longer than 10-14 days. The pathology of the disease had been 
well reported, and there was some work being done to develop diagnostic tests for 
use in both the farm and laboratory environment, but only limited immunological 
studies had been undertaken. 
It is interesting to note that, to date, the Paramoeba sp. causing AGD has not gained 
as much attention overseas as it has in Australia. This is probably due to the fact 
that, until recently, AGD had limited effects in fish stocks overseas. Much of the 
literature from overseas (as discussed in Chapter 1) is limited to descriptions of 
AGD, the species that it affects and in some cases it extends to some histological 
work. It is likely that the amount of research being conducted overseas will increase 
and the type of research will change from reporting occurrence and general 
pathological effects to experimental work on epidemiology and treatment of AGD as 
the effects of the disease increase overseas. 
As AGD became more limiting to the growth of the Tasmanian salmonid industry, 
research on this disease began assuming greater importance. Any strategy that would 
eliminate or reduce the number of freshwater baths for the control of AGD would be 
of significant commercial value. It was the anecdotal observation made by industry, 
that fish that had been previously infected with AGD appeared to demonstrate some 
resistance to reinfection that precipitated this project. The scientific demonstration of 
resistance to reinfection would pave the way for informed research to be conducted 
on methods of engendering protection against AGD in susceptible fish species. 
The most important findings emanating from this project were the demonstration of 
the resistance to infection with AGD in fish that had been variously exposed to the 
disease and the fact that this could be modulated. These developments facilitated the 
conduct of trials that further clarified and enhanced this pivotal development in the 
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understanding of AGD. Also, this is the first record of the use and efficacy of 
levamisole as an immunodulator of the nonspecific defence system in Atlantic 
salmon. 
To put things in context, the following section of discussion will present my 
hypotheses on the events leading to the infestation of Paramoeba on the gills of 
Atlantic salmon, how infestation occurs and what factors are involved in resistance. 
Like all pathogenic organisms, it is most likely that Paramoeba sp. virulence is 
related to a number of amoebic components and host factors. It is a well reported 
observation that the amoebic molecule chiefly responsible for adherence to target 
cells is a lectin. As shown by Zilberg, Gross & Munday (2000) Paramoeba sp. can 
be found in association with normal gill epithelium. This is more than likely 
mediated via a lectin, probably a galactosamine and/or glucosamine specific lectin. 
Once initial attachment has been made it seems likely that just as for Entamoeba 
histolytica, localised actin polymerisation would correlate with the extension of 
pseudopodia. 
Pseudopodia of the Paramoeba sp. have been demonstrated in the intercellular 
junction regions between adjacent cells of gill epithelium (Munday et al., 1990) and 
where this happens, irritation would ensue. Inflammation and epithelial hyperplasia 
results, whether it be from the mechanical damage inflicted by the pseudopodia or 
extracellular products of the amoeba is not known. The hyperplastic tissue that is 
seen in affected gills is particularly reactive, with a high cellular turnover, 
presumably trying to rid the area of the irritant. This results in an increasing area of 
immature surfaces and most likely a preferential attachment site for the Paramoeba, 
either because there are physically more areas to occupy or because the sugar 
moieties of immature cells preferentially attract amoeba. While it is recognised that 
Paramoeba may occur on normal gill tissue, it is well accepted by workers in the 
field (eg Roubal et al., 1989, Nowak & Munday, 1994) that Paramoeba 
preferentially attach to hyperplastic areas of the gill. 
All of these effects lead to increased bacterial loads, as seen by Garland (pers. 
comm., as cited in Munday et al., 1993), and more food for the amoeba. This 
establishes the cyclical escalation of disease, so often seen in parasitic infections of 
this nature. Until 'something' breaks the cycle, disease progresses until the affected 
fish dies. Spontaneous resolution of AGD in the absence of treatment has not been 
observed in this, or any other study. 
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Beginning with the anecdotal reports of the development of resistance in fish 
previously exposed to disease, through to the completion of my project and beyond, 
an issue that has exercised my mind is how a specific humoral response would 
actually occur. Other than a single report of pseudopodia being observed between 
the cellular junctions of hyperplastic tissue, there is little evidence to suggest that the 
bodily barriers are actually breached by whole Paramoeba. Therefore some other 
mechanism must be involved if antigens are.to be presented to antigen processing 
cells. 
There are three scenarios that may lead to the development of a humoral immune 
response: 
• Antigen presenting/processing cells may come into contact with pseudopodia that 
are inserted through cellular junctions. This may be a more regular event than 
reported, as fixation and histology techniques may result in disruption of the 
attachment (often areas on the gill epithelium that exactly match the shape of an 
amoeba close by can be found). 
• The amoebae that may be seen in the cysts that form in hyperplastic tissue (Plate 
3; Plate 4) presumably would die, thus making antigen available to invading 
macrophages. 
• Alternatively, soluble amoebic antigens may leak into the circulation via the 
disrupted epithelium. The events that follow initial antigen recognition have been 
reported in Chapter 1. 
Once antibodies have been produced, there are no guarantees that these will be 
protective and evidence from this study together with others mentioned in previous 
chapters certainly alludes to this. If protective antibodies are formed, are these of 
local or systemic origin? 
If the specific immune system is not providing the protection against reinfection with 
Paramoeba that has been reported in this study, what are the other options? 
It is a characteristic of an immune response in a vertebrate that the response time to a 
second exposure is less than to the first; this is known as anamnesis. However, the 
non-immunoglobulin humoral response factors of vertebrates seem to lack 
Page 107 
Chapter 7: General Discussion 
anarrmestic properties. But as with all statements in biology, there are exceptions to 
the rule. One possible reason for the retention of many nonspecific humoral defence 
mechanisms by fish is the reduced (primitive) immunoglobulin responses compared 
to higher vertebrates (Alexander & Ingram, 1992). 
On infection with Paramoeba, the nonspecific immune system is heightened as 
indicated by the phagocytic parameters measured in this study. Whether this is the 
result of stimulation via amoebic surface coat components, or via components of 
bacterial cell walls, is unknown at this stage. While the stimulation remains, the 
nonspecific defence system remains active, this presumably holds true for some 
period after the stimulation is removed also. If the 'stimulation is again provided 
before the defence system has returned to basal levels, this may result in a stepwise 
increase and ultimately a reaction sufficient to display a demonstrable resistance to 
reinfection. 
In all cases in this study, the immunostimulant levamisole heightened the nonspecific 
defence response, and although not measured, as discussed in Chapter 1, it is likely 
that it also stimulated the specific immune response. However, because salmonids are 
primitive fish compared to many of the other teleosts it is conceivable that their 
dependence on the nonspecific defense mechanisms is far greater than for the higher 
teleost. From what we know in the literature and what this study demonstrated, 
levamisole may act in the following ways: 
• Given the apparent importance of lectins in both adherence and pathogenesis of 
amoeba, if these can be inactivated then adherence ability and pathogenesis 
would logically be decreased. As lysozyme, the lytic agent that cleaves various 
sugar moieties increases in levamisole treated fish, there is evidence to suggest 
that adherence via a galactosamine/glucosamine lectin may be inhibited. Either 
-via an increase in the availability of preferred ligands due to the lysis of bacterial 
cell walls (ie gill epithelium is 'flooded' with exogenous lectin substrate) or 
because links established between the amoeba and the gill are split. 
• Reactive oxygen and nitrogen intermediates (ROI & RNI, respectively) have 
been reported to participate in the destruction of, inter alia, bacteria and protozoa. 
Once again levamisole treated fish displayed significantly heightened levels of 
ROIs as well as a capacity to sustain this for increased periods. The most likely 
scenario in relation to the efficacy of these products is that the pseudopodia 
inserted between gill cells are 'burnt off' after contact with these cytotoxic 
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factors and would be removed from the gills. The enhanced state of healing and 
wound repair engendered by levamisole may act to counteract the toxic cellular 
effects of these ROIs and RNIs. 
• Alternatively, and most simply amoeba may be removed from the gills via the 
production of mucus. As previously discussed, levamisole treatment appeared to 
increase mucus production thereby acting in addition to the benefits of the 
freshwater bath (which probably acts mainly to destabilise the seawater stable gill 
mucus, thus not only is the fish induced to have a 'big sneeze' it is stimulated to 
rapidly replace the lost mucus with fresh mucus rich in lysozyme). 
Any of the above scenarios would 'break' the AGD cycle. 
At the culmination of this project a number of observations stood out as being 
prospective candidates in the continuing efforts to develop a more efficient and less 
costly treatment and/or cure for AGD. 
I believe that amoebic lectins are the key to the pathogenesis of Paramoeba sp. 
Valuable developments can be made by looking at the different sugar properties of 
cultured and wild Paramoeba and also those associated with the gill tissue, both 
normal and hyperplastic. 
Work is required to establish whether extracellular products play a part in the 
development of resistance and to what extent. At this point in time, no assays have 
been conducted that would detect antibodies developed against extracellular 
products. 
Little is known of how Paramoeba interact with the gill. If the mode of interaction 
can be established work can be focussed on plausible scenarios that follow. 
Given the success of levamisole as a treatment for AGD in the experimental situation 
it would be prudent to look at different immunomodulators under similar conditions. 
By a process of elimination and establishing the modes of action of each modulator, a 
better understanding of the defence and/or immune mechanisms involved in AGD 
infections can be gained. 
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Still, it must be recognised that the knowledge of the immunological relationships 
between fish and their parasites is small in comparison with that concerning bacteria 
and viruses. Woo (1992) summarised the most significant of these: 
• Problems encountered in laboratory manipulation of parasites in comparison to 
bacteria and viruses 
• The difficulties of in vitro and in vivo culture of organisms 
• Intrinsic complexities of the parasites and their often complex lifecycles. 
The project presented in this thesis has contributed knowledge to each of these facets 
in relation to AGD. The success of defining resistance to AGD reinfection in 
Atlantic salmon and also in overcoming the hurdle that prevented large scale, long 
term AGD trials being conducted, by establishing a protocol for the in vivo 
continuous maintenance of Paramoeba sp, will contribute to much of the subsequent 
work that will be carried out. Principally it has provided a reliable source of 
parasites for conducting AGD trials at will, as well as for developing diagnostic 
techniques. It has established important immunological assays and experimental 
designs for research into defence and immune modulation. It will also facilitate the 
evaluation of the host-parasite relationship, which is now fundamental to the 
continuation of AGD research. 
A comment of the applicability of this research to the field situation is warranted. 
Because the expression of disease involves many interactive processes between host, 
pathogen and environment, it is important to remember that any treatment regime 
needs to be optimised for the current situation. None of this data should be 
misconstrued to indicate that levamisole is the answer to the amoebic gill disease 
problems in Tasmania. It does however indicate that the natural response of certain 
groups of salmon can be augmented under the correct administration and conditions 
in order to increase resistance and survival against amoebic gill disease. Most 
importantly it provides the sound scientific basis to continue AGD research in a well-
considered and calculated manner. 
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APPENDIX I 
SUMMARY OF IMMUNOSTIMULATION STUDIES IN FISH 
(Turn over for Table 1) 
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Table 1 Summary of immunostimulation studies in fish 
lmmunostimulant Administration Dose Fish species Results Authors 
Abalone extract Injection 10mg/fish Rainbow trout 1' phagocytosis Klontz & 
Anderson, 1970 
Injection Rainbow trout T disease resistance Sakai et al., 1991 
Achromobacter 
stenohalis cells 
Injection Char CL T, Complement T Kawahara et al., 
1994 
Alginate Injection 10-40 mg/kg 
via Artemia 
Carp T in survival when challenged Fujiki et al., 1994 
Oral Turbot T in survival when challenged Skjermo et al., 
1995 
In vitro Carp T head kidney phagocyte migration 
and activity 
Fujiki & Yano, 
1997 
Oral Atlantic salmon 1' lysozyme Gabrielsen & 
Austreng, 1998 
Aluminium 
hydroxide 
Injection 0.1 ml Atlantic salmon T survival when challenged Lillehaug et al., 
1992 
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lmmunostimulant Administration Dose Fish species 
Oral and anal (1:1 w/w ratio 
with 10 
mg.m1 -1 
Tilapia 
HGG) 
Aluminium 
phosphate 
Injection 0.1 & 0.2ml Atlantic salmon 
Injection 0.1 ml Atlantic salmon 
Injection 0.1 ml Atlantic salmon 
Oral/ Injection Salmonids 
Immersion & 5g/kg -1 feed Tilapia 
Injection 
Ascogen Injection 0.01 ml Rainbow trout 
Bacille Calmette Immersion 1/300 dilution Rainbow trout 
Guerin 
Results 	 Authors 
T level of antigen absorptioninto 	Jenkins et al., 
plasma. No effect on antibody titre 	1994 
T antibody titre 	 Midtlyng et al., 
1996 
T antibody titre & survival when 	Erdal & Reitain, 
challenged 	 1992 
T survival when challenged 	Lillehaug et al., 
1992 
T antibody and resistance 	Klontz & 
Anderson, 1970 
T antibody titre, mitogenic 	Ramadan et al., 
response, macrophage migration 	1994 
inhibition & survival when 
challenged 
No effect on antibody titre 	 Grayson et al., 
1987 
T bacterial clearance 	 Grayson et al., 
1987 
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lmmunostimulant Administration Dose 
	
Fish species 	Results 
	
Authors 
Oral 
Injection 
0.2% 
	
Channel catfish 
0.1 ml 
	
Turbot 
2-10mg.kg -1 	Common carp 
T macrophage & neutrophil 
migration & phagocytic activity. No 
effect on survival when challenged 
or antibody titres 
T respiratory burst & leucocyte 
killing ability. No adjuvant effect on 
bactericidal or lysozyme activity 
T survival when challenged, 
phagocytic activity & activation of 
alternative complement pathway 
Duncan & 
Klesius, 1996a 
Santarem et al., 
1997 
Yano et al., 1989 
B-glucan 
	
Injection 
50 & 70 ug 	Channel catfish 	T phagocytic 7 bactericidal ability, T 
survival when diseased 
2-10mg.kg -1 	Yellowtail 
	
T survival when challenged, serum 
complement, lysozyme & 
phagocytic activity 
1 g.kg -1 diet 	African catfish 
	
T respiratory burst & bactericidal 
ability 
1.0 & 0.7ml 	Atlantic salmon 
	T lysozyrne and complement 
activity  
Chen & 
Ainsworth, 1992 
Matsuyama et al., 
1992 
Yoshida et al., 
1995 
Engstad et al., 
1992 
B-1,3-glucans 
	Injection 
Injection 
Oral 
Injection 
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lmmunostimulant Administration Dose 	Fish species 	Results 	 Authors 
B-1,3 & B-1,6- 	Injection 	1 ml 	Rainbow trout 	T 02- and bactericidal activity. No 	Jorgensen et al., 
glucans 	 effect on lysozyme activity 	1993b 
Oral 	 0.2 g/100 g 	Rainbow trout 	T 02- and phagocytic and 	Siwicki et al., 
feed 	 myeloperoxidase activity, 1994 
immunoglobuline level and survival 
when challenged 
1' Phagocytic and acid phosphatase DaImo & Seljelid, 
activity 	 1995 
T antibody level. No effect on 	Aakre et al., 1994 
survival when challenged. 
No adjuvant effect on antibody titre. Midtlyng et al., 
1996b 
T antibody titres & 02- activity. No 	Ainsworth et al., 
effect on lysozyme & survival when 1994 
challenged 
T nonspecific defence, T 	Jeney et al., 
phagocytosis, T ROI 	 1994a 
Tnonspecific defence, 	 Jeney et al., 
Tphagocytosis, TROI 1994b 
In vitro Atlantic salmon 
Injection 5 mg.m11 Atlantic salmon 
B-1,3-M-glucans Oral Atlantic salmon 
B-1,3-M-glucans Injection and oral 250 ug & Channel catfish 
(Macrogard®) 0.1% or 1% 
B-glucan Bath/oral 100m u g/m1 Sturgeon 
& 0.1 - 
0.5%/food kg 
Bath 1.0-5.0mg/kg Sea bass 
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Immunostimulant Administration Dose Fish species Results Authors 
Oral 6 &60ug/kg Rainbow trout Is disease resistance Matsuo & 
BW Miyazono, 1993 
Bifidobacterium 
thermophilum 
Bath 10-12 ug/ml Gunners and 
striped bass 
T humoral antibody Robohm & Ra, 
1986 
Cadmium (Cd) In vitro 1 ug/ml Rainbow trout T chemiluminescent response. Elsasser et al., 
1986 
Oral 2.7g/1 00g 
feed 
Rainbow trout T 02- activity, myeloperoxidase 
level, neutrophil killing activity & 
survival when challenged. 
Siwicki et al., 
1994 
Candida utilis Oral Trout Phagocytosis T, ROI T Sakai et al., 
1995a,b 
C. butyricum Injection 100 mg.kg-1 Rainbow Trout i phagocytic activity, CL response Sakai et al., 1990 
& survival when challenged 
Chitin Injection Trout Phagocytosis T, Lysozyrne —> Sakai et al, 1992 
Oral Trout ROI T, Phagocytosis T Siwicki et al., 
1994 
Chitosan Injection Trout ROI T, Killing T Anderson et al., 
1995 
Injection 0.5 ml Rainbow trout Opportunistic infection. Munn & Trust, 
1983 
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lmmunostimulant Administration Dose Fish species 
Complete Freunds Injection 0.25 mg/kg European eel 
Adjuvant 
Con A Injection 0.1 ml/fish Coho salmon 
CFA Modified Injection 5 mg (2 days 
after antigen) 
Eel 
Ecteinscidia 
turbinate extract 
Oral 100-1000 
mg/kg 
Rainbow trout 
EF203 Injection 0.1 & 0.05 ml Rainbow trout 
Oral Trout 
Oral Trout 
NG American eel 
Ete Injection 0.5 ml American eel 
Results Authors 
Lymphophilia. 
resistance to disease 
phagocytosis and antibody 
Van der Heijden 
et al., 1993 
Olivier et al., 1985 
Sigel et al., 1983 
CL and phagocytic activities and 
survival when challenged 
phagocytic activity & ROI 
response. No effect on 
agglutinating titre 
Yoshida et al., 
1993 
Sakai et al., 1995 
Phagocytosis CL Yoshida et al., 
1993 
Phagocytosis 1', ROI Antibody —> 
leucocyte binding ability & 
phagocytic activity. resistence when 
challenged 
phagocytic activity, antibody titres 
& resistance to challenge 
Sakai et al., 1995f 
Sigel et al., 1983 
David & 
Hayasaka, 1984 
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T phagocytic activity. No effect on 	Stanley et al., 
antibody titres. Suppression of 	1995 
resistance when .challenged 
1.250/g 
Injection Channel catfish 0.625- 
ET-2 Oral 1.0g/100g 
feed 
Evestel 
FCA 
Injection . 	0.2 ml 
Injection 	1.2-2.3 x 109 
cells in FCA 
Injection & bath 	1 mg & 1.0 x 
1010 cells.ml -
1 respectively 
Injection 
Injection 
T antibody titre Cossarini-Dunier, 
1985 
T antibody & agglutination titres Whittington et al., 
1994 
lmmunostimulant Administration Dose 	Fish species 	Results 	 Authors 
Turbot 
Rainbow trout 
Rainbow trout 
Coho salmon 
Rainbow trout 
Coho 
Brook 
T nonspecific defence, T 
phagocytosis 
Romalde et al., 
1999 
Injection 
T 02- production. No effect on 	Siwicki et al., 
myeloperoxidase level and survival 	1994 
when challenged. 
T antibody titre & survival when 	Paterson & Fryer, 
challenged 	 1974 
T nonspecific immune system, T 	Olivier et al., 1985 
resistance to bacterial infection 
Phagocytosis T, T bactericidal 	Olivier et al., 1986 
activity 
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Immunostimulant Administration Dose Fish species Results Authors 
Injection Trout T disease resistance Adams et al., 
1988 
• Injection Trout T disease resistance Kajita et al., 1990 
Injection Yellowtail T disease resistance Kawakami et al., 
1998 
Injection 0.2 ml Brook trout T survival when challenged CInjectionriano & 
Pyle, 1985 
FIA Injection 0.2 ml Rainbow trout T antibody titre Cossarini-Dunier, 
1985 
Oral 1.5g/100g 
feed 
Rainbow trout T 02- production and 
myeloperoxidase level, no effect on 
neutrophil killing activity. 
Siwicki et al., 
1994 
Finnstim Injection 5, 10, 
10Oug/fish 
Rainbow trout T PFC and humoral antibody Kitao et al., 1987 
FK-565/FK-156 Injection 1 mg/kg Rainbow trout T Protection against A.salmonicida Kitao & Yoshida, 
1986 
Injection 1 mg.kg -1 Rainbow trout T intibody titre & splenic antibody Kitao et al., 1987 
producing cells 
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Immunostimulant Administration Dose Fish species Results Authors 
Injection Trout Phagocytosis T Kitao & Yoshida, 
1986 
In vitro Trout Antibody T Kitao et al, 1987 
Injection & 
immersion 
100/g & 
100/g.m1 -1 
Brook trout T survival when challenged Anderson & 
Siwicki, 1994 
Glucans Injection 0.1 & 0.2 ml Atlantic salmon T survival when challenged & 
antibody titres 
Midtlyng et al., 
1996 
Injection 2-10 mg/kg Carp Activated alternative pathway 
protection 
Yano et al., 1989 
Injection 100 ug-2.5 
mg/fish 
Atlantic salmon T protection Robertsen et al., 
1990 
Oral 0-1% Rainbow trout Tphagocytosis, T ROls Volpatti et al., 
1998 
Injection/Injection Trout Phagocytosis T, ROI T Jeney & 
Anderson, 1993b 
Glucan (Sigma) In vitro Rainbow trout T respitatory burst activity. Jang et al., 1996 
Glycyrrhizin 
Growth hormone Injection 0.1 ml/fish Coho salmon T protection. Olivier, et al., 
1985 
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Immunostimulant Administration Dose Fish species Results Authors 
Incomplete Freunds Injection 0.25 ml Sockeye salmon T antibody titers Evelyn, 1971 
Adjuvant 
IFA Injection 0.1 ml/fish Brook trout T protection. Cipriano & Pyle, 
1985 
Immersion 1 ug/m I Rainbow trout T Phagocytic activity TPFC Jeney & 
Anderson 1993a 
ISK • Injection 1 ug Rainbow trout 1S02- & phagocytic activity, 
leucocyte numbers, plaque forming 
cells, antibody titres & survival 
when challenged 
Anderson & 
Jeney, 1992 
ISK Immersion 1-5 ug.m1 1 Rainbow trout T 02- & phagocytic activity, 
leucocyte numbers, plaque forming 
cells, antibody titres & survival 
when challenged 
Jeney & 
Anderson, 1993b 
ISK Injection 1 ug/m I Rainbow trout T neutrophils Anderson & 
Jeney, 1993 
ISK Injection 2-10mg/kg 
BW 
Carp Phagocytosis, is resistance to 
bacterial infection 
Yano et al., 1989 
Lentinan Injection 5-20mg.kg-1 Common carp T leucocyte numbers, phagocytic 
activity, leucocyte migration, 
myeloperoxidase activity, lysozyme 
Siwicki, 1987 
Page 142 
Immunostimulant Administration Dose 
	
Fish species 	Results 
	
Authors 
level & antibody titre 
Levamisole 	Bath 
	
2-20 mg.dm -3 Common carp 
	
1' growth rate 	 Siwicki & Korwan- 
Kossakowski, 
1988 
Oral 	 3-8mg.kg-1 	Common carp 
	T 2 & phagocytic activity & 
	
Siwicki, 1989 
lysozyme level 
Injection 
In vitro 
Oral 
0.1-5.0 
mg.kg-1 
125- 
500mg.kg-1 
feed 
Rainbow trout 
Rainbow trout 
Gilthead 
seabream 
1' survival when challenged, 
phagocytic & natural killer cell 
activities, CL response. Activation 
of alternate complement pathway. 
No effect on bactericidal activity 
T 02- & phagocytic activity 
T phogocytic & respitaroty burst 
activity in leucocytes, growth, 
resistance when challenged, 
lymphokine production & serum 
complement activity 
Kajita et al., 1990 
Jeney & 
Anderson, 1993a 
Mulero et al., 
1998a 
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Immunostimulant Administration Dose 
	
Fish species 	Results 
	
Authors 
Injection 
In vitro 
Injection 
Immersion 
5 ug.fish -1 
5 ug.fish -1 
5 ug.m1 -1 
Rainbow trout 
Rainbow trout 
Rainbow trout 
Rainbow trout 
T plaque forming cells, phagocytic 
index & adherence index 
T antibody titre & 0 2- & phagocytic 
activity 
T 02- & phagocytic activity, 
leucocyte numbers & antibody titres 
T 02- & phagocytic activity, 
leucocyte numbers, antibody titres 
& survival when challenged. No 
adjuvant effect on plaque forming 
cells 
Anderson et al., 
1989 
Siwicki et al., 
1990 
Anderson & 
Jeney, 1992 
Jeney & 
Anderson, 1993b 
Injection 0.1 ml Atlantic salmon T survival when challenged. Midtlyng et al., 
1996 
Injection (time 
studies) 
5 ug/fish Rainbow trout T PFC Anderson et al., 
1989 
Injection 0.5 mg/kg Rainbow trout Activated alternative pathway 
increased phagocytes 
Kajita et al., 1990 
Immersion 2 mg/kg Carp T growth Siwicki et al., 
1988 
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Administration Dose Fish species Results Authors 
Injection 
immersion 
5 ug/ml Rainbow trout T protection Jeney & 
Anderson, (1993) 
In vitro 5 ug/ml Rainbow trout T PFC Anderson et al., 
1989 
In vitro 50, 25, 5 
ug/ml (in 
media) 
Rainbow trout T neutrophil, phagocytosis and PFC 
1990 
Siwicki et al., 
Injection Carp Phagocytosis T_ Siwicki 1987 
Oral Carp ROI T Siwicki 1989 
In vitro Trout Phagocytosis T, ROI T Siwicki et al., 
1990 
Injection Trout Phagocytosis T, CL T, Complement Kajita et al, 1990 
Injection Trout Phagocytosis 1', CL '1' Jeney & 
Anderson, 1993a 
Injection Carp T nonspecific defence Baba et al., 1993 
Immunostimulant 
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lmmunostimulant Administration Dose Fish species 	Results Authors 
5-25 mu g/ml Rainbow trout Siwicki et al., 
1992 
In vitro 
Levamisole in 
MFCA 
LPS 
0.2 ml 
1-100 ug 
Coho salmon 
Atlantic salmon & 
Rainbow trout 
Atlantic salmon 
T survival when challenged. 
Stimulation of leucocytes 
T phagocytic, pinocytic & acid 
phosphatase activity, intracellular 
02" production & stimulatin of 
macrophages 
Oliver et al., 1985 
Reitan & 
Thuvander, 1991 
Dalmo & Seljelid, 
1995 
Solem et al., 1995 
Clem et al., 1985 
MacArthur et al., 
1985 
Salati et al., 1987 
Neumann et al., 
1995 
Solem et al., 1995 
Injection 
In vitro 
In vitro 
In vitro 
In vitro 
Injection 
Injection 
In vitro 
In vitro 
Atlantic salmon 	T respitatory burst, phagocytic & 
bactericidal activities 
Catfish 	 IL1 T 
Plaice 	 Macrophage migration T 
Red sea bream 	Phagocytosis T 
Goldfish 	MAF T 
Salmon 	Phagocytosis T, ROI T 
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lmmunostimulant Administration Dose Fish species Results Authors 
In vitro Salmon Phagocytosis T, R011' DaImo & Seljelid, 
1995 
In vitro Atlantic cod T ROI Steiro et al. 1998 
Injection 0.2 ml Atlantic salmon Tsurvivai when challenged Robertsen et al., 
1990 
M-glucan Injection 2.5-5.0 
mg.m1-1 
Atlantic salmon 1' survival when challenged & 
antibody titre. 
Rorstad et al., 
1993 
Injection 200 ul Atlantic salmon T antibody titre & 02" activity. Rokstad et al., 
1996 
Microsilica Injection 0.2 ml Atlantic salmon 1' antibody titre & survival when 
challenged. 
Midtlyng et al., 
1996 
Mineral oil Injection 50 ug/fish Coho salmon 1' protection Olivier et al., 1985 
Muramyl 
dlnjectioneptide 
Injection 0.2 ml Coho salmon 1' survival when challenged. Olivier et al., 1985 
Muramyl 
dInjectioneptide in 
Injection 0.25 mg/kg Salmon Tiymphocyte proliferation Hoel & Lillehaug, 
1997 
MFCA 
Mycobacterium Oral Catfish ROI 1' Yoshida et al., 
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Immunostimulant Administration Dose Fish species Results Authors 
chelonae 1995 
Oligosaccharide In vitro Common carp T phagocytosis, cytotoxic activity Steinhagen & 
Hespe, 1997 
Parasite lysates Oral Yellow tail Phagocytosis ltami et al., 1996 
Peptidoglucan In vitro Atlantic salmon & 
rainbow trout 
Stimulation of leucocytes. Reitan & 
Thuvander, 1991 
PHA Injection 0.25-50 
mg.kg -1 
Atlantic salmon antiboty level and lymphocyte 
response. 
Hoel & Lillehaug, 
1997 
PGPL-Mc Injection 50-200 ul Rainbow trout No effect on survival when 
challenged 
Home et al., 1984 
Potassium alum Injection 2.5-5 ug Rainbow trout No protection difference. Home et al, 1984 
Injection 0.1mg.g -1 & 
oral (0.1 
Tilapia T phagocytic activity & survival 
when challenged. 
Park & Jeong, 
1996 
Polysaccharides Oral 2-10 mg.kg -1 Carp Range of levels in survival when 
challenged. 
Yano et al., 1991 
Pro!actin Oral Tilapia Phagocytosis Park & Jeong , 
1996 
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lmmunostimulant Administration Dose 
	
Fish species 	Results 
	
Authors 
PS-K 
	
Injection 	1 ug 	Rainbow trout 
	
T 02- & phagocytic activity, 	Anderson & 
leucocyte numbers, plaque forming Jeney, 1992 
cells, antibody titres & survival 
whcn challenged 
()AC (Quaternary 	Immersion 	1 ug.m1-1 
	
Rainbow trout 
	
02- & phagocytic activity, 	Jeney & 
ammonium 
	
leucocyte numbers, plaque forming Anderson, 1993b 
compound) cells, antibody titres & survival 
when challenged 
 
Injection 
immersion 
Immersion 
Oral 
Immersion 
Immersion 
Immersion 
1 ug/ml 
10 mg/1 
Rainbow trout 
Rainbow trout 
Japanese 
flounder 
Rainbow trout 
Catfish 
Rainbow trout 
neutrophil and phagocytic. 
is bacterial clearance 
Anderson & 
Jeney, (1993) 
Grayson et al., 
1987 
Quil A saponin 
 
1' survival when challenged, is 
agglutination titres 
Ashida et al., 
1999 
Salt 
1650m 
osmoles 
3% 
4.51% 
antigen uptake 
't antigen uptake 
antigen uptake 
Amend & Fender, 
1976 
Thune et al., 1984 
Fender et al., 
1978 
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lmmunostimulant Administration Dose Fish species Results Authors 
Oral 2.7g/100g 
feed 
Rainbow trout T leucocytes, 02- , phagocytic & 
myeloperoxidase activity, 
immunoglobulin level & survival 
when challenged 
Siwicki et al., 
1994 
Saccharomyces 
cerevisiae 
Oral 2.7% Channel catfish T phogocytic activity Duncan & 
Klesius, 1996a 
Injection 10mg/kg BW Yellow tail Complement T, Phagocytic index 1', 
Lysozyme T, 1' disease resistance 
Matsuyama et al. 
1992 
Schizophyllan 
scleroglucan . 
Injection Carp 1' disease resistance Yano et al., 1991 
In vitro 	 Salmon 	ROI 1', Pinocytosis T, Acid 	Sveinbjornsson & 
phosphatase T 	 Seljelid, 1994 
Schizophyllan 	Oral 	 0-0.8 
	
Channel catfish 	respitatory burst activity. 	Wise et al., 1993a 
polyglucose mg.Sekg-1 
diet & 0- 
240mqvitam i 
Page 150 
Immunostimulant Administration Dose Fish species Results Authors 
n E.kg -1 diet 
Selenium and 
Vitamin E 
Oral Trout TROI, phagocytosis, killing. Rumsey et al, 
1994 
Soy bean protein 
Span tween 
adjuvant 
Oral 2.7% Channel catfish T chemotaxis, phagocytic activity & 
antibody levels. No effect on 
resistance to challenge 
Duncan & 
Klesius, 1996b 
Spiralina Oral Catfish CL T Duncan & 
Klesius, 1996b 
Injection 0.1 ml Rainbow trout T survival when challenged. Adams et al., 
1988 
STA ISB 0.5 ml Tilapia T lysozyme activity & number of Chen et al., 1998 
ROI positive cells from swim 
bladder, peripheral blood & head 
kidney. 
Titremax Immersion 3% Catfish T antigen uptake Thune & Plumb, 
1984 
NaCI Immersion 4.51% Rainbow trout T antigen uptake Fender & Amend, 
1978 
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Oral 
Oral Channel catfish 
Oral Rainbow trout 
0-140mg 
0-3000 
mg.kg -1 diet 
0-2000 
• mg.kg -1 diet 
Oral 	 300-2000 	Turbot 
mg.kg -1 diet 
•Tsurvival when challenged,antibody 
levels & complement activity. No 
effect on phagocytic activity 
Is growth, survival when challenged 
& antibody levels 
T serum lysozyme & phagocytic 
activities 
Channel catfish 	T survival when challenged 
Immunostimulant Administration Dose Fish species 
NaCI Oral 1 g.kg -1 diet African catfish 
Vetregard Injection Trout 
Vibrio bacteria Injection Trout 
Oral 0.37- Atlantic salmon 
15.0mg.kg -1 
diet 
Vitamin A 
Vitamin C 
Authors 
Yoshida et al., 
1993 
Norqvist et al., 
1989 
Sakai et al., 1989 
Thompson et al., 
1994 
Durve & Lovell, 
1982 
Li & Lovell, 1985 
Navarre & Halver, 
1989 
Hardie et al., 
1991 
Results 
T respiratory burst & bactericidal 
activities. 
T disease resistance 
T disease resistance 
T serum antiprotease activity. No 
effect on respiratory burst, 
bactericidal, serum lysozyme & 
serum complement activities, 
survival when challenged & 
eicosanoid production. 
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Atlantic salmon 	T phagocytic activity 
Channel catfish 	T resistance to erythrocyte 
oxidative haemolysis, phagocytic 
activity & humoral antibody levels 
Coho 	 T immune response, 1' disease 
resistance 
Chinook 
	
1' disease resistance 
Hardie et al., 
1990 
Wise et al., 1993b 
Nikl et al., 1991, 
1992 
Nikl et al., 1993 
Vitamin C and 	Oral 	 7-8000 
glucan 	 mg.kg -1 
Vitamin E Oral 	 0-2500 
mg.kg -1 diet 
Injection/oral 
VitaSim 	Oral/Injection 
Immunostimulant Administration Dose 
	
Fish species 	Results 
	
Authors 
Oral 
	
150-4000 
	
Rainbow trout 
	
1' complement (alternataive 	Verlhac et al., 
mg.kg -1 diet pathway), CL & phagocytic 1996 
activities & antibody levels. 
 
Oral 
Injection 
Oral 
Injection 
0.1% Catfish 
Salmon 
Antibody 
1' disease resistance 
disease resistance 
Complement T, Lysozyme 1' 
Ainsworth et al., 
1994 
Robertsen et al., 
1990 
Yeast glucan 
 
Salmon 
Salmon 
Raa et al., 1992 
Engstad et al., 
1992 
Injection 	 Catfish 
	
Phagocytosis T, Killing T, Antibody 	Chen & 
• Ainsworth, 1992 
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Administration 	Dose Fish species Results Authors 
Injection Trout Lysozyme T, Killing T, 0 2 1' Jorgensen et al., 
1993a 
Injection Trout Killing T Jorgensen et al., 
1993b 
Injection Salmon T disease resistance Rostad et al., 
1993 
Injection Salmon Lysozyme T Aakre et al., 1994 
Injection Trout Roll' Thompson et al., 
1995 
Oral Catfish ROI T Yoshida et al., 
1995 
In vitro Salmon Lysozyme T, CL T Jorgensen & 
Robertsen, 1995 
Oral Turbot CL T, Migration T Baulny et al., 
1996 
Oral Catfish CL T, Migration 1' Duncan & 
Klesius, 1996a 
Oral Trout T CL, TComplement Verlhac et al., 
lmmunostimulant 
1996 
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SHORT COMMUNICATION 
Demonstration of resistance to reinfection with Paramoeba 
sp. by Atlantic salmon Salmo salar L. 
V. L. FINDLAY, M. HELDERS, B. L. YUNDAY & R. GURNEY Department of 
Aquaculture, University of Tasmania, Launceston, Tasmania, Australia 
Amoebic gill disease (AGD), caused by Paramoeba sp., is the most serious infectious disease affecting 
sea-caged Atlantic salmon, Salmo salar L., and rainbow trout, Oncorhynchus mykiss (Walbaum), in 
Tasmania (Munday, Foster, Roubal & Lester 1990). Indeed, this disease, together with the suboptimal 
osmoregulatory performance of rainbow trout in full sea water, has led to this species being almost exclu-
sively cultured in brackish water. In France, AGD has emerged as a major problem in sea-farmed Atlantic 
salmon, but it is of lesser importance in rainbow and brown trout, Salmo trutta L. (F. Baudin Laurencin, 
personal communication). Outbreaks in Pacific salmon have been minor and sporadic, and it may be that 
these species are inherently resistant to the disease. Kent, Sawyer & Hedrick (1988) reported minor out-
breaks in coho salmon, Oncorhynchus kisutch (Walbaum), in Washington State and California, and C. 
Anderson (personal communication) has diagnosed occasional outbreaks in chinook salmon, Oncorhynchus 
tshawytscha (Walbaum), held in poor water conditions ip New Zealand. 
Amoebic gill disease of salmonids in Tasmania is controlled by the use of freshwater baths lasting 
from 2 to 6 h, and up to three bathings may be undertaken during a normal summer. The long-term success 
of freshwater baths is dependent on the fish apparently acquiring immunity, and indeed, the third bath is 
often only given because 10-20% of the fish have relapsed, whereas the remainder appear to be resistant 
to reinfection (S. Percival, personal communication)) Further evidence for the development of a local 
immunity has been provided by Munday etal. (1990), who described the development of lymphoid nod-
ules on the filaments of recovered fish, especially rainbow trout. 
Atlantic salmon have been shown to respond to Paramoeba antigens, both when immunized parenterally 
with killed and live organisms, and when subjected to severe natural and experimental infections (Akhlaghi 
1994). As well as humoral antibodies, it is possible that local (gill mucus) antibodies may be formed, and 
as with bacterial gill disease (Lumsden, Ostland, MacPhee, Derksen & Ferguson 1994), these may be 
protective. The trial described here was designed to test this possibility, as well as provide firm evidence 
for protective immunity in fish which have previously suffered from AGD. 
All experiments were undertaken in 4000-1Rathburn tanks which were attached to individual biofilters 
to permit recirculation of the water. The water temperature in each tank was controlled by means of a heat 
exchanger connected to a heat pump with adjustments automatically initiated by a temperature probe 
connected to an electronic control box. Naive (unexposed) fish were maintained in fresh water and were 
acclimatized over 7-10 days to sea water when required for challenge experiments. 
Salmon were infected with Paramoeba sp. by cohabitating them with fish that had AGD, following 
the advice of L. Searle (personal communication). 
Correspondence: Dr B. L. Munday, Department of Aquaculture, University of Tasmania, P.O. Box 1214, Launceston, 
Tasmania, 7250, Australia. 
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Paramoeba antibodies were quantified using a modification of the enzyme-linked immunosorbent 
assay (ELISA) described by Bryant, Lester & Whittington (1995). The main variations were: 
(1) 3% casein in PBS was used in place of 1% gelatin for blocking; 
(2) 0.04% 0-phenylenediamine dihydrochloride (OPD) in sodium citrate/phosphate buffer with 0•012% 
hydrogen peroxide was used in place of ABTS in citrate phosphate buffer with hydrogen peroxide as 
the indicator; and 
(3) sera were absorbed with an equal volume of bacterial antigen (Xanthomonas maltophilia) with a 
protein concentration of 200 pg ml- '. 
Sera were used for the detection of humoral antibodies and gill mucus was prepared for ELISA testing 
according to the method of Lumsden, Ostland, Byrne & Ferguson (1993).. 
Initially, two replicates of 40 Atlantic salmon smolts of 100 g bodyweight were placed in tanks main-
tained at 14 °C with 15 Atlantic salmon post-smolts infected with AGD. 'Within a week, gill lesions, 
characterized by the development of patches of mucus, were present on some of the naive fish, and by the 
fourth week, all of these fish had lesions and mortalities had occurred. The surviving fish were transferred 
to a freshwater tank where they recovered quickly. After a further 4 weeks, the 70 surviving fish were 
divided into two groups and placed in seawater tanks with equal numbers of naive fish. Fifteen post-
smolts with AGD were added to each tank. The severity of the resultant AGD was quantified by counting 
the number of mucus patches on the first gill arches for both left and right sides (Alexander 1991) every 
week for 4 weeks. The presence of Paramoeba in the lesions was confirmed by microscopic examination 
of wet preparations of gill scrapings using both bright and dark field illumination. 
At the first weekly examination, AGD was present at comparable levels in all groups (Fig. 1). How-
ever, thereafter, until the fourth week, the naive fish developed many more lesions and were obviously 
distressed. The mean number of lesions in the previously exposed fish declined, and indeed, most fish 
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Figure 1. Lesion scores over time for different groups of experimental fish. 
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completely recovered or were displaying only one or two lesions. However, 11 fish did not recover and 
accounted for the majority of the total count of mucus patches for this group. 
At the end of the trial, all fish were anaesthetized with benzocaine (100 ppm), bled from the caudal 
vessels and their gills perfused as described in Lumsden et al. (1993). One gill was retained for histologi-
cal examination while the rest were collected for the extraction of mucus for the Paramoeba ELISA. The 
ELISAs were performed using known positive and negative sera as controls. Using the convention that 
the negative:positive threshold is calculated as the mean of the controls plus three standard deviations 
(Johnson, Roberts & Munday 1988), it was found that there were no significant ELISA reactions with the 
mucus samples. However, with the serum samples, it was found that 100% of the donor and freshly 
infected naive fish were positive as were 68% of the previously infected and re-exposed fish. 
This work has confirmed the hypothesis that salmonids which have suffered an attack of AGD 
are relatively resistant to reinfection. Also, it was noted that, as with field outbreaks, some fish did 
not develop a strong immunity. Another interesting observation was that the previously exposed fish 
initially appeared to be as susceptible as the naive fish, but at 2 weeks after re-exposure, they displayed 
resistance. This phenomenon may be an expression of immunological memory. The absence of demon-
strable Paramoeba antibodies in gill mucus suggests that surface antibodies are not involved in natural 
immunity to AGD. However, as fish mucus antibodies are frequently different in composition from serum 
antibodies and may not be recognized by monoclonals against the latter (Rombout, Taverne, van de Kamp 
& Taverne-Thiele 1993), this aspect of the immune response to Paramoeba sp. must remain unresolved. 
As has been demonstrated previously by Akhlagi (1994), infected fish develop a serological response 
to Paramoeba sp. as a result of AGD. Our results are particularly interesting in that the fish with continu-
ous infection (donors and naive fish) had a much higher reactor rate (100%) than those which had been 
cured of AGD and then re-exposed (68%). As shown in Fig. 1, these latter fish had few active lesions and 
this suggests that circulating antibody plays little, if any, role' in resistance against AGD. 
We believe that our observations provide a basis for further investigations, such as the potential for 
immunostimulants to enhance immunity against AGD and the possible development of vaccines with 
tropism for the gill epithelium. 
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Further studies on acquired resistance to amoebic gill 
disease (AGD) in Atlantic salmon, Salmo salar L. 
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Department of Aquaculture, University of Tasmania, Launceston, Tasmania, Australia, and the Cooperative Research 
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Abstract 
Trials were designed to test the efficacy of freshwater 
treatments for amoebic gill disease (AGD) of 
Adantic salmon, Salmo salar L., and the effect they 
had on the acquisition of resistance to reinfection 
with AGD. The first trial involved fish being given 
an industry-simulated freshwater bath of 2-3 h 
duration which simulated treatments given on farms. 
These fish did not display appreciable resistance to 
reinfection. The second trial involved four groups 
of fish which had been infected with and treated 
for AGD in a number of different ways. Once again 
the fish that had been infected for the first time 
and given a single 2-3 h freshwater bath and then 
re-exposed did not exhibit appreciable resistance to 
reinfection. In contrast, those fish that had been 
given a second 2-3 h freshwater bath and those that 
had been maintained in freshwater for 4 weeks 
displayed high levels of resistance. There is 
preliminary evidence to suggest that this resistance 
could be related to stimulation of the non-specific 
immune system. 
Introduction 
As indicated previously by Findlay, Helders, 
• Munday & Gurney (1995) amoebic gill disease 
(AGD) continues to be the main infectious disease 
constraining salmonid mariculture in Tasmania. 
•This disease is not confined to Tasmanian waters 
and has been described in Ireland (Rodger & 
McArdle 1996), France (F. Baudin Laurencin, 
Correspondence Dr B L Munday, Department of Aquaculture, 
University of Tasmania, PO Box 1214, Launceston, Tasmania, 
7250, Australia 
personal communication), Washington State and 
California (Kent, Sawyer & Hedrick 1988) and New 
Zealand (C. Anderson, personal communication), 
although to a lesser extent than in Tasmania. 
At present, the only successful treatment is the 
use of a series of freshwater baths given when the 
fish are experiencing outbreaks of AGD during 
temperatures in the range of 12-20 °C, and when 
the fish are held in full salinity water (Munday, 
Foster, Roubal & Lester 1990). 
A series of trials were designed to test a range of 
treatment possibilities and the effect these would 
have on the acquisition of resistance to AGD as 
previously demonstrated by Findlay et al. (1995). 
Of particular interest were the groups of fish that 
were given industry-simulated treatments, i.e. a 
freshwater bath of 2-3 h duration followed by a 
return to full salinity sea water. 
Materials and methods 
Adantic salmon weighing between 100 and 200 g 
were used throughout this study. All fish were naive 
in relation to AGD, having been maintained in 
fresh water in 4000 I Rathburn tanks connected to 
individual biofilters. The water temperature was 
maintained at 14 °C via an automated temperature 
probe connected to a heat exchanger and pump. 
When these naive fish were needed for challenge 
experiments, they were acclimatized to sea water 
over a 10 day period. All fish were identified by 
•colour-coded Hallmark®  tags which were ,:tiserted 
before the acclimatization period. 
'Salmon were infected with Paramoeba sp. by 
horizontal transmission after cohabitation with 
AGD-infected fish as described previously (Findlay 
et al. 1995). 
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Figure 1 Methods flow chart. 
The series of treatments undertaken were 
relatively complex and can best be understood by 
reference to the flow chart in Fig. 1. 
Initially, two replicates of 40 Atlantic salmon 
smolts were placed in tanks with 15 Atlantic salmon 
post-smolts infected with AGD (procedure A). 
During the first week, gill lesions characterized by 
mucoid patches were present on a number of the 
naive fish, and by the end of the fourth week, severe 
lesions, coupled with the presence of large numbers 
of Paramoeba sp., could be observed on most of the  
fish. After 4 weeks of infection these previously 
naive fish were removed and half were put into 
fresh water for 4 weeks (procedure B) while the 
other half were given an industry-simulated 
freshwater bath of 2 h (procedure C). An industry-
simulated bath involves the transfer of fish frAfri sea 
water to an oxygenated freshwater bath with a 
maximum salinity of 1%o. As the bath was 
performed in a separate tank, the opportunity was 
taken to remove the donor post-smolts, clean the 
tanks and perform a 100% water exchange. The 
: .ience Ltd 	 122 
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treated • smolts were then returned to the 
experimental tanks together with equal numbers of 
naive fish (procedure D). No infected donor fish-
were added for the second phase of this challenge, 
i.e. any recrudescence of AGD would result from 
residual infection in the treated fish. For 4 weeks 
the severity of infection was monitored weekly by 
counting the number of lesions on the first gill arch 
of both the left and right sides using the method 
described by Alexander (1991). At the end of the 
4 week challenge, all 40 fish were given another 
industry-simulated bath of 2 h (procedure E) and 
became the 'previously exposed X1' and the 
'previously exposed X2' groups in the next 
challenge. 
The second trial involved four groups of fish 
which had been infected for differing periods of 
time and treated for AGD in different ways. Into 
each replicate tank was added 15 naive fish, 15 fish 
that had been infected once and given a 2 h bath, 
15 fish that had been infected twice and given a 
2 h bath at the end of each 4 week period, and 15 
fish that had been infected once and kept in fresh 
water for 4 weeks (procedure F). No infected donor 
fish were added for this challenge. 
Weekly, for 4 weeks, the severity of infection was 
recorded by counting the number of lesions on the 
left and right sides of the first gill arch as described 
previously. 
Analysis of variance (P = 0.05) was performed 
on all data, using the SAS statistical package. A one-
way analysis of variance was performed on data 
from trial one, while a two-way nested analysis of 
variance combined with a Tukey's studentized range 
test was performed on data from trial two. 
Results 
The results of the first trial are shown in Fig. 2. Fish 
that had been treated with an industry-simulated, 
• h, freshwater bath displayed little more resistance 
to reinfection than previously unexposed (naive) fish. 
It was not until the middle of the fourth week that 
some signs of resistance were displayed in the 
previously exposed fish given a 2 h bath. There was no 
significant difference between the previously exposed 
groups and the naive groups for the first 3 weeks 
(P = 0.679, d.f. = 1; P = 0.858, d.f. = 1; and 
P = 0.167, d.E = 1, respectively). However, by week 
4, the, previously exposed fish displayed signifi-
cantly fewer lesions than their naive counterparts 
(P = 0.008, d.f. = 1). 
Figure 3 illustrates the changes in lesion numbers 
recorded for the fish in the second trial. It should be 
noted that it was necessary to truncate observations 
of the naive and 'previously exposed X1' treatment 
because of the mortalities due to AGD in these fish. 
In contrast, the group of fish that had experienced 
two waves of infection, and had been treated with 
industry-simulated freshwater baths of 2 h each, 
displayed only a moderate level of disease 1 week 
after challenge. There was a significant difference 
between treatments for week 1 (P = 0.0001, 
d.f. = 3). The results of the Tukey's test showed 
that there was a significant difference between all 
treatments with the exception of those that had 
been 'previously exposed X2' and those that had 
been kept in fresh water for 4 weeks. The significant 
difference between treatments remained for weeks 
2 and 3 (P = 0.0001, d.f. = 3 and P = 0.0001, 
= 3, respectively). The Tukey's test grouped the 
fish that had been given the 4 week freshwater bath 
with those given two rounds of industry-simulated 
freshwater baths (group 1) and the 'previously 
exposed X1' fish with the naive fish (group 2). 
The fish grouped in the first instance displayed 
significandy fewer lesions than those fish grouped 
in the second. This difference remained consistent 
in week 3. In week 4 no significant difference was 
found between treatments (P =- 0.542, d.f. = 1). 
This, however, is purely numeric because 
observations for the 'previously exposed X1' 
treatment and the nave treatment were truncated 
due to mortalities. It is obvious from Fig. 3 that 
the greatest potential difference between treatments 
existed in week 4. In fish that had been given two 
rounds of freshwater bathing, only a small number 
displayed lesions by the end of the fourth week. 
For those fish that had been given a 4 week 
freshwater bath, only a small number ever displayed 
lesions, and even then at a low level. In both these 
latter groups of fish, it is interesting to note that a 
small number of fish accounted for the majority of 
lesions. This is in contrast to the 'previously exposed 
X l' and naive treatments in which no or few fish 
survived past the third week. In fact, the remaining 
fish of these groups had to be rebathed to abate the 
high mortality rate. 
Discussion 
It is now well established that fish that have been 
previously exposed to AGD show resistance to 
reinfection (Findlay eta!', 1995). In that earlier 
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Week 
Figure 2 Changes in AGD lesion numbers (first trial). 
Figure 3 Changes in AGD lesion numbers (second trial). 
paper, it was shown that fish that had been exposed 
to AGD, kept in fresh water for 4 weeks and then 
re-challenged displayed a high level of resistance to 
reinfection. It is interesting that this same level of 
resistance is not reached when fish are given a single, 
industry-simulated freshwater bath of 2-3 h. Even 
the small decrease in lesion numbers in the fourth 
week after the freshwater bath is artificial due to 
the coalescence of lesions when fish exhibit such 
high numbers, as well as the death of the most 
severely affected fish which were carrying the highest 
number of lesions. Thus, it appears that the fish 
which are bathed for 2-3 h for the first time and 
then re-exposed to Paramoeba sp. do not develop 
appreciable signs of resistance to reinfection. In fact, 
their ability to cope with Paramoeba sp. challenge 
seems little different from that of fish which are 
experiencing their first wave of infection. In contrast, 
fish which have been given two industry-simulayed 
baths display a high level of resistance to reinfection 
and have an average of fewer than five lesions per 
first gill arch at the termination of the trial. It is 
notable that by weeks 3 and 4 after treatment, there 
was no difference between this group of fish and 
ence Lid 	 124 
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those that had remained in fresh water for 4 weeks. 
The initial difference between these latter two groups 
of fish during weeks 1 and 2 may be explained by 
the fact that fish which are given a 2-3 h bath 
probably still maintain low levels of amoebae on 
their gills after the bath, while fish which have been 
held in fresh Water for 4 weeks are completely cured 
beetre being re-challenged. This point is of particular 
interest because in the trials which involve fish being 
given an industry-simulated bath no donor fish are 
needed to re-establish infections, thus indicating 
some carry-over by treated fish. This is in contrast 
to the trials in which fish are held in fresh water 
for 4 weeks. This point has led us to believe that 
there may not necessarily be a reservoir of infection 
in the immediate environment, but rather there are 
enough viable infective stages left on the fish after a 
2-3 h bath that reinfection is immediately facilitated 
once the fish are returned to sea water. 
As we have previously shown in Findlay et al 
(1995), circulating antibody appears to play litde, 
if any, role in resistance to amoebic gill disease. The 
resistance demonstrated may be due to stimulation 
of the non-specific immune system by AGD 
infection. On this basis, further trials involving the 
assessment of the non-specific immune system and 
the use of immunostimulants to enhance this process 
have been initiated. 
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Abstract 
Levamisole, a known T-cell stimulator and im-
munomodulator in mammals, has been demon-
strated to enhance resistance to amoebic gill disease 
in Atlantic salmon, Salmo salar L. When used in 
fresh water baths, dose rates of 1.25, 2.5 and 5 
ppm levamisole stimulated resistance to reinfection 
with Paramoeba sp. that was evident from 2-3 
weeks post-treatment. It is proposed that this re-
sponse is related to enhancement of the non-spe-
cific immune system. 
Introduction 
Amoebic gill disease (AGD) has been diagnosed in 
Atlantic salmon, Salmi. salar L., in Tasmania 
(Munday 1985), Ireland (Palmer, Carson, Rut-
tledge, Drinan & Wagner 1997), France (Findlay 
& Munday 1998), Chile (D. Groman, personal 
communication) and the Pacific Northwest of 
North America (M. Sheppard, personal communi-
cation). It is the most important infectious disease 
affecting sea-caged salmon in Tasmania (Findlay & 
Munday 1998) and has emerged as a significant 
problem in Ireland (R. Palmer, personal communi-
cation). At present the only successful treatment is 
a series of fresh water baths of 2-3 h duration 
given when the fish are experiencing outbreaks of 
AGD (Munday, Foster, Roubal & Lester 1990). 
Many attempts to find a chemotherapeutic agent 
have been fruitless (Alexander 1991; Cameron 
Correspondence B L Munday, School of Biomedical Science, 
University of Tasmania, Locked Bag 1-320 Launceston, 
Tasmania 7250, Australia 
1994), but Howard & Carson (1994) have shown 
that a number of compounds, including 
levamisole, are capable of inhibiting the growth of 
the causative agent, Paramoeba sp. in vitro. Also, 
Findlay, Helders, Munday & Gurney (1995) 
found that some fish did not develop useful resis-
tance to reinfection with Paramoeba sp. after ac-
quiring AGD and being treated with a fresh water 
bath, suggesting immunological impairment. As 
such immunologically-impaired animals often re-
spond'to levamisole (Symoens & Rosenthal 1977), 
this was another reason to assess the utility of this 
compound for treating AGD in Atlantic salmon. 
The studies reported here were designed to test 
the efficacy of levamisole as an immunomodulator 
in ffie treatment of AGD of Atlantic salmon. 
Materials and methods 
Atlantic salmon of 100-200 g body weight (BW) 
were used throughout this study. Fish were not 
previously exposed to AGD, having been main-
tained in fresh water in 4000 L Rathburn tanks 
connected to individual biofilters. The water tem-
perature was maintained at 14 °C via an automated 
temperature probe connected to a heat exchanger 
and pump. 
The study was based on the experimental design 
described by Findlay & Munday (1998). In brief, 
fish which had previously experienced no, one or 
two episodes of AGD were given a variety of fresh 
water bath treatments with different levels of 
levamisole, and then re-exposed to infection in the 
form of cohabitation with clinically diseased fish. 
Science Ltd 	193 
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Details of the three individual trials are given in 
Table 1. For 4 weeks, the severity of infection was 
monitored weekly by counting the number of 
mucoid patches, typical of AGD in Atlantic 
salmon, on the first gill arch of both the left and 
right sides using the method described by Alexan-
der (1991). This has been verified as an appropri-
ate method for monitoring experimental AGD 
(Findlay et al 1995; Findlay & Munday 1998; 
Zilberg & Munday, unpublished) 
Two way analysis of variance (ANOVA) and 
Tukey's post hoc tests were performed to compare 
the number of gill lesions in the different treat-
ments in each tank, and between the replicate 
tanks (Sigma Stat, 1992-1994, Jandel Corpora-
tion). Data were considered significant at a 5% 
level (P < 0.05). 
Results 
Trial One 
Lesion numbers due to AGD were significantly 
reduced among levamisole-treated salmon experi-
encing their second wave of infection, when com-
pared to fish treated with fresh water only 
(P< 0.05; Fig. 1). This was particularly apparent 
at 3 and 4 weeks post-exposure to the disease. 
Lesions on levamisole-treated salmon experiencing 
their first wave of infection were variably signifi-
cantly lower than those on the fresh water treated 
fish (P< 0.05; Fig. 2). 
Trial Two 
It was noted that the continual passage of AGD 
through susceptible fish apparently raised the viru-
lence of Paramoeba sp. By the end of this trial 
(Trial Two) the effects of this increased virulence 
were evident. While the pattern of infection re-
mained similar to that of Trial One, the magnitude 
of infection was greater, thus affecting the outcome 
compared with Trial One. Because of the mortali-
ties that occurred in naive fish and fish that had 
been exposed to AGD on one occasion, but with-
out levamisole treatment, these two groups were 
prematurely withdrawn from the trial by 4 weeks 
post-exposure. Levamisole treatment appeared to 
be of assistance to naive fish and those that had 
experienced one wave of infection and had been 
immediately returned to sea water, significantly 
reducing the number of gill lesions at weeks 2-4 
post-exposure (P < 0.05; Fig. 2). Levamisole sig-
nificantly reduced the number of patches in fish 
that had experienced two waves of infection at 
weeks 1 and 2 post-exposure (P< 0.05), but not 
later in the trial (P> 0.05; Fig. 2). Also, such 
treatment did not affect the outcome for fish that 
had been returned to fresh water for 4 weeks after 
initial infection. 
Trial Three 
In Trial Three, groups of fish were treated with 
different concentrations of levamisole. There were 
Table 1 Summary data of experimental procedures for leyarnisole supplementation in fresh water bath treatments (Trials 1, 2 
and 3) 
Trial no. Treatment Levarnisole dose (mg/L) No. of fish in replicate tank 1 No. of fish in replicate tank 2 
1 PE x 1Lev 5.0 18 18 
1 PE x 1FW 0 18 18 
1 Naïve Lev 5.0 18 18 
1 Naive FW 0 18 18 
2 PE 4FW Lev 5.0 15 15 
2 PE 4FW FW 0 15 15 
2 PE x 2 Lev 5.0 15 15 
2 PEx 2 FW 0 15 15 
2 PE x 1 Lev 5.0 15 15 
2 PEx 1FW 0 15 15 
2 Naive Lev 5.0 15 15 
2 Ndfve FW 0 15 15 
3 PE x 1 Lev 5.0 17 19 
3 PE x 1 Lev 2.5 17 14 
3 PE x 1 Lev 1.25 18 15 
3 PE x 1 FW 19 20 
3 Naïve FIN 17 17 
PE= previously exposed, FW= 2-3 h fresh water bath only, Lev = 2-3 h fresh water bath +levamisole, 4FW = 4 weeks in fresh water before 
re-exposure. 
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Figure I Mean number of gill lesions on AGD-infected fish 
experiencing their first (naive) or second (PE x 1) waves of 
infection. Fish were treated with fresh water bath with or 
without 5 ppm levamisole, and equally divided between two 
4000 L tanks (n = 18 per replicate tank). PE= previously 
exposed, FV/= fresh water bath only, Lev = fresh water bath + 
levamisole. 
no significant differences between lesion numbers 
for any of the groups treated with levamisole 
throughout the experiment (P> 0.05; Fig. 4). 
However, the groups given a fresh water bath only 
had significantly more lesions at weeks 3 and 4 
post—exposure (P< 0.001; Fig. 3). Fish that were 
previously exposed and treated with fresh water 
only had fewer lesions compared to naive fish on 
weeks 3 and 4 in tank 1 (P < 0.05) and on week 
four in tank 2 (P < 0.001; Fig. 3). 
Discussion 
In regard to the beneficial effects of low concentra-
tions of levamisole added to a fresh water bath at the 
rate of 1.25-5 ppm, there is ample evidence for low 
levels of levamisole acting as immunostimulants in 
fish, including Atlantic salmon (Siwicici 1987, 1989; 
Kajita, Sakai, Atsuta & Kobayashi 1990; Jeney, 
Galeotti & Volpatti 1994; Mulero, Esteban, Munoz 
& Meseguer 1998; Findlay & Munday 2000). The 
fact that levamisole is a T-cell stimulant is particu-
larly relevant because Lin, Ellis, Davidson & Sec-
ombes (1999) have shown that leucocytes isolated 
from rainbow trout gills are predominantly T-cells. 
As a 5 ppm levamisole bath reduces the antibody 
response in salmon (Morrison 1998) and as there is 
no apparent relationship between detectable anti-
bodies against Paramoeba sp. and resistance to AGD 
(Findlay etal., 1995; Akhlaghi, Munday, Rough & 
Whittington 1996), this potential aspect of the drugs 
immunomodulatory repertoire is not likely to be 
relevant. Also, in vitro experiments have shown no 
deleterious effects of anti-Paramoeba antibody on 
Paramoeba sp. from Atlantic salmon gills (Zilberg & 
Munday, unpublished). 
Figure 2 Mean number of gill lesions on AGD-infected fish 
experiencing their first (naive), second (PE x 1) or third (PE x 
2) waves of infection, and a group of fish that was kept in fresh 
water for 4 weeks following their first wave of infection (PE 4 
weeks). Each one of these groups was treated with a fresh water 
bath with or without 5 ppm levamisole, and equally divided 
between two 4000 L tanks (n= 15 per replicate tank). PE = 
previously exposed, EV/ = fresh water bath only, Lev = fresh 
water bath + levamisole, 4FW = 4 weeks in fresh water before 
re-exposure. 
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Figure 3 Mean number of gill lesions on AGD-infected fish 
experiencing their first (naive) or second (PE x 1) waves of 
infection. Fish experiencing their second wave of infection 
were treated with a fresh water bath with or without 
levamisole, at concentrations of 1.25, 2.5 and 5 ppm. Naive 
fish were treated only with a fresh water bath. Each group 
was equally divided between two 4000 L tanks (n = 14-20 
per replicate tank, see Table 1). PE = previously exposed, 
FW= fresh water bath only, Lev = fresh water 
bath + levamisole. 
Much of the work reported here used the 
method of Alexander (1991) to quantify AGD 
infection. The validity of this method for field 
trials has since been questioned by Clark & Nowak 
(1999). However the authors' experience is that the 
use of counts of gill patches is a valid method for 
experimental AGD, although care is needed to 
ensure that standardized methods are used 
throughout individual trials. 
While there were significant decreases in lesion 
numbers in most of the groups of fish treated with 
levamisole, it was those fish experiencing their 
second wave of infection (i.e. fish which had previ-
ously been infected and given a fresh water bath 
before being re-exposed) that benefited most from  
the treatments. Incidental mortality data collected 
from the levamisole-treated fish support these find-
ings (Zilberg, Findlay, Girling & Munday 2000). 
Possibly this is the result of combined responses to 
both the infection and the immunomodulator. 
Fish that had experienced even more waves of 
infection presumably develop a high level of non-
specific immunity (Findlay et al. 1995; Akhlaghi et 
aL 1996; Findlay & Munday 1998) and the syner-
gistic effect of levamisole is not so apparent. It is 
notable that fish which have been infected and 
allowed to recover fully in fresh water for 4 weeks, 
display significant resistance to reinfection, whether 
or not they are treated with levamisole. It appears 
that stimulation of the non-specific immune sys-
tem following one wave of AGD, coupled with the 
fact that the fish's gills would have recovered 
completely from the infection, ensures that these 
fish are almost completely refractory to reinfection. 
It appears that re-establishment and develop-
ment of AGD is the result of interplay between 
immune responses (especially the non-specific im-
mune response), gill health, number and virulence 
of Paramoeba and environmental conditions (espe-
cially salinity and temperature). In this context, it 
has been reported that levamisole significantly en-
hances the healing process in mammals (Symoens 
& Rosenthal 1977). This enhanced healing was 
attributed to the increase of neutrophil and 
macrophage migration to the damaged area, and it 
is reasonable to assume that a similar mechanism 
may exist in teleosts. 
To put the various responses  to levarnisole given 
as a bath treatment in context, it is suggested that 
the factors involved are as follows: 
1. Fish infected for the first time and given a 2 
h fresh water bath only will develop a moderate 
increase in their non-specific immunity and will 
have mucus and amoebae removed from their gills. 
However, the lesions of gill hyperplasia and inflam-
mation will remain to attract amoebae (Nowak & 
Munday 1994) and some amoebae may survive 
within cystic lesions present in the gills (Munday et 
al. 1990). 
2. Fish infected for the first time and given a 2 
h fresh water bath containing levamisole will expe-
rience a very much enhanced non-specific immune 
response and, therefore, there will more likely be 
resolution, rather than persistence, of infection and 
resultant lesions. 
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3. in fish that have been previously exposed on 
two occasions and given two industry-simulated 
baths lesions are still present, but the nonspecific 
immune response has been augmented to a sufficient 
level to allow recovery. In this instance levamisole 
provides only a temporary advantage of a slightly 
higher resistance to reinfection in the early weeks of 
exposure. 
4. Fish that have been infected for the first time 
and allowed to recover in fresh water for 4 weeks 
have gills that are in excellent condition when 
re-exposed, so while their immune response may not 
remain at a high level, the condition of the gills 
compensates for this. 
The concentrations of levamisole used in Trials 
One, Two and Three were less than that shown by 
Howard & Carson (1994) to inhibit the growth of 
Paramoeba sp. in vitro (> 10 ppm). Therefore, it is 
reasonable to suggest that the effects reported here 
are entirely due to the drugs' immunomodulatory 
activity. 
With the increasing need for the use of therapeu-
tants in aquaculture, it is very important that 
potential chemicals be chosen carefully so as to 
minimize the accumulation of chemicals in food for 
human consumption and the effect on the environ-
ment. In this context, since its introduction 
levarnisole has been used extensively and safely in 
veterinary and human medicine (Symoens 8c Rosen-
thal 1977; Arundel 1985; Anon. 1991). Levamisole 
is a simple chemical that is rapidly adsorbed and 
excreted. Peak blood levels in farm animals are 
reached 2-3 h following oral dosage and concentra-
tions then decrease, little being present 20 h after 
oral dosage. In farm animals it is almost totally 
excreted in the urine and bronchial mucus. In man, 
levamisole has a plasma half-life of about 4 h, is 
extensively metabolized in the liver and is virtually 
eliminated from the body within 2 days (Symoens 
& Rosenthal 1977). The half-life in eels at 19 — 
23 °C is remarkably similar at 3.99 h (Blanc, 
Loussouarn & Pinault 1991). 
Levamisole is quite stable in acid aqueous media 
but hydrolyzes in alkaline solutions such as sea water 
(Symoens & Rosenthal 1977) and, therefore, is 
particularly suitable for use in fresh water baths, 
which are subsequently released into the sea. 
In conclusion, the present challenge experiments 
clearly demonstrate that levamisole, when given in 
a fresh water bath at a range of concentrations, can 
be therapeutic for fish with AGD. 
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The immunomodulatory effects of levamisole on the 
nonspecific immune system of Atlantic salmon, Salm° 
salar L. 
• V L Findlay and B L Munday 
School of Aquaculture, University of Tasmania, Launceston, Tasmania, Australia, and the Cooperative Research 
Center for Aquaculture 
Abstract 
Sea water-adapted Atlantic salmon, Salmo sabr L., 
were given a 2-h bath in a 2.5 mg L -1 levamisole 
(as levamisole hydrochloride) solution in fresh-wa-
ter. Following bathing, the fish were held in full 
salinity sea water for 2 weeks before being subjected 
to a number of immunological assays. Heightened 
activity of the nonspecific defence system was 
demonstrated by increases in phagocytic index, 
phagocytic capacity and phagocytic activity, in-
creased levels of the reactive oxygen intermediate, 
superoxide anion, and an increased lytic activity of 
both the mucus and the serum. These results 
indicate that levarnisole is effective in augmenting 
parts of the nonspecific defence system of Atlantic 
salmon. This is the first record of the use and efficacy 
of levamisole as an immunomodulator in Atlantic 
salmon. 
Introduction 
Nonspecific defence mechanisms are important to all 
vertebrates. Fish, however, depend more heavily on 
these nonspecific mechanisms than do mammals and 
this is especially true of cold water species (Avtalion 
1981). Furthermore, in those instances where patho-
gens infect sites that are relatively insulated from the 
specific humoral immune system, such as mucous 
surfaces, there seem to be few available options for 
treatment or prophylaxis, other than direct chemical 
Correspondence V L Findlay, Australian Quarantine and 
Inspection Service, PO Box 858, Canberra, ACT, Australia, 2601 
(e-mail: vanessa.findlay@aqis.gov.au) 
.therapeutics, or modulation of the nonspecific de-
fence system. 
In the last decade there has been increasing 
interest in the modulation of the nonspecific im-
mune system of fish as both a treatment and 
prophylactic measure against disease. A number of 
substances, including levamisole, have been shown 
to heighten the nonspecific defence system capacity. 
Levamisole is a levo-isomer of tetramisole. The 
compound was first introduced in 1966 as a broad 
spectrum anthelmintic (Theinpont, Vanparijs, 
Raeymaekers, Vandenberk, Deinoen, Allewijn, 
Marsboom, Neinmegeers, Schellekens & Janssen 
1966) and has since been used extensively and safely 
in veterinary and human medicine. Accumulated 
evidence has strongly suggested that levamisole 
treatment leads to an enhanced state of resistance to 
various kinds of infections (Symoens & Rosenthal 
1977; Jeney, Galeotti & Volpatti 1994; Mulero, 
Esteban, Munoz & Meseguer 1998). In this study 
augmentation of the nonspecific immune systems 
including lysozyme, reactive oxygen species and 
phagocytic ability in Atlantic salmon following 
levamisole treatment is reported for the first time. 
Studies have shown that bath treatment of At-
lantic salmon with levamisole resulted in increased 
resistance to amoebic gill disease (AGD) (Findlay, 
Zilberg & Munday, 2000). Levamisole has been 
demonstrated to modulate both the specific and 
nonspecific defence systems but, as has been 
demonstrated in previous studies (Findlay, Helders, 
Munday & Gurney 1995), there is no correlation 
between detectable antibody against the Paramoeba 
sp. causing AGD and resistance to disease. There- 
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fore; it has been hypothesized that the resistance 
levamis. ole affords Atlantic salmon is mediated via 
the nonspecific defence system. This hypothesis 
was the stimulus for the study described here. 
Materials and Methods 
Fish 
All experimental fish were post-smolt Atlantic 
salmon, Salmo salar L., weighing between 100 and 
200 g. Fish were maintained in full salinity sea 
water in 4000 L Rathburn tanks connected to 
individual biofilters. The water temperature was 
maintained at 14 °C via an automated temperature 
probe connected to a heat exchanger and pump. 
All fish were identified by colour coded Hallmark® 
tags which were inserted prior to each experiment. 
Of the fish in each group, half were bathed in a 
fresh water bath with levamisole added at a rate of 
2.5 mg L (treatment group) and the other half 
in a plain fresh water bath (control group). The 
fresh water bath mimics that used by industry to 
treat AGD and the dose rate of 2.5 mg L of 
levamisole has previously been demonstrated to 
increase resistance of Atlantic salmon to AGD 
(Findlay et al. 2000). Fish were killed 14 days 
post-treatment as this has previously been shown 
by Findlay et al. (2000) to be the time at which 
recovery from AGD becomes most consistently 
apparent in levamisole treated fish. 
Techniques 
Collection of serum and mucus 
To collect mucus samples the gills were first per-
fused.. With head elevated, the tail was severed at 
the peduncle region and then the heart was ex-
posed. The gills were perfused with heparinized 
saline by direct puncture of the bulbus arteriosus 
or ventricle. Depending on the size of the fish, 
complete perfusion occurred after about 30 sec and 
after 20-30 mL of saline had been injected. Perfu-
sion was judged as being complete when the gills 
were blanched white and the fluid from the caudal 
vessels was clear. The gills were then excised and 
the mucus removed with the blunt side of a plastic 
knife. Any contaminating detritus was removed by 
centrifugation (1500 x g for 10 min). The samples 
were examined for evidence of contamination by 
blood. 
Serum samples were collected by bleeding from 
the caudal vein. The blood was allowed to clot at 
room temperature for 1 h, kept for 8 h at 4 °C and 
then centrifuged at 1500 x g for 10 min to obtain 
the serum. Serum and mucus samples were stored 
at — 80°C or used immediately. 
Preparation of head kidney cell suspension 
The head kidney was removed and placed on a 
stainless steel mesh sieve (0.3 mm mesh) in a Petri 
dish containing 5 mL of PBS. The kidney tissue 
was pushed through the mesh and the resulting 
homogenate passed through a loosely-packed, glass 
wool syringe column to remove tissue fragments, 
cellular debris and red blood cells. The suspension 
was allowed to settle for 15 min and then gently 
layered upon 2 mL of Histopaque 1077 (Sigma). 
The layered cell suspension was centrifuged for 15 
min at 400 x g. 
Following centrifugation, the white blood cell 
interface layer was removed and washed in 3 mL 
PBS (3 min at 200 x g). The supernatant was 
decanted and the pellet resuspended in 0.5 mL of 
PBS. The solution was vortex mixed and a drop 
placed on a glass slide and covered with a Coverslip. 
Cell viability ( > 95%) was confirmed usirig trypan 
blue exclusion. 
Assays 
Lysozyme assay 
A turbidometric assay utilizing Micrococcus 
lysodeikticus lyophilized cells (Sigma) was used to 
determine lysozyme concentrations in the serum 
and mucus collected from Atlantic salmon. Eight 
samples were used in each assay. The method was 
a modification of that used by Sankaran 86 Gur-
nani (1972) who reported differences in the opti-
mal pH and buffer molarities according to whether 
the fish were from fresh water or sea water. There-
fore, a series of assays was conducted with pooled 
mucus and serum samples to optimize the test for 
use with Atlantic salmon maintained in sea water. 
While it is recognized that different buffers may 
further optimize results it was important to 
maintain some comparability so the same buffer 
(0.04 M phosphate buffer) was used for all assays. 
M lysodeikticus was suspended in phosphate 
buffer at a concentration of 0.25 mg mi.'. Two 
hundred microlitres of serum or mucus, diluted 
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with an equal volume of PBS, were added to 1.3 
mL of the substrate .solution at 25 °C and the 
optical density at 450 nm read immediately. After 
30 min incubation in a humidified environment 
at 25 °C the optical density was measured once 
again. Lyophilized hen egg white lysozyme 
(HEWL) was used to develop a standard curve. 
Serum and mucus lysozyme values are ex-
pressed as 1.1g mL - ' equivalent of hen egg white 
activity and were derived using the equation for 
the second order polynomial regression line. 
Phagorytosis assay 
The ability of fish phagocytes to ingest particles is 
usually demonstrated with an in vitro phagocyto-
sis assay (Duda 1996). These tests are expensive 
and labour intensive. In the present study, an in 
vivo phagocytosis assay that is very cheap to run 
and extremely robust (Duda 1996) was used. 
Two groups of fish were used in this assay; the 
first group was treated with levamisole and the 
second acted as a control group and were bathed 
in fresh water only. There were 20 fish per group. 
The phagocytic abilities of head kidney cells 
were examined as follows. Suspensions of cells of 
the yeast Saccaromyces cerevisiae 108 mL- ' were 
prepared in phosphate buffered saline (PBS) (pH 
7.4). The equivalent amount of 0.8% congo red 
was added to the yeast suspension before it was 
autoclaved at 121 °C for 20 min (the yeast cells 
may then be refrigerated for up to 72 h). Before 
use, the yeast cells were washed five times in 
sterile PBS for 3 min at 300 x g and resuspended 
in the initial volume of PBS. 
Fish were anaesthetized with 40 mg L -1 ben-
zocaine (10% wv-1 ethyl-4-aminobenzoate in ace-
tone) to Stage III or surgical procedure 
anaesthesia as described by Ross & Ross (1984), 
weighed and injected with 0.1 mL per 100 g 
body weight of the yeast solution via the caudal 
vein. The fish were revived and held in 400 L 
plastic tanks supplied with oxygen for 2 h. After 
the holding period the fish were anaesthetized 
once again and bled by severing the caudal pe-
duncle. 
Head kidney cells were collected using the 
method described above and the phagocytic cells, 
including neutrophils and macrophages, were 
counted until 100 cells that had consumed yeast 
had been recorded. The number of yeast cells in 
each phagocyte was counted and the phagocytic  
index, phagocytic capacity and phagocytic activity 
calculated as follows: phagocytic index (PI) equals 
the total number of yeast cells consumed, divided 
by the number of consuming phagocytes. The 
phagocytic capacity (PC) equals the total number 
of phagocytes containing a given number of yeast 
cells divided by the total number of phagocytes 
containing any yeast. Phagocytic activity (PA) is 
expressed as the number of phagocytizing cells 
divided by the total number of phagocytes 
counted. 
Reactive oxygen intermediate — superoxide anion 
assay 
Superoxide produced by the macrophages isolated 
from the head kidney was measured by the reduc-
tion of ferricytochrome C as described by Sec-
ombes, Chung & Jefferies (1988) and Zelikoff, 
Wang, Islam, Twerdok, Curry, Beaman & 
Flescher (1996). The specificity of the reaction 
was demonstrated by preventing the reduction of 
ferricytochrome C with exogenous superoxide dis-
mutase (SOD) which dismutates any 0,- gener-
ated to hydrogen peroxide. 
The amount of 0,- produced in the respiratory 
burst was quantified by comparing cells taken 
from an individual fish using four different reac-
tion mixtures. Each of these four mixtures con-
tained 500 liL of ferricytochrome C (Sigma) (final 
concentration of 2 mg mL -1 prepared in supple-
mented fish physiological saline) to which had 
been added 106 kidney cells (in a total volume of 
250 III. of supplemented Leibovitz medium). The 
first two reaction mixtures measured basal levels 
of OT so no membrane stimulant was added to 
these mixtures. Exogenous SOD [125 j_tI, at a 
final concentration of 37.5 lig mL -1 prepared in 
Hanks buffered salt solution (HBSS)] was added 
to one of these mixtures so any basal level 0,- 
was inhibited. The second two reaction mixtures 
mimicked the first, with the addition of 20 pi, of 
the soluble stimulant phorbal myristate acetate 
(PMA) (Sigma) (at a final concentration of 2.0 lig 
mL-1 , prepared in dimethylsulphoxide, working 
solution of 100 jtg mL - ' prepared in HBSS). An 
additional tube that contained all of the above-
mentioned reagents, but without cells, acted as 
the reaction blank. Fish physiological saline was 
added to all the mixtures to bring the final vol-
ume up to 1 mL. 
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Each of the mixtures was vortexed for 30 sec 
before 200 !IL aliquots were placed in triplicate in 
96-well microtitre plates. The absorbance was mea-
sured at 550 nm every 10 min for 2 h and again at 
24 h. Between readings the plates were placed in a 
humidified incubator at 30 °C. 
Change in absorbance was calculated by first 
subtracting the mean of the blank wells from all 
other wells and then subtracting the absorbance of 
the wells containing SOD from that of the non-
SOD-containing wells. The results were expressed 
by converting the optical density readings to nmol 
02- per 10 5 cells by multiplying with the correc-
tion factor of 15.87 as given by Pick 8c Mizel 
(1981). 
Haematocrit and leucocrit 
Fish were anaesthetized as previously described and 
a blood sample taken from the caudal vein. Hep-
arinized haematocrit capillary tubes (Chase Instru-
ment Corporation, Glens Falls, NY, USA) were 
filled to the red line. Duplicate samples were taken 
from each fish. The tubes were then centrifuged for 
1 min in a haematocrit centrifuge. The percentage 
erythrocyte (haematocrit) and leucocyte (leucocrit) 
volume was calculated by overlaying the tubes on a 
sliding scale haematocrit reader. 
Statistical analysis 
The regression for the HEWL standard curve was 
undertaken using the statistical package of Micro-
soft Excel 97. One way and nested analysis of 
variance tests were undertaken utilizing the general 
linear models procedure of the SAS ® system for 
Windows 6.11. 
Results 
Lysozyme assay 
The lysozyme activity in Atlantic salmon serum 
was found to have an optimum at pH 5.8 (see Fig. 
1). Lysozyme activity of mucus was also pH depen-
dent with an optimum at pH 6.2. HEWL in 
contrast, exhibited an optimal activity at pH 7.0 
with sharper declines in activity at acidic and 
alkaline pH. While it is acknowledged, that be-
cause of the above results, HEWL may not be the 
best standard to use for lysozyme assays involving 
fish, it is readily available and consistently used by 
workers in the field. It was used in this study to 
maintain some comparability between results of the 
present studies and those reported in the literature. 
A second order polynomial regression (r 2 = 
0.9862) was fitted to the standard curve for 
HEWL to allow resultant optical density readings 
Figure 1 Effect of pH on the lysozyme activity of serum, mucus and HEWL. 
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Figure 2 Lysozyme concentration of serum from Atlantic salmon treated with levamisole. 
for serum and mucosal lysozyme to be converted to 
equivalent HEva, concentration. The following 
formula was used in this conversion: lysozyme 
concentration = 0.4185-5.5969 x change in 
OD + 65.3178 x change in 0D 2 . In all cases 
serum and mucus obtained from levamisole treated 
fish displayed a significantly increased lysozyme 
activity when compared to control fish (F = 168.2, 
d.f. = 1, P< 0.0001, F = 425.44, d.f. = 1, P< 
0.0001 respectively) (see Fig. 2 and Fig. 3). Mu-
cosal samples had consistently higher lysozyme 
activity than serum samples. Furthermore, when 
serum and mucus samples were heat-treated, thus 
inactivating the heat labile component, there was a 
consistent drop in the lytic activity whether they 
were levamisole treated or not (F = 19.4, d.f. = 2, 
P <0.0001, F = 34.13, d.f. = 2, P< 0.0001 re-
spectively) (see Fig. 2 and Fig. 3). 
Phagocytosis assay 
Head kidney cells that had been collected from the 
fish treated with levamisole demonstrated enhanced 
phagocytic abilities. Phagocytic ability was assessed 
and represented using measures of PI, PC and PA. 
There was a significant increase in the number 
of yeast cells consumed per phagocyte in fish  
treated with levamisole (F = 338.27, d.f. = 1, P< 
0.0001). The treated fish had a PI of 2.31 com-
pared to control fish with a PI of 1.54. Levamisole 
treatment also significantly increased the phago-
cytic capacity of harvested phagocytes (F = 375.02, 
d.f. = 1, P< 0.0001). For phagocytes harvested 
from levamisole treated fish 84.75% had phagocy-
tosed 1-3 yeast cells and 15.25% had phagocy-
tosed 4-6 + yeast cells. For phagocytes harvested 
from control fish 97.05% had phagocytosed 1-3 
yeast cells and 2.95% had phagocytosed 4-6 + 
yeast cells. Thus, for levamisole treated fish there 
was a right shift in the phagocytic profile of yeast 
consumption per phagocyte that represents an in-
creased PC (see Fig. 4). Of the phagocytic cells 
harvested from fish that had been treated with 
levamisole, 50.03% had consumed one or more 
yeast cells. This is a significant increase (F = 
61.9415, d.f. = 1, P< 0.0001) when compared to 
a phagocytic activity of 33.47% for control fish. 
Superoxide anion production 
In all experiments the addition of exogenous SOD 
inhibited the reduction of ferricytochrome C by the 
macrophages, confirming that the assay was specific 
for 0 2 . Figure 5 shows that the macrophages 
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from levamisole treated fish had a significantly 
increased 02— production with or without PMA 
triggering (F = 209.66, d.f. = 3, P< 0.0001). The 
Tukey's test distinguished between all treatments. 
Furthermore, at 24 h post-harvest the production 
of 02- in PMA stimulated macrophages from 
levamisole treated fish remained at elevated levels 
while all other groups returned to basal levels. 
Haematocrit and leucocrit 
No significant differences were found between 
levamisole treated and control fish for haematocrits 
and leucocrits (F = 2.71, d.f. = 1, P= 0.1078 and 
F = 0.88, d.f. = 1, P= 0.3535, respectively). 
Treated fish exhibited a mean haematocrit level of 
48.8% and a mean leucocrit level of 1.78%. Con-
trol fish had a mean haematocrit level of 46.9% 
with a leucocrit value of 1.78% 
Discussion 
Levamisole has been shown to act as an immunos-
timulant in a number of fish species. Siwicki 
(1987, 1989) described the immunostimulatory 
activity of levamisole in carp spawners, with treated 
fish displaying elevated leucocyte and neutrophil 
numbers, enhancement of phagocytic activity, leu-
cocyte migration and myeloperoxidase activity, in- 
creases of lysozyme levels and natural antibody 
titres. In their studies, ICajita, Sakai, Atsuta & 
Kobayashi (1990) showed that levamisole stimu-
lated phagocytic activity, chemiluminescence re-
sponses and natural killer cell activity in rainbow 
trout, Oncorbyncbus mykiss (Walbaum). These 
workers demonstrated the activation of the alterna-
tive complement pathway. Levamisole also has an 
immunostimulatory effect on the sea bass, Dicen-
trarcbus labrax L., and the gilthead seabream, 
Sparus aurata L., as shown by Jeney et aL (1994) 
and Mulero et at (1998), respectively. Both 
groups demonstrated significant increases in res-
piratory burst and phagocytosis activities. The 
present study is the first record of the effect of 
levamisole on the nonspecific immune system of 
Atlantic salmon. 
In this study all groups of fish given a bath 
treatment of levamisole had increased nonspecific 
defence factor values when compared to control 
fish. In those circumstances where the capacity to 
mount an immune response is not sufficient to 
successfully combat an invasion  by pathogenic mi-
croorganisms, this demonstrated increase in the 
magnitude of the immune reaction may be ade-
quate to ensure improved protection. 
Granulocytes and mononuclear phagocytes or 
macrophages play a central role in the cellular part 
of the nonspecific defence of fish (Dalmo, Bog- 
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Figure 3 Lysozyme concentration of mucus from Atlantic salmon treated with levamisole. 
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wald, Ingebrigtsen & Seljelid 1996). In the present 
study, three phagocytic functions were assessed 
and, after treatment with levamisole, all were in-
creased. Whilst phagocyte killing mechanisms are 
not well established in fish many studies have 
shown that fish phagocytes have potent bactericidal 
and larvicidal activity and thus, presumably, pos-
sess both intracellular and extracellular killing 
mechanisms (Secombes & Fletcher 1992). If extra-
cellular killing can be facilitated then many impli-
cations may follow, particularly where parasites 
such as the causative agent of AGD infest areas 
that are relatively protected from the effects of 
antibody-mediated immunity. In this context, 
Whyte, Chappell & Secombes (1989) demon-
strated that normal macrophages from rainbow 
trout are capable of killing non-opsonized 
diplostomes. Also, the release of free radicals such 
as superoxide anions and hydrogen peroxide and 
enzymes such as lysozyme may also play a role in 
extracellular killing. It may be relevant that Ellis 
(1982) suggested that the fish neutrophils may 
carry out a microbicidal role extracellularly rather 
than intracellularly. 
If high levels of ROIs lead to the degeneration 
of parasitic invaders that would otherwise evade the 
immune system, then even if this killing were at 
the expense of cellular health, it must be seen as an 
advantage given the excellent regenerative powers 
of fish. Furthermore, Symoens & Rosenthal (1977)  
reported that levamisole treatment leads to an 
enhanced state of healing and wound repair. 
While lysozyme is generally recognized as being 
part of the humoral nonspecific defence system it 
could be argued that it makes up part of the 
cellular nonspecific component given that it em-
anates from phagocytes. Lysozymes are widespread 
enzymes occurring in many teleost tissues and 
secretions (Lindsay 1986). With the exception of 
their probable antibacterial role, their function in 
vertebrates is still open to question (Jones & Jolles 
1984). Given the distribution of lysozyme in fish 
(i.e. in tissues rich in leucocytes and at sites where 
the risk of invasion is high such as skin, gills and 
gastrointestinal tract) it is logical to hypothesize 
that lysozyme provides a protective function espe-
cially as it has been demonstrated to be involved in 
defence against viruses, neoplasms, bacteria, fungi 
and insects (Dobson, Prager & Wilson 1984). 
Prior to 1990, reports on the modulation of 
lysozyme activity in fish were limited (Mock & 
Peters 1990). Since that time, there has been an 
increase in the number of studies, perhaps reflect-
ing the recognized importance of the nonspecific 
immune system in fish. This study confirms that 
levamisole can induce increased activities of both 
mucus and serum lysozyme. We will not attempt 
to compare the activity of lysozyme between fish 
species because there is such a great interspecies 
variation as shown by Grinde, Lie, Poppe & Salte 
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(1988), who reported the lysozyme levels of 12 fish 
with up to four fold variations between species. 
Furthermore, variation exists depending on the 
origin of the sample. Lindsay (1986) assayed 
lysozyme from the oesophagus, stomach, kidney, 
spleen, swim bladder and in the mucus and serum. 
The lowest levels reported were from serum and 
the highest were from the stomach. This pattern is 
compatible with a defence function and it seems 
likely that lysozyme is an integral part of the 
arsenal of nonspecific defence mechanisms of fish. 
As part of the lysozyme assay, the heat labile 
component of both serum and mucus was also 
studied. Complement is an important part of this 
component and although the characterization of it 
is incomplete it is recognized as being relatively 
significant with respect to antimicrobial activity 
(Sakai 1992). 
Complement acts as a membrane attack se-
quence that may be initiated by either the classical 
pathway that requires Ig to react with an antigen 
or via the alternative pathway with stimulation 
from a variety of substances. Heat treating mucus 
and serum samples prior to conducting the 
lysozyme assay did reduce the lytic activity but 
there was not a significant difference between 
levamisole treated and control fish, which suggests  
that levamisole had no effect on complement activ-
ity or other heat labile components. 
Finally, the levels of haematocrit and leucocrit 
serve as a general indicator of fish health. These 
parameters are often used as confirmation that an 
immunostimulant is not disturbing the profile of 
the blood and thus homeostasis of the individual. 
No significant differences were found in the 
haematocrit or leucocrit levels between treated and 
control fish. Thus, it may be concluded that the 
modulatory effect of levarnisole does not extend to 
a modification of the blood profile. 
This study provides strong evidence that in vivo 
bath treatment with levamisole enhances the non-
specific immune system as measured by phagocytic 
ability, superoxide anion production and lytic 
lysozyme activity. While the present study has been 
conducted with the express interest of maximizing 
the effectiveness of AGD treatment (i.e. adding an 
immunostimulant to a therapeutic fresh water 
bath), it is acknowledged that, in cases where 
immunostimulation alone would be of sufficient 
benefit, oral treatment would be more practical. 
The findings in this study are in accordance with 
the previously discussed studies of the effects of 
levamisole in other fish species. The results of this 
study may prove to be of practical value given the 
Figure 5 Superoxide anion production by Atlantic salmon head kidney macrophages. 
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efficacy of this drug at such low concentrations 
and the ability to treat large quantities of fish at 
any given time. Furthermore, the prophylactic use 
of levamisole may be of value where situations 
known to result in stress and exposure to disease 
occur. 
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Abstract 
When levamisole was added to freshwater baths, used to treat Atlantic salmon for amoebic gill 
disease (AGD), there was a significant decrease in subsequent mortality of the fish. This was 
particularly the case in fish experiencing their first exposure to AGD. There were no significant 
differences in responses to 1.25, 2.5 and 5.0 mg / L levamisole. It is proposed that this response is 
related to enhancement of the non-specific immune system. Oral supplementation with levamisole 
or glucans did not prevent subsequent moplities when Atlantic salmon, naïve to AGD were 
subsequently exposed to this disease. 
Introduction 
Amoebic gill disease (AGD) is the most im-
portant disease of sea-caged Atlantic salmon 
in Tasmania (Findlay and Munday 1998) and 
is currently treated and controlled by the use 
of freshwater bathes and/or brackish water 
culture sites. There have been a number of 
attempts to find suitable chemotherapeutants 
which can be fed to the fish or used in 
seawater (Alexander 1991, Cameron 1994, 
Howard and Carson 1994), but the only en-
couraging results have been those of Lee et al 
(1994) and Lee (1995) who researched oral 
supplementation with B-glucans, which are 
known to be stimulators of the non-specific 
immune system in fish (Robertson et al. 1990, 
Nikl et al. 1991, Raa et al. 1996). This paper 
reports studies using 13-glucans and 
levamisole, another compound which acts as 
an immunostimulant of the non-specific im-
mune system in fish (Siwicki 1987 and 1989, 
Kajita et al. 1990, Jeney etal. 1994, Mulero 1998, 
Findlay and Munday 2000), as potential pro-
phylactic treatments for AGD. The informa-
tion on mortalities reported here was gath: 
ered incidentally to a major series of trials to. 
be reported elsewhere, in which the measure-
ment of disease was the extent of gill lesions. 
Materials and Methods 
Atlantic salmon of 100-200 g bouy weight 
(BW) and naïve in relation to AGD were used 
in all the trials. The major part of the study 
was based on the experimental design de- 
Bull. Eur. Ass. Fish Pathol., 20(1) 2000, 24 
scribed by Findlay and Munday (1998). In 
brief, fish which had previously experienced 
no, one or two episodes of AGO were given a 
variety of freshwater bath treatments with 
different levels of levamisole, and then re-ex-
posed to infection in the form of cohabitation 
with clinically diseased fish. Details of the 
three individual trials are given in Table 1. 
Mortalities were recorded over a four-week 
period. In a completely separate trial, fish 
were divided into three groups, each held in 
freshwater in 4000 Rathburn recirculating 
tanks. All fish were fed with commercial 
salmon feed, at the rate of 1% BW, supple-
mented as follows: 1. 8- glucans at lg/kg feed, 
commencing 31 days before exposure to AGD 
for a period of 21 days (i.e. no supplementa-
tion for the last 10 days). 2. Levamisole at 500 
mg/kg feed commencing 20 days before ex-
posure to AGD for a period of 10 days (i.e. no 
supplementation for the last 10 days). 3. Un-
supplemented salmon feed. The three groups 
were split between two tanks, acclimatized to 
seawater, and cohabited with fish with clini-
cal AGD. Mortalities due to AGD were re-
corded over a three-week period. Details of 
the group sizes used are given in Table 2. 
Mortality patterns were similar between rep-
licate tanks in individual trials, therefore the 
data for each treatment within an experiment 
were combined. Treatments were compared 
•by the chi-squared test. 
Results 
In the trials within the major integrated 
project (Table 1), it was found that both the 
use of levamisole in freshwater bath, and pre-
vious history of the fish in relation to AGD 
influenced the results (Table 1). In all in-
stances, when naïve fish (which had never 
previously experienced AGD) bathed in fresh-
water alone, were cohabited with fish with 
clinical AGD, they suffered significantly 
greater mortalities in comparison to all other 
groups, including naïve fish which were 
bathed in freshwater containing 5.0 mg / L 
levamisole (Table 1, trials 1 and 2). Because of 
the varying severity of disease induced in the 
different trials (1, 2 and 3), the other results 
were not so clear cut, but the main findings 
were: 1. Within the range of 1.25-5.0 mg / L, 
the concentration of levamisole in the fresh-
water bath did not appear to affect the out-
come (Table 1, trial 3). 2. The addition of 
levamisole to a freshwater bath appeared to 
reduce mortalities if the fish were naïve to 
AGD or had previously suffered one episode 
of AGD. (Table 1, trials 2, 3 and trial 1 with 
naïve fish groups, but not previously exposed 
groups). Levamisole had no significant effect 
if the fish had experienced two episodes of 
AGD or had experienced one episode and had 
been returned to freshwater for four weeks 
before re-exposure to AGD (table 1, trial 2). 
In contrast to the apparent efficacy of 
levamisole in freshwater baths in reducing 
mortalities, this chemotherapeutant and 
glucans given orally did not appear to pro-
vide useful protection against mortalities due 
to AGD (Table 2). 
Discussion 
As reported previously by Findlay and 
Munday (1998), the resistance developed by 
salmonids to reinfection with AGD appears 
to be due to stimulation of the fish's non-spe-
cific immune system. As both levamisole 
(Siwicki 1987 and 1989, Kajita et a/. 1990, Jeney 
etal. 1994, Mulero 1998, Findlay and Munday 
2000) and glucans (Robertson et al. 1990, Nikl 
Bull. Eur. Ass. Fish Pathol., 20(1) 2000, 25 
Trial no. Treatment 
Levamisole 
dose (mg/1) 
Total number of fish 
(two replicates) 
Total 
mortalities 
RPP% 
1 PE x 1 Lev 5.00 36 lb 97.2 
1 PE x 1 FW 0 36 lb 97.2 
1 Nal ye Lev 5.00 36 2b 94.4 
1 Nal ye Lev 0 36 83 77.8 
2 PE 4FW Lev 5.00 30 100 
2 PE4FWFW 0 30 Oc 100 
2 PE x 2 Lev 5.00 30 Oc 100 
2 PE x 2 FW 0 30 or 100 
2 PE x 1 Lev 5.00 30 2' 93.3 
2 PE x 1 FW 0 30 303 0 
2 Nal ye Lev 5.00 30 7b 76.6 
2 NaI veFW 0 30 303 0 
3 PE Lev • 5.00 36 oc 100 
3 PE Lev 2.50 31 Oc 100 
3 PE Lev 1.25 33 Or 100 
3 PE FW 34 6b 82.4 
3 Nal ve FW 40 153 62.5 
Table 1: Summary data of experimental procedures and mortalities for levamisole supplementation in 
freshwater bath treatments. ' I ' different superscript indicates a significant difference within a trial. l'E= 
previously exposed, FW= 2-3h freshwater bath only, Lev= 2-3h freshwater bath + levamisole, 4FW= 4 weeks 
in freshwater before re-exposure, RIT= relative percent protection. 
etal. 1991, Raa et 0.,1996) are capable of stimu-
lating the non-specific immune system in their 
own right, it would be logical that they would 
be useful in the treatment and prevention of 
AGD. However it appears that oral adminis-
tration of these immunomodulators is not as 
efficiouse as the use of levamisole in a fresh-
water bath, where it, presumably, acts locally 
on the gills. Unfortunately, the authors were 
unable to obtain soluble glucans preparations 
for use in baths, but an attempt to use stand-
ard preparations suggested that glucans may 
also be efficient by this route (Findlay unpub- 
lished). While these results are encouraging, 
their application in the field is not straight-
forward because farms may not know how 
many episodes of AGD their fish have been 
previously exposed to. The possibility of us-
ing levamisole during transport of smolts 
from the hatchery to their sea-cages° is. wor-
thy of consideration. In that instance, if low 
salinity, water is used as the .transport me-
dium, it would be necessary to ensure that the 
water was not sufficiently alkaline to 
hydrolyze the levamisole. 
Bull. Eur. Ass. Fish Pathol., 20(1) 2000, 26 
Treatment Total number of fish 
(two replicates) 
Total 
mortalities RPPA 
Glucans 30 11' 63.3 
Levamisole 33 - 16' 51.5 
Control 30 14a 53.3 
Table 2: Summary data of experimental procedures and mortalities for glucans and levarnisole 
supplementation in feed. 'br  different superscript indicates a significant difference. RPP= relative percent 
protection. 
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Amoebic gill disease (AGD) of mariculturod  
salmonids, =hot, Stop/Aka/mu maxima (L.), Afr 	1. 
European seabass. Dicentnirchar kbraz (L.), ancl'A41‘ifto'ltoal background 
sharpsnout scabream, Diplodar pinto:aro (Celjg eI
lc 
l,Ain. 	. gill disease (AGD) of sea caged Atlantic caused by 1Veoparamoeba pemaquidensh has li*.4  4i.1.4' 41 • .,,.,.. saIttion, Saline- solar I.., and rainbow trout, 
'Putted from Australia (Tasmania), lritn°''N.Oircorhyncino with, (Wellman)), was first described 
France, Chile, North America (Washingt, jate by Munday (1986) soon after Atlantic salmon 
and California) and Spain. Of the salmotar 
1 CIO: culture was initiated in Tasmania. The causative 
Atlantic salmon, Solmo solar L, appeantjUst.he the' amoeba was not further Identified at that time 
most susceptible with rainbow trout. leti‘io, rloinewe but subsequently Roubal, Lester & Foster (1989) inykirs ('Walbaum), also suffering signifitAnt diseasp. ascribed it to the genus Pararnorba. In the 
Only minor outbreaks have been rept ,lit*.i&o. intervening period Kent, Sawyer & Hedrick O. kinuch (Walbaum), and cbint Jl salmon, 	(1988) desaibod AGD in coho salmon, 0. ki.nrwly O. tshaurytscha (Walbaum).1'fiV44j,Seasf . now (Walltaum), in Washington State and California 
accounts for 10-20% of OA' 5ti[ooses of 	and identified the aetiological age's! as P. pensa- 
Atlantic salmon in Tasmact:la &Ads' lead to quideruir, although Page (1987) had redescrIbed 
temporary abandonment of idifit .,1,gf this species in the organism as Neopararnotba prmaquidenris The parts of Spain. It is of ltifig,41,sui! All significant. devdoprttent of immunohistochemical techniques 
importance in other cOntre.44tich is known by Howard & Carson (1993) simplified identifica- about the pathology of 'AV4but the pathophysi- tion of N. pemaquidensis and the organism was 
ology of the discase fiSVBVy*derstood. There is subsequendy identified as the cause of AGE) evidence that non-irecifie itOmunity Is involved in In Atlantic salmon in Ireland and Chile and in 
fish acquiring resisince totD, hut no unequl- chinook salmon, O. trhatoyucha (Wolhaum), in 
vocal evidence;,10talinfivii:tection as a result of New Zealand by use of the indirect fluorescent 
specific immtme respnsea. To date, for salmonids, antibody test (I PAT). 
the only ec 	eatriibt for AGE) is a freshwater Initially, the disease caused devastating losses in 
bath. Contiittifb . 	es based on modification of Tasmanian sea-caged salmonids hut the intn:glue, 
manna:11,Tc , „,..cfpcs have been minimal and tion of freshwater bathing reduced losses consider- 
virt ual4It d. 	 ably, although die financial impact was still great 
..•:,,,,, , ..1, (Munday, Foster, Roubal & Lester 1990). 
,:,.. 	 However, recent increases in stocking densities 004.4.0r, Or 8 1. Afunday, School of Slomadical 	together with sequential introductions of nave fish 
Scionoo,T 'Ay of Tasmania. Looked aagi 1420, 
Launossron, Tasmania 7260, Australia 	 (spring smolts, out-of-season smolts and pre- 
(a-maa: barr)'.mundayeutas.erataw smolts) and warm summers have coincided with 
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worrying losses and costs which now amount 	Apart from outbreaks in rainbow trout very little 
to 10-20% of production costs. Similarly. in 	AGD has been reported ,Om..Oneerhyrehtu spp. 
the warm Spanish waters AGD has made 	Despite the fact that islks ,g.7Caland produces a 
Atlantic salmon farming potentially unviable (Arlin, 	significant tonnage of salrii644 .roduct Under very 
personal communication). 	. 	• 	 similar environmental .".'8104ipistio those existing 
	
Amoebic gill disease of turbot, Scopinhalmto 	in Tasmania, only arfew mini outbreaks of AGD 
maxims (L.), was first reported by Dykova, 	have. been diagnoslit. in the chinook salmon 
Figueras & Navoa (1995), but it was nor until 	cultured in thaOhittY`OPAitstralasia. Only one 
1998 that the causative agent was identified as a 	significant oukhfreak ofigjdisease was described by 
Parameeba sp, (Dykova, Figueras, Novoa & Casal 	Kent a aL (1980)., in dte*ho salmon monitored In 
1998). The disease has also been reported in 	Washingtore4taientid'talifornia from 1985 to 
European scabass, Dicensnatinss labs= (L.), and 	1987. 1, • 
shatinnout scabream, Dipktius puntazeo 	 Amoelkgfi'disease caused by N. pemaquidnuis 
from the Mediterranean (Dylaava, Figuems & Peric 	has ootitted-iiii# problem of mann culture in 
2000; Dykova & Novoa 2001), 	 nurçb.AvecSpain since 1995 (Dykova a 4 1995. -.:• 
199804 .such problein has been reported with 
turbot culttirc in France,. although the disease is • Speoles affected and geographical 
distribution of AGO ,Ac. w.griixecl in salmonitis (Baud i n-Laurenci n, iiliedsitialt communication). Only fleeting reference 
Adantic salmon is apparently the salmonid-species betAi made to AG!) In European scabass and 
most susceptible to AG!). Outbreaks of disease itt mark .. out seabream (Dykova & Novoa 2001). 
this species have been reported from Tasman 	The only report of amoebae consistent with 
(Munday, Lange, Foster, Lester & Handl ' 	Nfthparamtleba on wild fish was that of Foster 
199.3), Ireland (Rodger & McArcile 1996; P Ina; 	Pcrcival (1988b) who observed the organisms on 
Carson, Ruttledge, Drinan & Wagner ..et 	.the gills of immature couta, Thynita attat 
France (Findlay & Munday . 1998), Chile ow&V (Euphrasen), in the vicinity of infected salmonids 
2001a), Spain (Rodger & McArdle 	, Aran, 	in Tasmania. Red cad,' Pieudophyass baehus 
personal communication) and Wathiron Sra, 	(Forams), jack mackerel, Ttorbstass dedivir (lenyns), 
USA (Douglas-Helders, Saksida, Raver 	rilc " 	Tasmanian blenny, Piaiblentrins tannaniansss 
2001). The disease has not 	 rom 	(Richardson), and sand flathead, Phoyorphatur 
Canada, Iceland, Scotland or 	rtly, pOtably 	bassenth (Cuvier), caught in the vicinity of, and 
because the water temperaturestroa ty lower 	remote from, sea cages have nor been found to have 
at these locations. In some int:stslcx.almonid 	amoebae on their gills . (Dawson 1999; Nowak 
species cultured alonpidelT i4t4t1 01 	in/112001h; Munday & Woodworth, unpublished 
the areas where AGD,4e, 	have not 	observations). However, it has proven .possible to 
had clinical AGD or nsidered of 	 experimentally produce gill infection, but not 
AG I), with N. pemaquidetnis in greenback flounder. 
• Rhombosokta tapirina (Gunther), and big-bellied . 
Rainbow trout d. T mita su ffered severe 	seahorses, Hippo campus abdorninalit (Lesson) 
disease because of ' 1. 	Infection and 	(Nowak, Douglas-Helders & Dawson 2000). 
that, together 	 temperatures, 
has 	h . limited tilrotltphon of 'ocean trout' in 
Tasmania. 	France 'high water temperatures 
have been,,,40Asnotrffrequent limiting factor 	Peak mortalities in Atlantic salmon sntolts In 
with this 	(Baudin-Laurencin, Aldrin, 	Tasmania have been 10% per week with losses of 
Messages.4caidaint 1985) although AGD has 	2-4% per week in fish weighing 1-2 kg and 1-2% 
occurKeAntradically (Baudin-Laurencin, personal 	per week in fish over 2 kg (Foster & Percival 
1988b). 
,fa-cagedts,h.rown trout, S. moo L., are only 	Clinical signs of lethargy and respiratory distress 
cultdie4p,)lgnificant extent in France and AGD— manifested as rising to the surface of the water and 
has been diagnosed in that species. (Baudin- 	increased rate of operculat movement have been 
Laurencin, personal communication). 	 described in salmonids by Kent a rti (1988), 
minor importance (F. Autlitil-Lauien. cin, personal • 
communication) 
Clinical and pathological features 
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Figure 1 Lien amoebic gill dirsase infection In an Atlantic 
salmon. Mows point to small, dkeeete patches typical of the 
disease. 
Figura 3 Photoinicrograph of amoebir gill disease showing 
lamella, fusion and the pa-tenet of amoebae which are 0111y 
identIWIc hy,their shape (.18r F. bar 100 Pm). 
Nato 2 I leery amoebk gill disease infection In an Atlantic 
salmon. Some patches have coalesced 
kq4„.* Munday a at (1990) and R3I &Ardle 
(1996). However, inexpainitiial* 41 .. .e 
Fisk & Nowak (2000) wercAnab , to crfi that n rin 
• AGD,infected fish accu.14a measurable 
increase in ventilation4tr gg In Atlantic 
salmon macroscopic le41bs4l e Mlnlly multifocal 
patthes of white to gmi olJMen  gill tissue with 
associated excess 94'61 8c 2) (Munday 
a la 1990; Rodg4& McAllc 1996): These are 
most numemus ,m.; portions of the gill 
arch (Adams :AO; *his & Nowak 2001). In 
rainbow trott, the 4coid 'branchitis is more 
diffuse. HiscopedninOil descriptions of the disease 
in salmonicli,'J.410 .. ..Iiiibot have been remarkably 
similar..,Ki0v,..4te . 41iitin lesion being hyperplasia and 
hyperc010.!-Af. the gill epithelium (Fig,. 3) (Kent 
a at )98...X1Iiihday a at 1990; Dykova et al. 
19.9,5„; Rodgalk McArdle 1996; Zilberg & Munday 
2000):1144tralar fusion is also prominent often__ 
leading to the formation of cystic spaces -(Fig. 4). In 
particular, the description of the experimental 
Figure 4 Photomicrograph of amoebic gni disease showing a 
cyst formed as a result of lamdiar Anion. Note staining or 
amocb*e which makes them more readily klenitriable 
(PAS/Alcisn blue, bar c 25 sun), 
disease by Zilbcrg & Munday (2000) provides 
information on the sequential development or 
lesions and will bc paraphrased here. At 2 days 
after exposure to AGD-infecied fish Neoparermoeba 
could be seen on the gills, which were otherwise 
normal. Ily 4 days post-.exposure (DPE) multifocal 
hyperplasia and lamdlar fusion was present and this 
involved up to 15 gill lamellae per focus by 7 DPE. 
At that time the epithelial cells were both hyper-
plastic and hypernophic and the tissues were 
spongiotic. Neoparamoeba became more abundant, 
associated mainly with the hyperplastic epithelium 
and, in NOM instances, were sloughed off with 
hyperplastic tissue. This 'self-cleansing' action may 
be important in both natural and iatrogcnic 
recovery from the disease. Also, a marked increase 
in mucous ails was noted. At 28 DPE epithelial 
hyperplasia and lamellar fusion was extensive with 
numerous associated Neniaramorbet sp. (Pig. 5). 
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Hgarc 5 PhotornitrogrAph of amoebic gill disease rhowing 
amoebae staining the tame or the gill thaw. (H&E. 
bar 25 pm). 
Journal of Flab Dlooasea 2001, 21. 000.000 	B L Monday et al. Neopanmoeba ranaquidetult and gill Aram iff rnitrifir fid, 
ore recently. Wong fic Elliot 2000) and Elliott, 
Wong & Carson (2001)„4Mvc..developed a PCR 
which identifies N. pentiOsietertis with great spec-
ificity. This assay was dcvereekd.afier the complete 
18S rDNA gene seqp*ei'iVis.filAained for the type 
N. pemagesidentis ad icien0fies the organisms 
recovered from AGIof salMnnids in Australia, 
Irdanc1 and Washington Siiie end turbot in Spain 
as being iden'Oeal. Th salmonid isolates were 
shown to shai -08-9914'sequence similarity over 
2104 base 1,'Itirs..plihel'aS rDNA gene (Elliott a at 
2001). .I.g•w4; :.ax,.thc American and Spanish 
organisniV4Arvive in much lower salinities than 
the sky4esdiaiil)ttlemagisidensis it appears that the 
d istinguish between biovars . with 
diffaiiitAysiological characteristics. Also, Dykova 
Other authors noted the development of interla- ci at (2066Avere unablc.to distinguish six strains of 
metier vesicles often containing amoebae and .„permaquidensis from fish with AG!) from the 
inflammatory infiltrates in the supporting tissues ,/lyitetti:.4in of N. oestuarista by electron microscopy. 
(Munday a t 1990; Adams & Nowak 2001). Anuiiksac freshly removed from infected gills 
Severely affected fish have been shown to ha tss subsPherical (15-40 pm diameter), trans-
longer ventricles in comparison with their .ventrg: „tion,al forms with up to 50 digitate pseudopodia 
ulat width or height compared with minirntily..4r (. t a at 1988; Munday a nt 1990; Rodger 
affected fish (Powell & Nowak - 2001)./ithis'....F4eMcArdle 1996; Dykova a al. 1998) (Pig. (,). 
macroscopic change is accompanied by th: {1, The organisms possess a nucleus 5 pm diem- 
of the compact ventricular muscle. 	 eter) and one or more parasomes 	4 pm). The 
	
The crucial metabolic perturbational' cstied 	latter have been identified as the symblont Perkin- 
with AGD are still unclear. Munday at (199 . ) 	sena amoebae (Dykova et. at 2000). 
reported elevated blood sodium levels 	Y 	Roth Munclay it at (1990) and Dykova es at 
affected fish and Powell it at a 	(1995) described the amoebae in histological 4410Q.),I: 
respiratory acidosis, but in bo t, iian  the! 	sections as being vacuolated and frequently closely 
' 	-  
abnormalities were nor widesgr,f, ..tanstreevere 	adherent to the gill eptlidium, an observation 
enough to explain the clinicaliVO4,7kv 	confirmed by electron microscopy (Roubal a at 
More recently Powell 807tio 	a601) have 	1989). 
found that affected fish alerA 	lye and this 	These gill-associated N. pemaqsadensis have been 
condition is anw1Iorat?:1Jtcr bathing, 	grown on lawns of Ill1111C111115. bacterial species On 
This effect on the attotlaesystirn is perhaps 
comparable with !be lattkation in bacterial 
gill disease where0460s 'produce vascular 
constriction (Byrnei . Osdantry Lumsden, Mac.Phee 
& Ferguson 199). -Pe,.,‘,„. 
The aetIolealcal anent 
Kent ad (4911.1. )aid Foster 8c Percival (1988b) 
rell(m0414atAseiisative agent was a Paramoeba 
sp•, KoVitidy.„, A . ptmoquidensis. Subsequently. 
liowardApson developed a polyclonal antibody 
agatst a 1 iOanian isolate of the agent and this 
i 	 a 
reaCtedixisk.ilte agents present In Ireland (Rodger- 	 tsetis:4 
& 	 MeArdl 1996), New Zealand nd Prance with arc 6:0)1;1:Tine preteh nCer grofit 
 P
nill"tiolivedi: n4n thbace a 
cr. Howard & J. Carson, personal communication). 	Is dlagnortie (utns.tained, br 30 pm). 
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from the problem that amoebae can be difficult to 
differentiate from gill epittelial cells and typical 
amothoid shapes arc rareli„SeFig in smears from fish 
which have been dead for 'dir44sime (Monday a at 
1993). In experiment0 . 18tection'ii'histology reveals 
amoebae attached 4-Ithe gill ie,pithelium at 2 days 
after exposure and tls gbg: ,earliest any method 
confirms the infe,01thg,(Zill4rg & Munday 2000). 
pre4Ofict of amoebae can be 
Maiticast—sta water agar by a number of workers 
(Kent a al 1988; Munday a al 1990; Dykova 
a al. 1998). Attempts to produce AGD with 
cultured organisms have been uniformly unsuccess-
ful (Kern a al 1988; Howard, Carson & Lewis 
1993; Findlay 2001) and this has orily be achieved 
by cohabiting naive fish with infected fish 
(Howard et at 1993; Alehlashi, Munday, Rough 
& Whittington 1996; Findlay 2001) or by exposing 
them to isolated, gill-associated N panaquldemis 	better appreci 	by tiaining with l'AS/Alcian 
(Zithers, Gross & Munday 2001). 	11111blue (Pigs4ti4'5-LAIi5 not unusual for other 
	
Very few detailed studies have been undertaken 	protozoa,Pdodibtesther genera of amochae, to be 
on the organisms to identify possible virulence 	present ititnigd infections with N. pemaquidauir 
factors. The presence of extracellular products is 	(MunAarfr g11)93; Dykova & Novoa 2001). 
assumed but has not been demonstrated_ A galac- 	1iJ IPS and dot-blot techniques have been 
tose-specific lectin has been found In cultured 	deviii544 for diagnosis of N. pemaquitlemit 
11111N. pcmaquidouis (Cane, personal communication) 	infirotionMising polyclonal antiscra against the 
and could he involved in expression of pathogen- 	ogen. However, the IFAT does not give a 
icity. Also, Dykova a at (2000) noted that the e result until 7 Dm:, (Zilherg & Munday 
number of N. pcmaquitlerstis with fully developed 4:1...,..,3000) 1--nd the dot-blot cross-reacts with N 
P. amoebae decreased as the cultures aged suggest; 	'dirts4 ;sill and Pteadoparamorba pagri (bourlas- 
that the metabolic state of the Neoparamoeba ;- changed. 
214. 
In the first instance it is important tolist'4:::::Ohl 
4 	'4hle 
between AGI) and the presence of N p aguidei  
with no or inconsequential gill .pat 	k.-43..Stt 
aquaculturist the former is the p 	cfliknosis 
whereas clinicians and, pardcularly kgs 	.ard have 
an interest in both these aspcp5JP. bgosis. In 
some instances diagnosis o( tively 
simple but at other times, *cMth mt discaset, 
differential diagnosis de 
and balanced considerkg 
observations. 
On-farm diagnosis .A 	salmon is usually 
by counting the triklcil h dna patches on the 
gills (Alexander 1901) (Fig. 1.  White this has been 
shown to 'be- hig)y'çsd with the presence of 
N. pemaquitl i  experimental infections 
(Zilberg & 4unday 10 00; Findlay 2001), the 
association,,,,i,f51kcktn4A nt in the field (Clark 
& Nowak —199A' Also, this technique is nor 
applicalko.ltairtlaiv trout (MUnday et al. 1990) 
or tuclkni-OxItova & Novoa 2001). 
The iiitIserti44161 presumptive N pemaquidensit 
cakke con tif0 ed by examining wet mounts oaken 
fronant igilh (Fig. 6), staining with Quick Dip! 
1/11(Fronine *Pry Ltd) (Zilberg, Nowak, Carson 
& Wagner 1999) or histology. The former suffers 
Diagnosis 
na proper 
factors and 
rs, Carson, Nowak & Wagner 2000; 
r11,0Iiglas-Heldcrs,. Carson, Howard & Nowak 
400. A specific PCP has been developed (Wang 
& Elliott 2000; Elliott a at 2001) and Is suitable 
for use with fish gills, sea water and biofouling. 
Pathogenesis 
• 
It is apparent from the studies of Zingers & Munday 
(2000) that N. Nato. quidemis is capable of colon-
izing the normal gill epithelium, probably by 
virtue of a lectintglycoconjugate bond. It is likely 
that the glycoconjugate is galactose or Ai-acetyl-
galactossmine (Findlay 2001), At Padilla-Vaal, 
Ankri, Bracha, Koolc & Mirelman (1999) have 
shown that the glycoconjupte profile of the 
bacteria used as the nutritional lawn for cultured 
Entamaba histolytini Is crucial in deciding if the 
organism is to be pathogenic or not, similar studies 
arc warranted for N. peradquidentit. This mechan-
ism may also be involved in the apparent 
preference. of N. pemaquieleasit for hyperplastic gill 
epithelium (Munday a a 1990; Nowak & 
Monday 1994; Dykova . a at 1995). Indeed, a 
vicious cycle seems to develop whereby the infection 
.leads to the production of hyperplastIc gill 
epithelium which attracts more amoebae and so 
on until the fish dies, immunity intervenes and/or 
the environmental conditions become less suitable 
for the pathogen. This will be discussed further 
under 'Epidemiology'. 
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Bpidamlology 	 1998). However, this is o ily relative and can be overcome by excessive challenge. Sexually mature 
The epidemiology of AGD will be discussed 	fish appear to' be mOe fissuptible, whereas 
according to parasite, host and environmental 	so-called 'pinheads' have felkIlecions than normal 
Variables. 	 fish in the same cagaqlstfelA 2001; Percival, 
personal communicon). 
The Minor hyperplasik,..,,lesio* 	Elle gills art parasite associated with parlitii ciiate in severity of AGI) 
There is some evidence from experimental studies 	(Nowak & /viiinday 94; Zilberg & Monday 
that N. pentaquideatit becomes more virulent with 	2000) but arelikobahlr h'or significant in deciding 
sequential passage through nahte hosts (Findlay, 	the cvsentualfgal!tairteillowevcr, severe gill lesions 
Zilherg & Munday 2000). This may have profound 	ressilting,0m341Ylish damage and clubbing and 
implications for current husbandry in Tasmania 	neerotic'illOyndrome are sometimes rapidly 
where pre-smolts (conditioned in brackish water), 	colonixed. 	N,f4tniaquisietuis with drastic consc- 
spring smolts and out-of-season smolts are sequen- 	quep (0:Handlinger. personal communication). 
daily introduced onto farms. 
• The main source of infective organisms is 
undoubtedly infected fish. Zilberg 	al (2,001) Enisonmert vi
have shown that the minimum infecdous dose for -4t.'7.4h44ett consistent association for clinical AGD is .:41. 	.. . 
Adantic salmon is about 230 N. pemaquielouit L'-'. ft:.ith 	 er temperature (coupled with the appro.. 
When it is realized that a single amok with ACP' . xiiiiitselitlinity). In general, outbreaks in saltnonick (3-`‘ 	,  may be carrying between several hundred thou rtd ,i,;Thave•4, - only occurred am water temperatures of 
to a few million amoebae; the .danger posed . h 	' 1;420 °C (Kent et al 1988; Monday ef 4 1990; 
cage of infected fish can be appreciated. Eve ger & McArdlc 1996), although amoebae can 
fish carry live N. pemaguidentis for up - to.A 4axics be found on the gills at 10 °C (Munday et al 1990) 
postmortem (Douglas-Helders, Nowalc,:tilbeilt• and Clark & Nowak (1999) and Douglas-liclders 
& Carson 2000; .Dykova & Novas 29 ltsoAse : et a/ (2001) reported AGI) In Atlantic salmon at 
danger does not cease with the demise.. 1 the fii.  : water temperatures in the range 9.1-10.6 °C. In 
Poster & Percival (1988b) rept7i ... - -sttsg,.0,to . experimental infections the disease can he effectively 
nets but not fouled nets suppo# ploggi of manipulated within a range of 12-14 °C (Findlay 
amoebae and this has essentially bet.p.Mhfirofed by 1 2001) but at 16-18 °C k tsastAl be very difficult to 
Teti, Nowak & Hodson (2009140*Ommu- . control (Althlaghi re 4 1996; Munday. unpub-
nication) who found that cyfitii#fed with halted observations). Dre'AGI) was recorded - in 
copper-based antifoulants sutikor# niSic Neopar-1 turbot at maximum trmpetatures ranging from 14 
amoeba than untreated ne*.lilitskuled nets • do to 18.8 °C (Dyknva et al. 1998). 
not appear to constnum. b i *f II reservoir of 	The situation in relation to salinity is intriguing. 
infection. 	,::-, 	• All reported long-term Infections in salmonids have 
There is some evid l''It,more severe AGI) ' been associated with high salinity (a 32%„) sea 
is associated with ige iltili.,coDints or chlorophyll 	water (Clark & Nowak 1999; Foster & Percival 
levels- in the wter colUiin (Nowak 2001b; 	1988b; Munday it al 1990; Rodger & McArdlc 
S. Percival, personaherrtsilcation). 	1996; Zilberg De Munday, unpublished observe- 
S. -  
4•
,,
•
i- 
	•441. 	 tions). -In contrast, AGD in turbot has occurred at a :::,, constant salinity of 22%„, a salinity at which 
The hen 	'.:t».. 	i:L.fi 
■ 'i•'' ' . ' . ", 	 7!' 	 amoebae disappear from the gills of infected As mentionW„mA4 'Species affected and geo- 	rainbow trout within 24 h (Monday & Houle, 
81-aPhicf.141)Mibuiletit of AGD' Atlantic salmon and 	unpublished observations). 
rainboili64,5„appeat to be the most susceptible 
salmork;.-084 is good field and experimental 
evittence thatHn previously exposed fish acquire a Treatment 
. , ..1,.,... 	P t• degrce,of,rmistance to re-infection after freshwater_ Foster & Percival (1988a) were the first to 
bathing (P6itcr & Percival 1988a; Findlay, Helders, 	document the efficacy of freshwater baths in the 
Monday & Gurney 1995; Findlay 8r Monday 	treatment of salmonid AC!.). They recommended a 
carif 
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Table I In vivo Ittatifitin found 4* 
ineffective SgAinst smut:411dt 
,J44 
Journal of Fish Moans 2001, 21, 000-400 	A L Monday et t1. Neopernmectu renutquIdensie mul gill Agate in marine fuh 
bath of 2-6 h duration with dose to zero salinity 
water. Thcy also emphasized the need for gentle 
handling of the fish, the need to maintain high 
levels of dissolved oxygen and the hazards of water 
with high iron content or gas supercaturation. 
Cameron (1993) further qualified the data relating 
to salinity and suggested that salinities greater than 
4L were associated with unsatisfactory control of 
IMAGD. More recently, Powell (personal communi-
cation) has found that N. pemagaidettair survives 
better in water rich in CaCl2 and/or MgC12. 
Munday .et al (1990) suggested that freshwater 
baths had three effects: 
1.To reduce the number of amoebae on the gills. 
2.To remove sea water-stable mucus from the gills. 
3. To reduce any hypernatraemia which may have 
developed. 
& Nowak 2001). It is probable, but unproven, that 
the replacement fillICUR i,ijiiC1.1 in such immune 
	
irtl 	• components as lysozymekchle  t... 1 p in i h'b' it recol-
onization of the gills by :it:Wei/yr/den -sir. 
As only severely affeatPfisli -have hypernatra- .y:' 	.'.‹. 	• . emia (Findlay 2001)ereversat o.,:trs u change is likely 
to be of only minorlinporwict . 
A large numIrfAtiltreitnients other than fresh-
water have beettitrlalleOn vivo and in vireo, but RS 
there has not iteFit uniirersa/ correlation between 
these only,.efie s;i1Miltaitudies will he considered 
here. Tillie 1 iit'eavides documentation on the . 	.„ 	.. 
treatmerftfilythlth have been tried and found to be 
ineffczpiT .in "(141gYing diniad AGI) at the concen-
tratii/dtite nues -used. The only compounds 
foutialolitate to influence pre-exisling Acr) have 
been naiiiiin [(4S)-4-methylsalinontycin)) and 
viable after normal on-farm freshwater baths 	AGD gill lesions but there were palatability 
reagent grade freshwater, more recent studies have '.7‘,..CartitIron (1992) reported that narasin fed at 
shown that up to 27% of the amoebae remqi 41444 of 50-60 mg kg-' hodywcight fin 7 days 
N pemaquidentit was inactivated by exposure to e:71.13)4Attiatole). 
Although Howard & Carson (1993) found that . .kvotisole 11-2,3,5,6-tetrallydro-6-phenyimadazet 
these organisms are capable of initiating rum Ilems and the trials were not persisted with. 
AGD under experimental conditions 	ark, 	Cnicron (1992) also Mailed oral lcvamisolc 
Nowak & Powell 2000; Findlay 2001: ,F,*; 	(15 mg kg"' bodyweight every third day for 
Powell, Fisk & Nowak 2001). Thus, Willi 4' . 0 	.4.g 15 days) without benefit for infected fish. In 
amoebae on thc gills seems to bç 6f lqser 	contrast, Findlay et al (2000) found that 
importance in comparison with returitrug the glI 	1.25-5 p.p.m. levamisole in freshwater for 2-3 h 
epithelium to normality as a result of trek/4Q qr,3' , ' 	significantly augmented the effiatcy of the freshwa- 
Removal of mucus from the gillOceeetts 	an 	ter bath, especially in fish that had been in the sea 
important function of a fresh4tOntOhis 
	for a short period and had only limited exposure to 
process removes amoebae mv..4,4.0111140Sanner 	Neoparatnoeba. Based on studies by Akblaglti et aL 
similar to natural exfoliation (glItiptee(Zilherg 
	(1996), Findlay 8t Munday (2000) and Zilberg 
& Munday 2000) and 	slate term it 	& Munday (unpublished observations) it is 
potentially alleviates the phkqeiiikt I :perturbations 	presumed that levamisole acts by stimulating the 
produced by AGI) (Pos,imi*# .2000; Powell 	non-specific immune system. However, Clark 
Akot 
Typo of treatment 
	Specific agent used lot treatment 
Antimiotobials 	Albondazolo (0). emprollum (o). lumagillin (o), ppm) (o). 
malachite green (b). mebondazolo (b). rnstranidazoie (o), 
quinectine (b, o), Romelatimethoprim (0). lottraziell (b), 
Inciabendazole (0). B-hyclroxycannnions (0) 
Detergents 	towel 15 (b), LWA 1570 (0), 'won 20 (b) 
Disinfectants 	Copper sulphate (b), cobbled copper (b), ohloromine T (b). 
formatin (b). hydrogen peroxide (b), potassium 
permanganate (b) 
MuColytic 	 r-cyeteine elhO 0010r (0) 
b itbath (44do1 to eta wotcs). o nod. Sauna erinformedum Aleunder (1991). Celneudi ($991, 
1993), Feuer at Perrin! (1968a), Monday ft (1993), 7111xts er Monday (unpuhilated 
elnetvationa). 
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Journal of Fish Diseases 2001. U. 000-000 	DL Munch), et al. Nroparsmodu pv1,4'0((1155 and gill flume in nntrInt fish 
& Nowak (1999) were Unable to detect a beneficial 	Corsohaslons 	v.'.. 
effect of levamisole under field conditions Which 
emphasizes the strict criteria which must be met for 	AG!) of salmonids atuseflby.f prmaquidenrir is a 
this immunomodulator to exert a beneficial effect 	major constraint on selliiitnicl mariculuire In 
'Preliminary trials With higher doses oflevarnis. ole in 	Tasmania and Spain..leikelso,i'aiuse of intermit- 
sea water adjusted to pH 7 with citric acid have 	rent, serious diseaselil Atlaniik salmon In Ireland, 
yielded promising results by returning the gill 	Prance and North klikerica...Tfie economic impact 
been noted (Munday & Zilberg, unpublished 	is not well-dOument4 but the potential for 
. 	- 	, 
epithelium to normal, although some toxicity has 	of AGD on the.tOrbtiondittry in southern Purope 
observations). It is also possible that the increase 	significant morkidity anti:mortality is apparent. • 
in gill mucous cell numbers reported by Morrison. 	For saltirksiOitailiient by freshwater baths is 
Nowak & Carson (2001) may play a role in the 	the only jtisiwepierepy but is stressful on the fish 
therapeutic effect of levamisole. 	 and forlotuel operators can impose substantial 
	
Chlorine dioxide and chloramine T added to 	manateritit aritl(financial imposts. In view of the 
freshwater baths increase the amoebacidal capacity 	relaq§ly .;litw salinity at which AGI) occurs in 
of the baths (Powell & Clark 2001), but the effect 	ru rliikipti doubtful if freshwater bathing will prove 
was variable depending on water quality and 	to be as siodessfiti as with salmonids. 
toxicity occurred at 50 p.p.m. for each chemical. 	. , i It.tsearch to date has nor shown that immunize- 
Whether or nor these treatments lead to a greater kionlijilcely to be an useful prophylactic measure 
cure rate of the disease has not yet been deter- ef!..111thou# the use of extracellular products (ECP) as 
mined. 	 .4. Vriligiii has not been explored. , g ip. There is a great lack of information relating to 
Control 	tlifffects of such managerial practices as keeping a 
number of classes of fish at one site and increasing 
To date control of AG!) of salmonids in TAW* . 	overall stocking levels at individual sites. 
has revolved mainly around the riming of . '': watt,PP.i.,, 	If control is to be achieved then a number of areas 
baths, some of which arc regarded as Oil 'ylatilic 	of research need to be investigated. These inchicie: 
but are more likely to be countte4produatte ' I. Resistance and immune factors 
Pouglas.Helders, Nowak & Oarsoft226011.„.A0ie 	(I) It is anomalous that very little Is known 
farmers avoid the problem entirel 'itr arially by 	about the effects, if any, of a freshwater bath on 
utilizing low salinity sites for all4 rtif the 	the immune status of salmonids with AG!). 
marine culture phase. 	 ,::.0" 	Studies to elucidate this may well provide Atif 
To date the Ta mania .4ndUsy, as kept 	information which will enable better - use of 
multiple classes of stock ( 	molts, out-of- 	immunotnodulators. 
season smolts, etc.) on a 5 	Itd, although 	(ii) Research on possible immune responses to 
no objective data arek 	blt:the apparent 	RCP could lead to development of pmtective 
increase in virulence IA" p. einig. uiriensit with 	vaccines — something which has been elusive to 
serial passage underNkrt ,.ntal conditions sug- 	date. 
gem that' all-in allkiiii -if tiles may be more 	(iii) Identification of lectin/recepior complexes 
desirable. SimilarlYZincreas Isiomass at Individual 	responsible for N. peoraquidraris colonizing the 
lease sites inevitalityi,,ere 	distances between 	gills could lead to the production of vaccines v- • 
cages and the.tebj malkT transfer of infection from 	targeting key•lectins involved in adherence. 
()ages with ellkically drecced fish to other cages 	(iv) As has been accomplished for other diseases 
more likely,:: 01140 011y, the effects of manage- 	there could he selection for resistance to AGE). 
ment strittegi'kik.'ilie occurrence and severity of 	The present system of using cver-incrcajing 
AGD witInquirtifitore intensive investigation in 	numbers of freshwater baths ensures th 11- 
d1C flghIst . '4u, 	 tinued susceptibility of the salinonid stock  
Altliiiiightliiiieok salmon are more difficult to 	(v) The apparent, inherent resistance of chinook 
culi,re than'tAtlantic 'salmon and rainbow trout 	salmon to AG!) needs to be scientifically tested. g - 
tieràu1dcmerir in having at least a proportion-. 	2. Parasite factors 
of these. TWsii at a site If their apparent, relative 	(i) More research is required to identify differ- 
resistance to ACID can . be confirmed. 	 ences (apart from pathogenicity) between 'wild' 
ID 2001 
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B-I. Monday et al. Neoparamoelo pemaquidensis and gill Am, M marine fhb 
and cultured N pow:fallen:is especially as such 
uncial procedures such as serology and PCR are 
based on cultured organism. 
(ii) More studies arc required to understand 
salinity preferences of various strains of N penta-
quitictitit. Indeed, it is essential that historic and 
contemporary isolates art compared because it is 
possible that amoebae regularly exposed to 
freshwater may become tolerant of low salinities. 
3. Management factors 
6) The effects of introducing sequential popu-
lations of naïve fish onto a single production site 
needs to he monitored. 
who provided unpublished or yet-io-bepblished 
information for this review. 	 4•kl. 
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